{
  "Record": {
    "RecordType": "CID",
    "RecordNumber": 3345,
    "RecordTitle": "Fentanyl",
    "Section": [
      {
        "TOCHeading": "Structures",
        "Description": "Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.",
        "Section": [
          {
            "TOCHeading": "2D Structure",
            "Description": "A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ",
            "URL": "https://doi.org/10.1186/s13321-018-0293-8",
            "DisplayControls": {
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 136,
                "Value": {
                  "Boolean": [
                    true
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "3D Conformer",
            "Description": "A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.",
            "URL": "https://doi.org/10.1186/1758-2946-5-1",
            "DisplayControls": {
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 136,
                "Description": "Fentanyl",
                "Value": {
                  "Number": [
                    3345
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Crystal Structures",
            "Description": "This section provides links to crystallographic information from various sources.",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "Subsections",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "MoveToTop": true,
              "ShowAtMost": 1
            },
            "Section": [
              {
                "TOCHeading": "CCDC Number",
                "Description": "A 6- or 7-digit-long numeric identifier assigned to the crystal structure in the Cambridge Crystallographic Data Centre (CCDC).",
                "URL": "https://www.ccdc.cam.ac.uk",
                "Information": [
                  {
                    "ReferenceNumber": 124,
                    "Name": "CCDC Number",
                    "URL": "http://doi.org/10.5517/ccs2072",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "716913"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "COD Number",
                "Description": "An identifier assigned to the crystal structure in the Crystallography Open Database (COD).",
                "URL": "https://www.crystallography.net/cod",
                "DisplayControls": {
                  "ListType": "Columns"
                },
                "Information": [
                  {
                    "ReferenceNumber": 10,
                    "Name": "COD Number",
                    "URL": "https://www.crystallography.net/cod/1551786.html",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "1551786"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Associated Article",
                "Description": "Publication associated with the crystal structure of the compound. Typically it is the paper in which the crystal structure was originally reported.",
                "Information": [
                  {
                    "ReferenceNumber": 10,
                    "Name": "Associated Article",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "OGAWA, Noriko; NAGASE, Hiromasa; ENDO, Tomohiro; LOFTSSON, Thorsteinn; UEDA, Haruhisa. Crystal Structure of Fentanyl Base. X-ray Structure Analysis Online 2009;25:83-. DOI: 10.2116/xraystruct.25.83",
                          "Markup": [
                            {
                              "Start": 173,
                              "Length": 39,
                              "URL": "http://doi.org/10.2116/xraystruct.25.83"
                            },
                            {
                              "Start": 108,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 124,
                    "Name": "Associated Article",
                    "Reference": [
                      "doi:10.2116/xraystruct.25.83"
                    ],
                    "URL": "http://doi.org/10.2116/xraystruct.25.83",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DOI:10.2116/xraystruct.25.83"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Crystal Structure Data",
                "Description": "Information about this crystal structure record.",
                "Information": [
                  {
                    "ReferenceNumber": 10,
                    "Name": "Crystal Structure Depiction",
                    "URL": "https://www.crystallography.net/cod/1551786.html",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/30594906_1"
                      ],
                      "MimeType": "image/png"
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "Hermann-Mauguin space group symbol",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "P 1 21/n 1"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "Hall space group symbol",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "-P 2yn"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "Space group number",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "14"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "a",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "5.69263"
                        }
                      ],
                      "Unit": "Å"
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "b",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "25.1851"
                        }
                      ],
                      "Unit": "Å"
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "c",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "13.8608"
                        }
                      ],
                      "Unit": "Å"
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "α",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "90.0000"
                        }
                      ],
                      "Unit": "°"
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "β",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "104.2037"
                        }
                      ],
                      "Unit": "°"
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "γ",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "90.0000"
                        }
                      ],
                      "Unit": "°"
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "Z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "4"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 10,
                    "Name": "Z'",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "1"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 124,
                    "Name": "Crystal Structure Data",
                    "Reference": [
                      "doi:10.5517/ccs2072"
                    ],
                    "URL": "http://doi.org/10.5517/ccs2072",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DOI:10.5517/ccs2072"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 124,
                    "Name": "Crystal Structure Depiction",
                    "URL": "http://doi.org/10.5517/ccs2072",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/3364305_1"
                      ],
                      "MimeType": "image/png"
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Chemical Safety",
        "Description": "Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.",
        "DisplayControls": {
          "HideThisSection": true,
          "MoveToTop": true
        },
        "Information": [
          {
            "ReferenceNumber": 136,
            "Name": "Chemical Safety",
            "Value": {
              "StringWithMarkup": [
                {
                  "String": "          ",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 1,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS06.svg",
                      "Type": "Icon",
                      "Extra": "Acute Toxic"
                    },
                    {
                      "Start": 1,
                      "Length": 1,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg",
                      "Type": "Icon",
                      "Extra": "Irritant"
                    },
                    {
                      "Start": 2,
                      "Length": 1,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg",
                      "Type": "Icon",
                      "Extra": "Health Hazard"
                    }
                  ]
                }
              ]
            }
          }
        ]
      },
      {
        "TOCHeading": "Names and Identifiers",
        "Description": "Chemical names, synonyms, identifiers, and descriptors.",
        "Section": [
          {
            "TOCHeading": "Record Description",
            "Description": "Summary Information",
            "DisplayControls": {
              "HideThisSection": true,
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 3,
                "Name": "Record Description",
                "Description": "Ontology Summary",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is a monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid. It has a role as an opioid analgesic, a mu-opioid receptor agonist, an anaesthesia adjuvant, an intravenous anaesthetic, an adjuvant and an anaesthetic. It is a member of piperidines, an anilide and a monocarboxylic acid amide.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 106,
                          "Length": 43,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/N-phenyl-1-%282-phenylethyl%29piperidin-4-amine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-88890"
                        },
                        {
                          "Start": 155,
                          "Length": 14,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/propanoic%20acid",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-20746924"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 14,
                "Description": "DEA drug/substance description",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence. It is a Opiates substance.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 15,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia. Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia. Fentanyl is related to other opioids like [morphine] and [oxycodone].  Fentanyl's high potency has also made it a common adulterant in illicit drugs, especially heroin. In 2017, 47600 overdose deaths in the United States involved some opioid (over 2/3 of all overdose deaths). Opioid overdoses kill an average of 11 Canadians daily.  Fentanyl was FDA approved in 1968.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 143,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 216,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 259,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 274,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxycodone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284603"
                        },
                        {
                          "Start": 287,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 377,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5462328"
                        },
                        {
                          "Start": 550,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 57,
                "Description": "FDA Pharmacology Summary",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is an Opioid Agonist. The mechanism of action of fentanyl is as a Full Opioid Agonist.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 58,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 98,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is a synthetic, lipophilic phenylpiperidine opioid agonist with analgesic and anesthetic properties. Fentanyl selectively binds to and activates the mu-receptor in the central nervous system (CNS) thereby mimicking the effects of endogenous opiates. Activation of the mu-subtype opioid receptor stimulates the exchange of GTP for GDP on the G-protein complex and subsequently inhibits adenylate cyclase. This causes a decrease in intracellular cAMP which inhibits cAMP-mediated calcium influx into the cell via the calcium channels and thereby results in hyperpolarization and reduced neuronal excitability.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 36,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/phenylpiperidine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-20038"
                        },
                        {
                          "Start": 110,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 331,
                          "Length": 3,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/GTP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-135398633"
                        },
                        {
                          "Start": 394,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/adenylate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6083"
                        },
                        {
                          "Start": 453,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6076"
                        },
                        {
                          "Start": 473,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6076"
                        },
                        {
                          "Start": 487,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Calcium",
                          "Type": "PubChem Internal Link",
                          "Extra": "Element-Calcium"
                        },
                        {
                          "Start": 524,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Calcium",
                          "Type": "PubChem Internal Link",
                          "Extra": "Element-Calcium"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 113,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 6 approved and 38 investigational indications. This drug has a black box warning from the FDA.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/FENTANYL",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 128,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)",
                      "Markup": [
                        {
                          "Start": 116,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 280,
                          "Length": 5,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/p1078",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-12214896"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 135,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "See Also",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "See also: Fentanyl Citrate (has salt form); Fentanyl Hydrochloride (has salt form).",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "#section=Other-Relationships"
                        },
                        {
                          "Start": 10,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/13810"
                        },
                        {
                          "Start": 10,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=13810",
                          "Type": "Icon"
                        },
                        {
                          "Start": 44,
                          "Length": 22,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/83932"
                        },
                        {
                          "Start": 44,
                          "Length": 22,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=83932",
                          "Type": "Icon"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Computed Descriptors",
            "Description": "Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.",
            "Section": [
              {
                "TOCHeading": "IUPAC Name",
                "Description": "Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.",
                "URL": "https://iupac.org/what-we-do/nomenclature/",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by Lexichem TK 2.7.0 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 1,
                              "Type": "Italics"
                            },
                            {
                              "Start": 9,
                              "Length": 1,
                              "Type": "Italics"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "InChI",
                "Description": "The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.",
                "URL": "https://iupac.org/who-we-are/divisions/division-details/inchi/",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by InChI 1.0.6 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "InChIKey",
                "Description": "An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ",
                "URL": "https://iupac.org/who-we-are/divisions/division-details/inchi/",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by InChI 1.0.6 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "PJMPHNIQZUBGLI-UHFFFAOYSA-N"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "SMILES",
                "Description": "The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by OEChem 2.3.0 (PubChem release 2024.12.12)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Molecular Formula",
            "Description": "A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.",
            "URL": "https://pubs.acs.org/doi/abs/10.1021/ja02046a005",
            "DisplayControls": {
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 136,
                "Reference": [
                  "Computed by PubChem 2.2 (PubChem release 2021.10.14)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "C22H28N2O"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Other Identifiers",
            "Description": "Other identifiers assigned to this chemical.",
            "Section": [
              {
                "TOCHeading": "CAS",
                "Description": "A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.",
                "URL": "https://www.cas.org/support/documentation/chemical-substances/faqs",
                "Information": [
                  {
                    "ReferenceNumber": 1,
                    "URL": "https://commonchemistry.cas.org/detail?cas_rn=437-38-7",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "437-38-7"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 6,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "437-38-7"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 15,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "437-38-7"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 37,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "437-38-7"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 40,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "437-38-7"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 48,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "437-38-7"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "437-38-7"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 60,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "437-38-7"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 99,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "437-38-7"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Related CAS",
                "Description": "The Chemical Abstract Service (CAS) registry numbers for related chemicals (e.g., parents, components, mixtures, salt forms, etc.)",
                "DisplayControls": {
                  "ShowAtMost": 3
                },
                "Information": [
                  {
                    "ReferenceNumber": 6,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "990-73-8 (citrate)"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Deprecated CAS",
                "Description": "The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.",
                "Information": [
                  {
                    "ReferenceNumber": 6,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "80832-90-2"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "European Community (EC) Number",
                "Description": "The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).",
                "URL": "https://echa.europa.eu/information-on-chemicals/ec-inventory",
                "Information": [
                  {
                    "ReferenceNumber": 40,
                    "URL": "https://echa.europa.eu/substance-information/-/substanceinfo/100.006.468",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "207-113-6"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "UNII",
                "Description": "UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).",
                "URL": "https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system",
                "Information": [
                  {
                    "ReferenceNumber": 48,
                    "URL": "https://gsrs.ncats.nih.gov/ginas/app/beta/substances/UF599785JZ",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "UF599785JZ"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "ChEBI ID",
                "Description": "Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)",
                "URL": "https://www.ebi.ac.uk/chebi/",
                "Information": [
                  {
                    "ReferenceNumber": 3,
                    "URL": "https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:119915",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CHEBI:119915"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "ChEMBL ID",
                "Description": "ChEMBL compound identifier",
                "URL": "https://www.ebi.ac.uk/chembl/",
                "Information": [
                  {
                    "ReferenceNumber": 4,
                    "URL": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL596/",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CHEMBL596"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "DEA Code Number",
                "Description": "A Drug Enforcement Administration (DEA) code number (also known as DEA number) is a 4-digit number assigned to a controlled substance listed in 21 CFR Part 1380.",
                "URL": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
                "Information": [
                  {
                    "ReferenceNumber": 14,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "9801 (DEA schedule II controlled substance)"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "DrugBank ID",
                "Description": "Drug identifier used by the DrugBank database",
                "URL": "https://go.drugbank.com/",
                "Information": [
                  {
                    "ReferenceNumber": 15,
                    "URL": "https://www.drugbank.ca/drugs/DB00813",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DB00813"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "DSSTox Substance ID",
                "Description": "Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.",
                "URL": "https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database",
                "Information": [
                  {
                    "ReferenceNumber": 37,
                    "URL": "https://comptox.epa.gov/dashboard/DTXSID9023049",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DTXSID9023049"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "HMDB ID",
                "Description": "A chemical substance identifier from the HMDB database",
                "URL": "https://hmdb.ca/",
                "Information": [
                  {
                    "ReferenceNumber": 60,
                    "URL": "https://hmdb.ca/metabolites/HMDB0014951",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HMDB0014951"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "KEGG ID",
                "Description": "KEGG compound/drug identifier",
                "URL": "https://www.kegg.jp/",
                "Information": [
                  {
                    "ReferenceNumber": 69,
                    "URL": "https://www.kegg.jp/entry/D00320",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "D00320"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Metabolomics Workbench ID",
                "Description": "Registration number used by Metabolomics Workbench",
                "URL": "https://www.metabolomicsworkbench.org/",
                "Information": [
                  {
                    "ReferenceNumber": 93,
                    "URL": "https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=43104",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "43104"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "NCI Thesaurus Code",
                "Description": "Stable, unique code for biomedical concept",
                "URL": "https://ncithesaurus.nci.nih.gov",
                "Information": [
                  {
                    "ReferenceNumber": 98,
                    "URL": "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C494",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "C494"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Nikkaji Number",
                "Description": "Substance identifier used in the Japan Chemical Substance Dictionary (Nikkaji).",
                "URL": "https://jglobal.jst.go.jp/en/",
                "Information": [
                  {
                    "ReferenceNumber": 68,
                    "URL": "http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J5.736C",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "J5.736C"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "PharmGKB ID",
                "Description": "PharmGKB chemical identifier",
                "URL": "https://www.pharmgkb.org/",
                "Information": [
                  {
                    "ReferenceNumber": 114,
                    "URL": "https://www.pharmgkb.org/chemical/PA449599",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "PA449599"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Pharos Ligand ID",
                "Description": "Ligand identifier used by Pharos",
                "URL": "https://pharos.nih.gov/",
                "Information": [
                  {
                    "ReferenceNumber": 115,
                    "URL": "https://pharos.nih.gov/ligands/4ZQJCPWP7BNN",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "4ZQJCPWP7BNN"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "RXCUI",
                "Description": "RxNorm concept unique identifier (RXCUI)",
                "URL": "https://www.nlm.nih.gov/research/umls/rxnorm/index.html",
                "Information": [
                  {
                    "ReferenceNumber": 110,
                    "URL": "https://rxnav.nlm.nih.gov/id/rxnorm/4337",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "4337"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Wikidata",
                "Description": "Wikidata entity identifier for the given compound.",
                "URL": "https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662",
                "Information": [
                  {
                    "ReferenceNumber": 132,
                    "URL": "https://www.wikidata.org/wiki/Q407541",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q407541"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Wikipedia",
                "Description": "Wikidata entity identifier for this compound.",
                "Information": [
                  {
                    "ReferenceNumber": 133,
                    "URL": "https://en.wikipedia.org/wiki/Fentanyl",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Synonyms",
            "Description": "Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.",
            "Section": [
              {
                "TOCHeading": "MeSH Entry Terms",
                "Description": "Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.",
                "URL": "http://doi.org/10.1186/s13321-016-0142-6",
                "DisplayControls": {
                  "ListType": "Columns"
                },
                "Information": [
                  {
                    "ReferenceNumber": 135,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Duragesic"
                        },
                        {
                          "String": "Durogesic"
                        },
                        {
                          "String": "Fentanest"
                        },
                        {
                          "String": "Fentanyl"
                        },
                        {
                          "String": "Fentanyl Citrate"
                        },
                        {
                          "String": "Fentora"
                        },
                        {
                          "String": "Phentanyl"
                        },
                        {
                          "String": "R 4263"
                        },
                        {
                          "String": "R-4263"
                        },
                        {
                          "String": "R4263"
                        },
                        {
                          "String": "Sublimaze"
                        },
                        {
                          "String": "Transmucosal Oral Fentanyl Citrate"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Depositor-Supplied Synonyms",
                "Description": "Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.",
                "DisplayControls": {
                  "ListType": "Columns",
                  "MoveToTop": true
                },
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "fentanyl"
                        },
                        {
                          "String": "Phentanyl"
                        },
                        {
                          "String": "Fentanil"
                        },
                        {
                          "String": "Fentanest"
                        },
                        {
                          "String": "Fentora"
                        },
                        {
                          "String": "437-38-7"
                        },
                        {
                          "String": "Duragesic"
                        },
                        {
                          "String": "Durogesic"
                        },
                        {
                          "String": "Fentanila"
                        },
                        {
                          "String": "Fentanylum"
                        },
                        {
                          "String": "Sentonil"
                        },
                        {
                          "String": "Sublimase"
                        },
                        {
                          "String": "Sublimaze"
                        },
                        {
                          "String": "Matrifen"
                        },
                        {
                          "String": "Duragesic-100"
                        },
                        {
                          "String": "N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide"
                        },
                        {
                          "String": "Duragesic-12"
                        },
                        {
                          "String": "Duragesic-25"
                        },
                        {
                          "String": "Duragesic-50"
                        },
                        {
                          "String": "Duragesic-75"
                        },
                        {
                          "String": "Fentanyl-12"
                        },
                        {
                          "String": "Fentanyl-25"
                        },
                        {
                          "String": "Fentanyl-50"
                        },
                        {
                          "String": "Fentanyl-75"
                        },
                        {
                          "String": "Recuvyra"
                        },
                        {
                          "String": "Subsys"
                        },
                        {
                          "String": "Fentanyl-100"
                        },
                        {
                          "String": "PecFent"
                        },
                        {
                          "String": "Fentanyl CII"
                        },
                        {
                          "String": "1-Phenethyl-4-N-propionylanilinopiperidine"
                        },
                        {
                          "String": "Fentanylum [INN-Latin]"
                        },
                        {
                          "String": "Fentanila [INN-Spanish]"
                        },
                        {
                          "String": "N-(1-Phenethyl-4-piperidyl)propionanilide"
                        },
                        {
                          "String": "Fendrop"
                        },
                        {
                          "String": "IONSYS"
                        },
                        {
                          "String": "N-Phenethyl-4-(N-propionylanilino)piperidine"
                        },
                        {
                          "String": "1-Phenethyl-4-(N-phenylpropionamido)piperidine"
                        },
                        {
                          "String": "Durotep MT"
                        },
                        {
                          "String": "N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide"
                        },
                        {
                          "String": "R 4263"
                        },
                        {
                          "String": "HSDB 3329"
                        },
                        {
                          "String": "N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide"
                        },
                        {
                          "String": "N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide"
                        },
                        {
                          "String": "Abstral-"
                        },
                        {
                          "String": "CHEBI:119915"
                        },
                        {
                          "String": "Durogesic d-trans"
                        },
                        {
                          "String": "Fentanyl Transdermal System"
                        },
                        {
                          "String": "JNS020QD"
                        },
                        {
                          "String": "N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide"
                        },
                        {
                          "String": "EINECS 207-113-6"
                        },
                        {
                          "String": "Propionanilide, N-(1-phenethyl-4-piperidyl)-"
                        },
                        {
                          "String": "UNII-UF599785JZ"
                        },
                        {
                          "String": "BRN 0494484"
                        },
                        {
                          "String": "IDS-NF-001"
                        },
                        {
                          "String": "DTXSID9023049"
                        },
                        {
                          "String": "En3267"
                        },
                        {
                          "String": "N02AB03"
                        },
                        {
                          "String": "UF599785JZ"
                        },
                        {
                          "String": "AD-923"
                        },
                        {
                          "String": "Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)-"
                        },
                        {
                          "String": "CHEMBL596"
                        },
                        {
                          "String": "EN-3267"
                        },
                        {
                          "String": "DTXCID103049"
                        },
                        {
                          "String": "R4263"
                        },
                        {
                          "String": "Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-"
                        },
                        {
                          "String": "Fentanyl [USAN:USP:INN:BAN]"
                        },
                        {
                          "String": "5-22-08-00049 (Beilstein Handbook Reference)"
                        },
                        {
                          "String": "AD 923"
                        },
                        {
                          "String": "NCGC00168252-01"
                        },
                        {
                          "String": "Fentanylum (INN-Latin)"
                        },
                        {
                          "String": "Fentanila (INN-Spanish)"
                        },
                        {
                          "String": "FENTANYL (MART.)"
                        },
                        {
                          "String": "FENTANYL [MART.]"
                        },
                        {
                          "String": "Fentanil [DCIT]"
                        },
                        {
                          "String": "FENTANYL (EP IMPURITY)"
                        },
                        {
                          "String": "FENTANYL [EP IMPURITY]"
                        },
                        {
                          "String": "FENTANYL CII (USP-RS)"
                        },
                        {
                          "String": "FENTANYL CII [USP-RS]"
                        },
                        {
                          "String": "FENTANYL (EP MONOGRAPH)"
                        },
                        {
                          "String": "FENTANYL [EP MONOGRAPH]"
                        },
                        {
                          "String": "FENTANYL (USP MONOGRAPH)"
                        },
                        {
                          "String": "FENTANYL [USP MONOGRAPH]"
                        },
                        {
                          "String": "Fentanyl (USAN:USP:INN:BAN)"
                        },
                        {
                          "String": "PROPANAMIDE, N-PHENYL-N-(1-(2-PHENYLETHYL)-4-PIPERIDINYL)"
                        },
                        {
                          "String": "FENTANYL (EMA EPAR VETERINARY)"
                        },
                        {
                          "String": "FENTANYL [EMA EPAR VETERINARY]"
                        },
                        {
                          "String": "Fentanyl-37"
                        },
                        {
                          "String": "Fentanyl-62"
                        },
                        {
                          "String": "Fentanyl-87"
                        },
                        {
                          "String": "N-phenyl-N-(1-(2-phenylethyl)piperidin-4-yl)propanamide"
                        },
                        {
                          "String": "Fentanilo"
                        },
                        {
                          "String": "Fentanyl System"
                        },
                        {
                          "String": "n-phenyl-n-"
                        },
                        {
                          "String": "N-Phenyl-N-{1-[2-(~2~H_5_)phenylethyl]piperidin-4-yl}propanamide"
                        },
                        {
                          "String": "Duragesic (TN)"
                        },
                        {
                          "String": "fentanyl transdermal"
                        },
                        {
                          "String": "7V7"
                        },
                        {
                          "String": "Fentanylum (Latin)"
                        },
                        {
                          "String": "Subsys (TN)"
                        },
                        {
                          "String": "FENTANYL-HCl"
                        },
                        {
                          "String": "n-phenyl-n-(1-"
                        },
                        {
                          "String": "201415-26-1"
                        },
                        {
                          "String": "Tranq component fentanyl"
                        },
                        {
                          "String": "FENTANYL [HSDB]"
                        },
                        {
                          "String": "FENTANYL [USAN]"
                        },
                        {
                          "String": "FENTANYL [INN]"
                        },
                        {
                          "String": "FENTANYL [JAN]"
                        },
                        {
                          "String": "FENTANYL [MI]"
                        },
                        {
                          "String": "DURAGESIC-37"
                        },
                        {
                          "String": "FENTANYL [VANDF]"
                        },
                        {
                          "String": "Epitope ID:153507"
                        },
                        {
                          "String": "FENTANYL [WHO-DD]"
                        },
                        {
                          "String": "SCHEMBL8804"
                        },
                        {
                          "String": "Fentanyl (JAN/USP/INN)"
                        },
                        {
                          "String": "FENTANYL [EMA EPAR]"
                        },
                        {
                          "String": "Oprea1_152073"
                        },
                        {
                          "String": "Oprea1_207148"
                        },
                        {
                          "String": "N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide"
                        },
                        {
                          "String": "BIDD:GT0555"
                        },
                        {
                          "String": "FENTANYL [GREEN BOOK]"
                        },
                        {
                          "String": "Fentanyl, 1mg/ml in Methanol"
                        },
                        {
                          "String": "FENTANYL [ORANGE BOOK]"
                        },
                        {
                          "String": "GTPL1626"
                        },
                        {
                          "String": "Fentanyl 0.1 mg/ml in Methanol"
                        },
                        {
                          "String": "Fentanyl 1.0 mg/ml in Methanol"
                        },
                        {
                          "String": "Fentanyl, 0.1mg/ml in Methanol"
                        },
                        {
                          "String": "N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylpropanamide"
                        },
                        {
                          "String": "N01AH01"
                        },
                        {
                          "String": "Fentanyl (1.0 mg/mL in Methanol)"
                        },
                        {
                          "String": "Tox21_112611"
                        },
                        {
                          "String": "BDBM50008984"
                        },
                        {
                          "String": "HY-U00158"
                        },
                        {
                          "String": "PDSP1_000860"
                        },
                        {
                          "String": "PDSP2_000846"
                        },
                        {
                          "String": "CS-7211"
                        },
                        {
                          "String": "DB00813"
                        },
                        {
                          "String": "CAS-437-38-7"
                        },
                        {
                          "String": "NS00000044"
                        },
                        {
                          "String": "N-(1-Phenylethyl-4-piperidinyl)propionanilide"
                        },
                        {
                          "String": "D00320"
                        },
                        {
                          "String": "1-(2-Phenylethyl)-4-(N-propananilido)piperidine"
                        },
                        {
                          "String": "L001275"
                        },
                        {
                          "String": "Q407541"
                        },
                        {
                          "String": "N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide #"
                        },
                        {
                          "String": "N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide(Fentanyl)"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Removed Synonyms",
                "Description": "Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.",
                "DisplayControls": {
                  "HideThisSection": true
                },
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Abstral"
                        },
                        {
                          "String": "Lazanda"
                        },
                        {
                          "String": "Actiq"
                        },
                        {
                          "String": "effentora"
                        },
                        {
                          "String": "Innovar"
                        },
                        {
                          "String": "Fentanyl buccal"
                        },
                        {
                          "String": "FENTANYL CITRATE"
                        },
                        {
                          "String": "Pemetrexed"
                        },
                        {
                          "String": "Instanyl"
                        },
                        {
                          "String": "Nasalfent"
                        },
                        {
                          "String": "Pentanyl"
                        },
                        {
                          "String": "Onsolis"
                        },
                        {
                          "String": "Rapinyl"
                        },
                        {
                          "String": "Fentanyl HCl"
                        },
                        {
                          "String": "Fentanyl-d5"
                        },
                        {
                          "String": "Fentanyl [INN:BAN]"
                        },
                        {
                          "String": "Fentanyl hydrochloride"
                        },
                        {
                          "String": "D09ISU"
                        },
                        {
                          "String": "D0E1WI"
                        },
                        {
                          "String": "AC1L1FQ2"
                        },
                        {
                          "String": "PJMPHNIQZUBGLI-UHFFFAOYSA-N"
                        },
                        {
                          "String": "DEA No. 9801"
                        },
                        {
                          "String": "C22H28N2O"
                        },
                        {
                          "String": "CTK8G2863"
                        },
                        {
                          "String": "CID3345"
                        },
                        {
                          "String": "SUBLIMAZE PRESERVATIVE FREE"
                        },
                        {
                          "String": "McN-JR-4263-49"
                        },
                        {
                          "String": "Transmucosal Oral Fentanyl Citrate"
                        },
                        {
                          "String": "ACN-S001735"
                        },
                        {
                          "String": "ZINC2522669"
                        },
                        {
                          "String": "C22-H28-N2-O"
                        },
                        {
                          "String": "CF0052"
                        },
                        {
                          "String": "R-4263"
                        },
                        {
                          "String": "FENTANYL CITRATE PRESERVATIVE FREE"
                        },
                        {
                          "String": "LS-124439"
                        },
                        {
                          "String": "9235-EP2275420A1"
                        },
                        {
                          "String": "9235-EP2277861A1"
                        },
                        {
                          "String": "9235-EP2277875A2"
                        },
                        {
                          "String": "9235-EP2280008A2"
                        },
                        {
                          "String": "9235-EP2298764A1"
                        },
                        {
                          "String": "9235-EP2298765A1"
                        },
                        {
                          "String": "9235-EP2298768A1"
                        },
                        {
                          "String": "9235-EP2305652A2"
                        },
                        {
                          "String": "9235-EP2305654A1"
                        },
                        {
                          "String": "9235-EP2308509A1"
                        },
                        {
                          "String": "9235-EP2308872A1"
                        },
                        {
                          "String": "9235-EP2314585A1"
                        },
                        {
                          "String": "9235-EP2314590A1"
                        },
                        {
                          "String": "9235-EP2316829A1"
                        },
                        {
                          "String": "STANDARD DRUG STOCKFENTANYL 62.7% 1 ML"
                        },
                        {
                          "String": "D005283"
                        },
                        {
                          "String": "rac-cis-1-Benzyl-2-methyl-4-(N-propananilido)piperidine"
                        },
                        {
                          "String": "N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide"
                        },
                        {
                          "String": "pain therapy (transmucosal film), Auxilium Pharmaceuticals"
                        },
                        {
                          "String": "fentanyl (transmucosal film, pain), Auxilium Pharmaceuticals"
                        },
                        {
                          "String": "4-(4-Chloro-benzyl)-2-(1-methyl-azepan-4-yl)-2H-phthalazin-1-one"
                        },
                        {
                          "String": "Fentanyl solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material"
                        },
                        {
                          "String": "Fentanyl solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material"
                        },
                        {
                          "String": "N-(2,3,4,5,6-pentadeuteriophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide"
                        },
                        {
                          "String": "118357-29-2"
                        },
                        {
                          "String": "1443-54-5"
                        },
                        {
                          "String": "150399-23-8"
                        },
                        {
                          "String": "N-(Phenyl)-N-(1-[2-phenylethyl]-4-piperidinyl)propanamide; 1-Phenethyl-4-(N-phenylpropionamido)piperidine; Durogesic; Durogesic D-Trans; Durotep MT; Fentanest; Fentanil; Fentora; Matrifen; Phentanyl; R 4263; Sublimase; Fentanyl; N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide; N-(1-Phenethyl-4-piperidyl)propionanilide; 1-Phenethyl-4-N-propionylanilinopiperidine; N-[1-(2-Phenylethyl)-4-piperidinyl]propionanilide"
                        },
                        {
                          "String": "sodium (S)-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioate"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Create Date",
            "Description": "Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/docs/record-dates",
            "DisplayControls": {
              "HideThisSection": true,
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 136,
                "Value": {
                  "DateISO8601": [
                    "2005-03-25"
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Modify Date",
            "Description": "Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/docs/record-dates",
            "DisplayControls": {
              "HideThisSection": true,
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 136,
                "Value": {
                  "DateISO8601": [
                    "2025-01-04"
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Chemical and Physical Properties",
        "Description": "Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.",
        "Section": [
          {
            "TOCHeading": "Computed Properties",
            "Description": "Properties of this compound computed from its molecular formula and structure.",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "Subsections",
                "NumberOfColumns": 3,
                "ColumnHeadings": [
                  "Property Name",
                  "Property Value",
                  "Reference"
                ],
                "ColumnContents": [
                  "Name",
                  "Value",
                  "Reference"
                ]
              }
            },
            "Section": [
              {
                "TOCHeading": "Molecular Weight",
                "Description": "Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).",
                "URL": "https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en",
                "DisplayControls": {
                  "MoveToTop": true
                },
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem 2.2 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "336.5"
                        }
                      ],
                      "Unit": "g/mol"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "XLogP3",
                "Description": "XLogP3 is a predicted octanol-water partition coefficient, computed using the algorithm described in J. Chem. Inf. Model. 2007, 47, 6, 2140-2148. It is used as a measure of hydrophilicity or hydrophobicity of a molecule.",
                "URL": "https://pubmed.ncbi.nlm.nih.gov/17985865/",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by XLogP3 3.0 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "Number": [
                        4
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Hydrogen Bond Donor Count",
                "Description": "The number of hydrogen bond donors in this compound.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Hydrogen Bond Acceptor Count",
                "Description": "The number of hydrogen bond acceptors in this compound.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "Number": [
                        2
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Rotatable Bond Count",
                "Description": "A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "Number": [
                        6
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Exact Mass",
                "Description": "The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem 2.2 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "336.220163521"
                        }
                      ],
                      "Unit": "Da"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Monoisotopic Mass",
                "Description": "The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem 2.2 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "336.220163521"
                        }
                      ],
                      "Unit": "Da"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Topological Polar Surface Area",
                "Description": "The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.",
                "URL": "https://pubmed.ncbi.nlm.nih.gov/11020286/",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "Number": [
                        23.6
                      ],
                      "Unit": "Å²"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Heavy Atom Count",
                "Description": "The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        25
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Formal Charge",
                "Description": "Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Complexity",
                "Description": "The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)"
                    ],
                    "Value": {
                      "Number": [
                        391
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Isotope Atom Count",
                "Description": "Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Defined Atom Stereocenter Count",
                "Description": "An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The \"defined atom stereocenter count\" is the number of atom stereocenters whose configurations are specifically defined.  ",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Undefined Atom Stereocenter Count",
                "Description": "The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the \"defined atom stereocenter count\" above.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Defined Bond Stereocenter Count",
                "Description": "A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The \"defined bond stereocenter count\" is the number of bond stereocenters whose configurations are specifically defined.  ",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Undefined Bond Stereocenter Count",
                "Description": "The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the \"defined bond stereocenter count\" above.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Covalently-Bonded Unit Count",
                "Description": "A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The \"covalently-bonded unit count\" property is the number of such units in this compound compound.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        1
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Compound Is Canonicalized",
                "Description": "Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process.",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Reference": [
                      "Computed by PubChem (release 2021.10.14)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Yes"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Experimental Properties",
            "Description": "Various experimentally determined properties for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.",
            "Section": [
              {
                "TOCHeading": "Physical Description",
                "Description": "The appearance or features of this compound, including color, odor, state, taste and more in general.",
                "Information": [
                  {
                    "ReferenceNumber": 60,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Solid"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 125,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Crystals or crystalline powder."
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Color/Form",
                "Description": "Color is the aspect of any object that may be described in terms of hue, lightness, and saturation.",
                "URL": "https://www.britannica.com/science/color",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 734"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Crystals"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Melting Point",
                "Description": "This section provides the melting point and/or freezing point. The melting point is the temperature at which a substance changes state from solid to liquid at atmospheric pressure. When considered as the temperature of the reverse change (from liquid to solid), it is referred to as the freezing point.",
                "URL": "https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_Lab_Techniques_(Nichols)/06%3A_Miscellaneous_Techniques/6.01%3A_Melting_Point",
                "Information": [
                  {
                    "ReferenceNumber": 15,
                    "Reference": [
                      "US. Patent 3,141,823."
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "83-84"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Haynes, W.M. (ed.). CRC Handbook of Chemistry and Physics. 95th Edition. CRC Press LLC, Boca Raton: FL 2014-2015, p. 3-272"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "85.2 °C"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 734"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "White crystalline powder; MP: 149-151 °C; bitter taste. Soluble in methanol; slightly soluble in chloroform /Fentanyl citrate/",
                          "Markup": [
                            {
                              "Start": 67,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/methanol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-887"
                            },
                            {
                              "Start": 97,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/chloroform",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-6212"
                            },
                            {
                              "Start": 109,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 60,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "87.5 °C"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Solubility",
                "Description": "The solubility of a substance is the amount of that substance that will dissolve in a given amount of solvent. The default solvent is water, if not indicated.",
                "URL": "https://chem.libretexts.org/Courses/Purdue/Purdue%3A_Chem_26505%3A_Organic_Chemistry_I_(Lipton)/Chapter_4._Intermolecular_Forces_and_Physical_Properties/4.4_Solubility",
                "Information": [
                  {
                    "ReferenceNumber": 15,
                    "Reference": [
                      "https://www.ncbi.nlm.nih.gov/pubmed/2569731"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "0.74mg/mL"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Roy SD, Flynn GL; Pharmaceut Res 5: 580-86 (1988)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "In water, 200 mg/L at 25 °C",
                          "Markup": [
                            {
                              "Start": 3,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 60,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2.40e-02 g/L"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Vapor Pressure",
                "Description": "Vapor pressure (or equilibrium vapor pressure) is the pressure of a vapor in thermodynamic equilibrium with its condensed phases in a closed system.",
                "URL": "https://chem.libretexts.org/Bookshelves/General_Chemistry/Map%3A_Chemistry_-_The_Central_Science_(Brown_et_al.)/11%3A_Liquids_and_Intermolecular_Forces/11.05%3A_Vapor_Pressure",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Gupta PK et al; J Chem Eng Data 53: 841-5 (2008)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "4.43X10-9 mm Hg at 25 °C (estrapolated)"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "LogP",
                "Description": "Log P is the partition coefficient expressed in logarithmic form.  The partition coefficient is the ratio of concentrations of a compound in a mixture of two immiscible solvents at equilibrium.  This ratio is therefore used to compare the solubilities of the solute in these two solvents.  Because octanol and water are the most commonly used pair of solvents for measuring partition coefficients, the Log P values listed in this section refer to octanol/water partition coefficients, unless indicated otherwise.",
                "Information": [
                  {
                    "ReferenceNumber": 15,
                    "Reference": [
                      "SANGSTER (1993)"
                    ],
                    "Value": {
                      "Number": [
                        4.05
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Sangster J; LOGKOW Databank. Sangster Res. Lab., Montreal Quebec, Canada (1993)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "log Kow = 4.05"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 60,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "3.9"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Decomposition",
                "Description": "Information on the decomposition of this compound, including the decomposition conditions and products.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2893"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "When heated to decomposition it emits toxic fumes of /nitrogen oxides/."
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Dissociation Constants",
                "Description": "A specific type of equilibrium constant that measures the propensity of a larger object to separate (dissociate) reversibly into smaller components, as when a complex falls apart into its component molecules, or when a salt splits up into its component ions. This includes pKa (the negative logarithm of the acid dissociation constant) and pKb (the negative logarithm of the base dissociation constant).",
                "Information": [
                  {
                    "ReferenceNumber": 5,
                    "Name": "Basic pKa",
                    "Reference": [
                      "Tested as SID 103182112 in AID 781328: https://pubchem.ncbi.nlm.nih.gov/bioassay/781328#sid=103182112",
                      "Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharm Res. 2014; 31(4):1082-95. DOI:10.1007/s11095-013-1232-z. PMID:24249037"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "8.43"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 15,
                    "Name": "pKa",
                    "Reference": [
                      "https://www.ncbi.nlm.nih.gov/pubmed/2569731"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "8.99"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Boleda MR et al; Chemosphere 84: 1601-7 (2011)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "pKa = 7.3"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 1044"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Odorless; pKa: 8.3 /Fentanyl citrate/",
                          "Markup": [
                            {
                              "Start": 20,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Collision Cross Section",
                "Description": "Collision cross section (CCS) represents the effective area for the interaction between an individual ion and the neutral gas through which it is traveling (e.g., in ion mobility spectrometry (IMS) experiments).  It quantifies the probability of a collision taking place between two or more particles.",
                "URL": "https://pubmed.ncbi.nlm.nih.gov/28035808/",
                "Information": [
                  {
                    "ReferenceNumber": 2,
                    "Reference": [
                      "https://www.sciencedirect.com/science/article/pii/S0021967318301894"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "184.1 Å² [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]",
                          "Markup": [
                            {
                              "Start": 14,
                              "Length": 1,
                              "Type": "Superscript"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Kovats Retention Index",
                "Description": "The Kovats retention index is a dimensionless quantity that characterizes the rate at which a compound is processed through a gas chromatography column.",
                "URL": "https://goldbook.iupac.org/terms/view/R05360",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ListType": "CommaSeparated"
                },
                "Information": [
                  {
                    "ReferenceNumber": 109,
                    "Name": "Standard non-polar",
                    "Value": {
                      "Number": [
                        2701,
                        2701,
                        2681,
                        2725,
                        2718,
                        2720,
                        2714,
                        2695.2,
                        2690.1,
                        2730,
                        2730,
                        2720
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 109,
                    "Name": "Semi-standard non-polar",
                    "Value": {
                      "Number": [
                        2757,
                        2731.7,
                        2725.9
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Other Experimental Properties",
                "Description": "Other experimental properties of this chemical.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 734"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Partition coefficient (n-octanol/water): 860",
                          "Markup": [
                            {
                              "Start": 23,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/n-octanol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-957"
                            },
                            {
                              "Start": 33,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Chemical Classes",
            "Description": "Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.",
            "Information": [
              {
                "ReferenceNumber": 58,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Other Uses -> Pharmaceuticals"
                    }
                  ]
                }
              }
            ],
            "Section": [
              {
                "TOCHeading": "Drugs",
                "Description": "Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.",
                "Information": [
                  {
                    "ReferenceNumber": 111,
                    "Reference": [
                      "S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Pharmaceuticals -> Listed in ZINC15"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 111,
                    "Reference": [
                      "S58 | PSYCHOCANNAB | Synthetic Cannabinoids and Psychoactive Compounds | DOI:10.5281/zenodo.3247723"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 111,
                    "Reference": [
                      "S56 | UOATARGPHARMA | Target Pharmaceutical/Drug List from University of Athens | DOI:10.5281/zenodo.3248837"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Pharmaceuticals -> Analgesics (Anesthetics)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 111,
                    "Reference": [
                      "S10 | SWISSPHARMA | Pharmaceutical List with Consumption Data | DOI:10.5281/zenodo.2623484"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Pharmaceuticals"
                        }
                      ]
                    }
                  }
                ],
                "Section": [
                  {
                    "TOCHeading": "Human Drugs",
                    "Description": "Chemicals are used as active ingredients in human drug products.",
                    "Information": [
                      {
                        "ReferenceNumber": 16,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Breast Feeding; Lactation; Milk, Human; Analgesics, Opioid; Narcotics; Anesthetics, Intravenous; Opiates"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 18,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Prescription; Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 19,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 20,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Prescription; Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 21,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 22,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 23,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> None (Tentative Approval); Discontinued; Active ingredient (FENTANYL)",
                              "Markup": [
                                {
                                  "Start": 74,
                                  "Length": 8,
                                  "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/FENTANYL",
                                  "Type": "PubChem Internal Link",
                                  "Extra": "CID-3345"
                                }
                              ]
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 24,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Prescription; Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 25,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 26,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Prescription; Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 27,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Prescription; Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 28,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 29,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Prescription; Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 30,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 31,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 32,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 33,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Prescription; Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 34,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 35,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drug -> Prescription; Discontinued"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 41,
                        "Name": "Human Drugs",
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drugs -> Analgesics -> Human pharmacotherapeutic group -> EMA Drug Category"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 42,
                        "Name": "Human Drugs",
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drugs -> Analgesics -> Human pharmacotherapeutic group -> EMA Drug Category"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 43,
                        "Name": "Human Drugs",
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drugs -> Analgesics -> Human pharmacotherapeutic group -> EMA Drug Category"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 45,
                        "Name": "Human Drugs",
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Human drugs -> Analgesics -> Human pharmacotherapeutic group -> EMA Drug Category"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 111,
                        "Reference": [
                          "S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664"
                        ],
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Pharmaceuticals"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 131,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Opioid analgesics"
                            }
                          ]
                        }
                      }
                    ]
                  },
                  {
                    "TOCHeading": "Animal Drugs",
                    "Description": "Chemicals are used as active ingredients in animal drug products.",
                    "Information": [
                      {
                        "ReferenceNumber": 44,
                        "Name": "Animal Drugs",
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Veterinary drugs -> Nervous system -> Veterinary pharmacotherapeutic group -> EMA Drug Category"
                            }
                          ]
                        }
                      },
                      {
                        "ReferenceNumber": 46,
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "Active Ingredients (Fentanyl) -> FDA Greenbook",
                              "Markup": [
                                {
                                  "Start": 20,
                                  "Length": 8,
                                  "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                                  "Type": "PubChem Internal Link",
                                  "Extra": "CID-3345"
                                }
                              ]
                            }
                          ]
                        }
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Spectral Information",
        "Description": "Spectral data for this compound, including 1-D and 2-D nuclear magnetic resonance (NMR), Infrared (IR), Raman, and Ultraviolet (UV) spectroscopy, mass spectrometry (MS), and chromatography.",
        "Section": [
          {
            "TOCHeading": "1D NMR Spectra",
            "Description": "One-dimensional (1D) nuclear magnetic resonance (NMR) spectra.",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 2
            },
            "Section": [
              {
                "TOCHeading": "13C NMR Spectra",
                "Description": "Carbon-13 nuclear magnetic resonance (NMR) spectroscopy (also known as 13C NMR) is a version of NMR spectroscopy used to elucidate the structure of carbon-containing compounds.",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 2
                },
                "Information": [
                  {
                    "ReferenceNumber": 122,
                    "Name": "Copyright",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 122,
                    "Name": "Thumbnail",
                    "URL": "https://spectrabase.com/spectrum/9yR04l1s2nm",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4543564_1"
                      ],
                      "MimeType": "image/png"
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Mass Spectrometry",
            "Description": "Mass spectrometry (MS or mass spec) is a technique to determine molecular structure through ionization and fragmentation of the parent compound into smaller components.",
            "URL": "https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Supplemental_Modules_(Organic_Chemistry)/Spectroscopy/Mass_Spectrometry",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 2
            },
            "Section": [
              {
                "TOCHeading": "GC-MS",
                "Description": "Data from gas chromatography-mass spectrometry (GC-MS) experiments.",
                "URL": "https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 2
                },
                "Information": [
                  {
                    "ReferenceNumber": 101,
                    "Name": "NIST Number",
                    "Value": {
                      "Number": [
                        250541
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 101,
                    "Name": "Library",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Main library"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 101,
                    "Name": "Total Peaks",
                    "Value": {
                      "Number": [
                        95
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 101,
                    "Name": "m/z Top Peak",
                    "Value": {
                      "Number": [
                        245
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 101,
                    "Name": "m/z 2nd Highest",
                    "Value": {
                      "Number": [
                        146
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 101,
                    "Name": "m/z 3rd Highest",
                    "Value": {
                      "Number": [
                        189
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 101,
                    "Name": "Thumbnail",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/213033_1"
                      ],
                      "MimeType": "image/png"
                    }
                  },
                  {
                    "ReferenceNumber": 102,
                    "Name": "NIST Number",
                    "Value": {
                      "Number": [
                        408737
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 102,
                    "Name": "Library",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Replicate library"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 102,
                    "Name": "Total Peaks",
                    "Value": {
                      "Number": [
                        148
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 102,
                    "Name": "m/z Top Peak",
                    "Value": {
                      "Number": [
                        146
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 102,
                    "Name": "m/z 2nd Highest",
                    "Value": {
                      "Number": [
                        245
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 102,
                    "Name": "m/z 3rd Highest",
                    "Value": {
                      "Number": [
                        189
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 102,
                    "Name": "Thumbnail",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/270737_1"
                      ],
                      "MimeType": "image/png"
                    }
                  },
                  {
                    "ReferenceNumber": 103,
                    "Name": "NIST Number",
                    "Value": {
                      "Number": [
                        125737
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 103,
                    "Name": "Library",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Replicate library"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 103,
                    "Name": "Total Peaks",
                    "Value": {
                      "Number": [
                        58
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 103,
                    "Name": "m/z Top Peak",
                    "Value": {
                      "Number": [
                        245
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 103,
                    "Name": "m/z 2nd Highest",
                    "Value": {
                      "Number": [
                        146
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 103,
                    "Name": "m/z 3rd Highest",
                    "Value": {
                      "Number": [
                        189
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 103,
                    "Name": "Thumbnail",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/278638_1"
                      ],
                      "MimeType": "image/png"
                    }
                  },
                  {
                    "ReferenceNumber": 104,
                    "Name": "NIST Number",
                    "Value": {
                      "Number": [
                        247650
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 104,
                    "Name": "Library",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Replicate library"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 104,
                    "Name": "Total Peaks",
                    "Value": {
                      "Number": [
                        92
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 104,
                    "Name": "m/z Top Peak",
                    "Value": {
                      "Number": [
                        245
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 104,
                    "Name": "m/z 2nd Highest",
                    "Value": {
                      "Number": [
                        146
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 104,
                    "Name": "m/z 3rd Highest",
                    "Value": {
                      "Number": [
                        189
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 104,
                    "Name": "Thumbnail",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/278639_1"
                      ],
                      "MimeType": "image/png"
                    }
                  },
                  {
                    "ReferenceNumber": 105,
                    "Name": "NIST Number",
                    "Value": {
                      "Number": [
                        312939
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 105,
                    "Name": "Library",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Replicate library"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 105,
                    "Name": "Total Peaks",
                    "Value": {
                      "Number": [
                        97
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 105,
                    "Name": "m/z Top Peak",
                    "Value": {
                      "Number": [
                        245
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 105,
                    "Name": "m/z 2nd Highest",
                    "Value": {
                      "Number": [
                        146
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 105,
                    "Name": "m/z 3rd Highest",
                    "Value": {
                      "Number": [
                        189
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 105,
                    "Name": "Thumbnail",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/278640_1"
                      ],
                      "MimeType": "image/png"
                    }
                  },
                  {
                    "ReferenceNumber": 106,
                    "Name": "NIST Number",
                    "Value": {
                      "Number": [
                        379198
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 106,
                    "Name": "Library",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Replicate library"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 106,
                    "Name": "Total Peaks",
                    "Value": {
                      "Number": [
                        115
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 106,
                    "Name": "m/z Top Peak",
                    "Value": {
                      "Number": [
                        245
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 106,
                    "Name": "m/z 2nd Highest",
                    "Value": {
                      "Number": [
                        146
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 106,
                    "Name": "m/z 3rd Highest",
                    "Value": {
                      "Number": [
                        189
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 106,
                    "Name": "Thumbnail",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/278641_1"
                      ],
                      "MimeType": "image/png"
                    }
                  },
                  {
                    "ReferenceNumber": 119,
                    "Name": "Source of Spectrum",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Mass Spectrometry Committee of the Toxicology Section of the American Academy of Forensic Sciences"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 119,
                    "Name": "Copyright",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Copyright © 2012-2024 John Wiley & Sons, Inc. Portions provided by AAFS, Toxicology Section. All Rights Reserved."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 119,
                    "Name": "Thumbnail",
                    "URL": "https://spectrabase.com/spectrum/BRMfiqjdWaw",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4543560_1"
                      ],
                      "MimeType": "image/png"
                    }
                  },
                  {
                    "ReferenceNumber": 120,
                    "Name": "Source of Spectrum",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Mass Spectrometry Committee of the Toxicology Section of the American Academy of Forensic Sciences"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 120,
                    "Name": "Copyright",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Copyright © 2012-2024 John Wiley & Sons, Inc. Portions provided by AAFS, Toxicology Section. All Rights Reserved."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 120,
                    "Name": "Thumbnail",
                    "URL": "https://spectrabase.com/spectrum/EeDI7sVdVTF",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4543561_1"
                      ],
                      "MimeType": "image/png"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "MS-MS",
                "Description": "Data from tandem mass spectrometry (MS-MS) experiments.",
                "URL": "https://goldbook.iupac.org/terms/view/T06250",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 2
                },
                "Information": [
                  {
                    "ReferenceNumber": 61,
                    "Name": "Spectra ID",
                    "URL": "https://hmdb.ca/spectra/ms_ms/2226737",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2226737"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 61,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Positive"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 61,
                    "Name": "SPLASH",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query==exists(splash.splash:%27splash10-000i-0900000000-da874163fadaa39d25ad%27)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0900000000-da874163fadaa39d25ad"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 61,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188.1428 100"
                        },
                        {
                          "String": "132.08 20.82"
                        },
                        {
                          "String": "134.0956 11.97"
                        },
                        {
                          "String": "189.1457 11.14"
                        },
                        {
                          "String": "216.1374 7.23"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 61,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1428:100,132.08:20.82,134.0956:11.97,189.1457:11.14,216.1374:7.23",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1428:100,132.08:20.82,134.0956:11.97,189.1457:11.14,216.1374:7.23"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 62,
                    "Name": "Spectra ID",
                    "URL": "https://hmdb.ca/spectra/ms_ms/2228007",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2228007"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 62,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Positive"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 62,
                    "Name": "SPLASH",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query==exists(splash.splash:%27splash10-000i-0901000000-09bd125eea134f8811a4%27)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0901000000-09bd125eea134f8811a4"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 62,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188.1428 100"
                        },
                        {
                          "String": "337.2283 14.38"
                        },
                        {
                          "String": "189.1459 8.51"
                        },
                        {
                          "String": "216.1378 8.32"
                        },
                        {
                          "String": "338.2312 2.63"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 62,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1428:100,337.2283:14.38,189.1459:8.51,216.1378:8.32,338.2312:2.63",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1428:100,337.2283:14.38,189.1459:8.51,216.1378:8.32,338.2312:2.63"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 63,
                    "Name": "Spectra ID",
                    "URL": "https://hmdb.ca/spectra/ms_ms/2229058",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2229058"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 63,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Positive"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 63,
                    "Name": "SPLASH",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query==exists(splash.splash:%27splash10-000i-0009000000-e126a8d88c9106409cac%27)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0009000000-e126a8d88c9106409cac"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 63,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2283 100"
                        },
                        {
                          "String": "338.2312 20.09"
                        },
                        {
                          "String": "339.2338 1.83"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 63,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2283:100,338.2312:20.09,339.2338:1.83",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2283:100,338.2312:20.09,339.2338:1.83"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 64,
                    "Name": "Spectra ID",
                    "URL": "https://hmdb.ca/spectra/ms_ms/2230377",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2230377"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 64,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Positive"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 64,
                    "Name": "SPLASH",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query==exists(splash.splash:%27splash10-000i-0209000000-d550d803c25d31570227%27)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0209000000-d550d803c25d31570227"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 64,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2283 100"
                        },
                        {
                          "String": "188.1427 34.45"
                        },
                        {
                          "String": "338.2312 15.97"
                        },
                        {
                          "String": "189.1458 3.15"
                        },
                        {
                          "String": "339.2338 1.64"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 64,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2283:100,188.1427:34.45,338.2312:15.97,189.1458:3.15,339.2338:1.64",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2283:100,188.1427:34.45,338.2312:15.97,189.1458:3.15,339.2338:1.64"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 65,
                    "Name": "Spectra ID",
                    "URL": "https://hmdb.ca/spectra/ms_ms/2231385",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2231385"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 65,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Positive"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 65,
                    "Name": "SPLASH",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query==exists(splash.splash:%27splash10-001r-0900000000-2ed12cf85c72a16b8cdb%27)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-001r-0900000000-2ed12cf85c72a16b8cdb"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 65,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "132.0801 100"
                        },
                        {
                          "String": "188.1429 93.09"
                        },
                        {
                          "String": "134.0955 22.12"
                        },
                        {
                          "String": "146.0954 17.92"
                        },
                        {
                          "String": "189.1459 13.01"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 65,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=132.0801:100,188.1429:93.09,134.0955:22.12,146.0954:17.92,189.1459:13.01",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=132.0801:100,188.1429:93.09,134.0955:22.12,146.0954:17.92,189.1459:13.01"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 66,
                    "Name": "Spectra ID",
                    "URL": "https://hmdb.ca/spectra/ms_ms/2231893",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2231893"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 66,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Positive"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 66,
                    "Name": "SPLASH",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query==exists(splash.splash:%27splash10-000i-0907000000-c867b27f23c6a5d8d42c%27)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0907000000-c867b27f23c6a5d8d42c"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 66,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188.1432 100"
                        },
                        {
                          "String": "337.2271 92.29"
                        },
                        {
                          "String": "105.0697 3.58"
                        },
                        {
                          "String": "216.1382 3.43"
                        },
                        {
                          "String": "281.2011 2.05"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 66,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1432:100,337.2271:92.29,105.0697:3.58,216.1382:3.43,281.2011:2.05",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1432:100,337.2271:92.29,105.0697:3.58,216.1382:3.43,281.2011:2.05"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "NIST Number",
                    "Value": {
                      "Number": [
                        1184403
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "IT/ion trap"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "Collision Energy",
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "Spectrum Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "Precursor Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "Precursor m/z",
                    "Value": {
                      "Number": [
                        337.2274
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "Total Peaks",
                    "Value": {
                      "Number": [
                        16
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "m/z Top Peak",
                    "Value": {
                      "Number": [
                        188.1
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "m/z 2nd Highest",
                    "Value": {
                      "Number": [
                        216.1
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "m/z 3rd Highest",
                    "Value": {
                      "Number": [
                        281.1
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 107,
                    "Name": "Thumbnail",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/283026_1"
                      ],
                      "MimeType": "image/png"
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "NIST Number",
                    "Value": {
                      "Number": [
                        1006563
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "IT/ion trap"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "Collision Energy",
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "Spectrum Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "Precursor Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "Precursor m/z",
                    "Value": {
                      "Number": [
                        337.2274
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "Total Peaks",
                    "Value": {
                      "Number": [
                        14
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "m/z Top Peak",
                    "Value": {
                      "Number": [
                        188
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "m/z 2nd Highest",
                    "Value": {
                      "Number": [
                        216
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "m/z 3rd Highest",
                    "Value": {
                      "Number": [
                        132
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 108,
                    "Name": "Thumbnail",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/285711_1"
                      ],
                      "MimeType": "image/png"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "LC-MS",
                "Description": "Data from liquid chromatography-mass spectrometry (LC-MS) experiments.",
                "URL": "https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 2
                },
                "Information": [
                  {
                    "ReferenceNumber": 70,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU154501",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Athens_Univ-AU154501"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nikiforos Alygizakis, Nikolaos Thomaidis, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Bruker maXis Impact"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QTOF"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "10 eV"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CID"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Acclaim RSLC C18 2.2um, 2.1x100mm, Thermo"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.1 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2283 999"
                        },
                        {
                          "String": "338.2312 201"
                        },
                        {
                          "String": "339.2338 18"
                        },
                        {
                          "String": "188.1427 6"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0009000000-62593b54c6285a566893",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0009000000-62593b54c6285a566893"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2283:999,338.2312:201,339.2338:18,188.1427:6,",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2283:999,338.2312:201,339.2338:18,188.1427:6,"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 70,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-SA"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU154502",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Athens_Univ-AU154502"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nikiforos Alygizakis, Nikolaos Thomaidis, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Bruker maXis Impact"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QTOF"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "20 eV"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CID"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Acclaim RSLC C18 2.2um, 2.1x100mm, Thermo"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.1 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2283 999"
                        },
                        {
                          "String": "188.1427 344"
                        },
                        {
                          "String": "338.2312 159"
                        },
                        {
                          "String": "189.1458 31"
                        },
                        {
                          "String": "339.2338 16"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0209000000-d550d803c25d31570227",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0209000000-d550d803c25d31570227"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2283:999,188.1427:344,338.2312:159,189.1458:31,339.2338:16",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2283:999,188.1427:344,338.2312:159,189.1458:31,339.2338:16"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 71,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-SA"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU154503",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Athens_Univ-AU154503"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nikiforos Alygizakis, Nikolaos Thomaidis, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Bruker maXis Impact"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QTOF"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "30 eV"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CID"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Acclaim RSLC C18 2.2um, 2.1x100mm, Thermo"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.1 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188.1428 999"
                        },
                        {
                          "String": "337.2283 144"
                        },
                        {
                          "String": "189.1459 85"
                        },
                        {
                          "String": "216.1378 83"
                        },
                        {
                          "String": "338.2312 26"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0901000000-09bd125eea134f8811a4",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0901000000-09bd125eea134f8811a4"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1428:999,337.2283:144,189.1459:85,216.1378:83,338.2312:26",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1428:999,337.2283:144,189.1459:85,216.1378:83,338.2312:26"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 72,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-SA"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU154504",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Athens_Univ-AU154504"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nikiforos Alygizakis, Nikolaos Thomaidis, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Bruker maXis Impact"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QTOF"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "40 eV"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CID"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Acclaim RSLC C18 2.2um, 2.1x100mm, Thermo"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.1 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188.1428 999"
                        },
                        {
                          "String": "132.08 208"
                        },
                        {
                          "String": "134.0956 119"
                        },
                        {
                          "String": "189.1457 111"
                        },
                        {
                          "String": "216.1374 72"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0900000000-2c34993eade063cb426f",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0900000000-2c34993eade063cb426f"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1428:999,132.08:208,134.0956:119,189.1457:111,216.1374:72",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1428:999,132.08:208,134.0956:119,189.1457:111,216.1374:72"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 73,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-SA"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU154505",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Athens_Univ-AU154505"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nikiforos Alygizakis, Nikolaos Thomaidis, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Bruker maXis Impact"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QTOF"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "50 eV"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CID"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Acclaim RSLC C18 2.2um, 2.1x100mm, Thermo"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.1 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "132.0801 999"
                        },
                        {
                          "String": "188.1429 930"
                        },
                        {
                          "String": "134.0955 221"
                        },
                        {
                          "String": "146.0954 179"
                        },
                        {
                          "String": "189.1459 130"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-001r-0900000000-beb72ea99dc9c125d29b",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-001r-0900000000-beb72ea99dc9c125d29b"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=132.0801:999,188.1429:930,134.0955:221,146.0954:179,189.1459:130",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=132.0801:999,188.1429:930,134.0955:221,146.0954:179,189.1459:130"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 74,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-SA"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ364001",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Eawag-EQ364001"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Stravs M, Schymanski E, Singer H, Department of Environmental Chemistry, Eawag and Thomaidis N, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q Exactive Plus Orbitrap Thermo Scientific"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QFT"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "15 (nominal)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HCD"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "XBridge C18 3.5um, 2.1x50mm, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.0 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2271 999"
                        },
                        {
                          "String": "188.143 9"
                        },
                        {
                          "String": "105.07 2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0009000000-bf70e4d857c26d30032f",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0009000000-bf70e4d857c26d30032f"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2271:999,188.143:9,105.07:2,",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337.2271:999,188.143:9,105.07:2,"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 75,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ364002",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Eawag-EQ364002"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Stravs M, Schymanski E, Singer H, Department of Environmental Chemistry, Eawag and Thomaidis N, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q Exactive Plus Orbitrap Thermo Scientific"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QFT"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "30 (nominal)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HCD"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "XBridge C18 3.5um, 2.1x50mm, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.0 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188.1432 999"
                        },
                        {
                          "String": "337.2271 921"
                        },
                        {
                          "String": "105.0697 35"
                        },
                        {
                          "String": "216.1382 34"
                        },
                        {
                          "String": "281.2011 20"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0907000000-a9f5d0c422eff1474d38",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0907000000-a9f5d0c422eff1474d38"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1432:999,337.2271:921,105.0697:35,216.1382:34,281.2011:20",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1432:999,337.2271:921,105.0697:35,216.1382:34,281.2011:20"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 76,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ364003",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Eawag-EQ364003"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Stravs M, Schymanski E, Singer H, Department of Environmental Chemistry, Eawag and Thomaidis N, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q Exactive Plus Orbitrap Thermo Scientific"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QFT"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "45 (nominal)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HCD"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "XBridge C18 3.5um, 2.1x50mm, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.0 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188.1433 999"
                        },
                        {
                          "String": "105.0699 393"
                        },
                        {
                          "String": "134.0964 40"
                        },
                        {
                          "String": "146.0964 39"
                        },
                        {
                          "String": "132.0808 35"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0900000000-0c03ba9ef576114a9503",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0900000000-0c03ba9ef576114a9503"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1433:999,105.0699:393,134.0964:40,146.0964:39,132.0808:35",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188.1433:999,105.0699:393,134.0964:40,146.0964:39,132.0808:35"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 77,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ364004",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Eawag-EQ364004"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Stravs M, Schymanski E, Singer H, Department of Environmental Chemistry, Eawag and Thomaidis N, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q Exactive Plus Orbitrap Thermo Scientific"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QFT"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "60 (nominal)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HCD"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "XBridge C18 3.5um, 2.1x50mm, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.0 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "105.0698 999"
                        },
                        {
                          "String": "188.1433 353"
                        },
                        {
                          "String": "132.0807 57"
                        },
                        {
                          "String": "146.0964 39"
                        },
                        {
                          "String": "84.0807 31"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-0900000000-d2a36b402c3a7424fab6",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-0a4i-0900000000-d2a36b402c3a7424fab6"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105.0698:999,188.1433:353,132.0807:57,146.0964:39,84.0807:31",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105.0698:999,188.1433:353,132.0807:57,146.0964:39,84.0807:31"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 78,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ364005",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Eawag-EQ364005"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Stravs M, Schymanski E, Singer H, Department of Environmental Chemistry, Eawag and Thomaidis N, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q Exactive Plus Orbitrap Thermo Scientific"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QFT"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "75 (nominal)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HCD"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "XBridge C18 3.5um, 2.1x50mm, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.0 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "105.0698 999"
                        },
                        {
                          "String": "79.0542 77"
                        },
                        {
                          "String": "103.0542 55"
                        },
                        {
                          "String": "188.1433 49"
                        },
                        {
                          "String": "132.0807 37"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-1900000000-e0cbdfad80c306baabc1",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-0a4i-1900000000-e0cbdfad80c306baabc1"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105.0698:999,79.0542:77,103.0542:55,188.1433:49,132.0807:37",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105.0698:999,79.0542:77,103.0542:55,188.1433:49,132.0807:37"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 79,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ364006",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Eawag-EQ364006"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Stravs M, Schymanski E, Singer H, Department of Environmental Chemistry, Eawag and Thomaidis N, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q Exactive Plus Orbitrap Thermo Scientific"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QFT"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "90 (nominal)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HCD"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "XBridge C18 3.5um, 2.1x50mm, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.0 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "105.0698 999"
                        },
                        {
                          "String": "79.0542 213"
                        },
                        {
                          "String": "103.0542 158"
                        },
                        {
                          "String": "95.0491 46"
                        },
                        {
                          "String": "77.0385 33"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-2900000000-ea551550ac6cbe6d3960",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-0a4i-2900000000-ea551550ac6cbe6d3960"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105.0698:999,79.0542:213,103.0542:158,95.0491:46,77.0385:33",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105.0698:999,79.0542:213,103.0542:158,95.0491:46,77.0385:33"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 80,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ364007",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Eawag-EQ364007"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Stravs M, Schymanski E, Singer H, Department of Environmental Chemistry, Eawag and Thomaidis N, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q Exactive Plus Orbitrap Thermo Scientific"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QFT"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "120 (nominal)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HCD"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "XBridge C18 3.5um, 2.1x50mm, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.0 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "105.0698 999"
                        },
                        {
                          "String": "79.0542 916"
                        },
                        {
                          "String": "103.0542 702"
                        },
                        {
                          "String": "95.0491 481"
                        },
                        {
                          "String": "105.0447 338"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-0pdi-8900000000-89b1a77e558ec74cf3ac",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-0pdi-8900000000-89b1a77e558ec74cf3ac"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105.0698:999,79.0542:916,103.0542:702,95.0491:481,105.0447:338",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105.0698:999,79.0542:916,103.0542:702,95.0491:481,105.0447:338"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 81,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ364008",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Eawag-EQ364008"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Stravs M, Schymanski E, Singer H, Department of Environmental Chemistry, Eawag and Thomaidis N, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q Exactive Plus Orbitrap Thermo Scientific"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QFT"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "150 (nominal)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HCD"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "XBridge C18 3.5um, 2.1x50mm, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.0 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "95.0491 999"
                        },
                        {
                          "String": "79.0542 870"
                        },
                        {
                          "String": "105.0447 729"
                        },
                        {
                          "String": "103.0542 630"
                        },
                        {
                          "String": "77.0385 613"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-0kdj-9400000000-358833c028a079789d0b",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-0kdj-9400000000-358833c028a079789d0b"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=95.0491:999,79.0542:870,105.0447:729,103.0542:630,77.0385:613",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=95.0491:999,79.0542:870,105.0447:729,103.0542:630,77.0385:613"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 82,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ364009",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Eawag-EQ364009"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Stravs M, Schymanski E, Singer H, Department of Environmental Chemistry, Eawag and Thomaidis N, University of Athens"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q Exactive Plus Orbitrap Thermo Scientific"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-QFT"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS2"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Collision Energy",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "180 (nominal)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Fragmentation Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "HCD"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "XBridge C18 3.5um, 2.1x50mm, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "6.0 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Precursor m/z",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337.2274"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Precursor Adduct",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "[M+H]+"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "95.0491 999"
                        },
                        {
                          "String": "105.0447 722"
                        },
                        {
                          "String": "51.023 698"
                        },
                        {
                          "String": "77.0385 669"
                        },
                        {
                          "String": "79.0542 410"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-0ufs-9200000000-ff2c211a084a5f124781",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-0ufs-9200000000-ff2c211a084a5f124781"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=95.0491:999,105.0447:722,51.023:698,77.0385:669,79.0542:410",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=95.0491:999,105.0447:722,51.023:698,77.0385:669,79.0542:410"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 83,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA001015",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Waters-WA001015"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nihon Waters K.K."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ZQ, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-Q"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2.1 mm id - 3. 5{mu}m XTerra C18MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "12.950 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "105 999"
                        },
                        {
                          "String": "103 188"
                        },
                        {
                          "String": "106 82"
                        },
                        {
                          "String": "132 47"
                        },
                        {
                          "String": "188 39"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-0900000000-7e5507a8c116f91ad31c",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-0a4i-0900000000-7e5507a8c116f91ad31c"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105:999,103:188,106:82,132:47,188:39",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105:999,103:188,106:82,132:47,188:39"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 84,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-NC"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA001016",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Waters-WA001016"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nihon Waters K.K."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ZQ, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-Q"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2.1 mm id - 3. 5{mu}m XTerra C18MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "12.950 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "105 999"
                        },
                        {
                          "String": "188 341"
                        },
                        {
                          "String": "106 94"
                        },
                        {
                          "String": "132 94"
                        },
                        {
                          "String": "134 82"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-0900000000-bab016d2395f790207a1",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-0a4i-0900000000-bab016d2395f790207a1"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105:999,188:341,106:94,132:94,134:82",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=105:999,188:341,106:94,132:94,134:82"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 85,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-NC"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA001017",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Waters-WA001017"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nihon Waters K.K."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ZQ, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-Q"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2.1 mm id - 3. 5{mu}m XTerra C18MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "12.950 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188 999"
                        },
                        {
                          "String": "105 881"
                        },
                        {
                          "String": "189 145"
                        },
                        {
                          "String": "337 125"
                        },
                        {
                          "String": "134 121"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-052r-0900000000-0138160ee35d414400a7",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-052r-0900000000-0138160ee35d414400a7"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188:999,105:881,189:145,337:125,134:121",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188:999,105:881,189:145,337:125,134:121"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 86,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-NC"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA001018",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Waters-WA001018"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nihon Waters K.K."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ZQ, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-Q"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2.1 mm id - 3. 5{mu}m XTerra C18MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "12.950 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188 999"
                        },
                        {
                          "String": "337 834"
                        },
                        {
                          "String": "338 176"
                        },
                        {
                          "String": "189 118"
                        },
                        {
                          "String": "105 78"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0907000000-17800f363b08ed95ac7f",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0907000000-17800f363b08ed95ac7f"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188:999,337:834,338:176,189:118,105:78",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188:999,337:834,338:176,189:118,105:78"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 87,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-NC"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA001019",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Waters-WA001019"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nihon Waters K.K."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ZQ, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-Q"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2.1 mm id - 3. 5{mu}m XTerra C18MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "12.950 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337 999"
                        },
                        {
                          "String": "338 227"
                        },
                        {
                          "String": "188 31"
                        },
                        {
                          "String": "339 20"
                        },
                        {
                          "String": "359 8"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0009000000-41e6d9c94ae3c4129ec3",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0009000000-41e6d9c94ae3c4129ec3"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337:999,338:227,188:31,339:20,359:8",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337:999,338:227,188:31,339:20,359:8"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 88,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-NC"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Accession ID",
                    "URL": "https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA001020",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MSBNK-Waters-WA001020"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Authors",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Nihon Waters K.K."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ZQ, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-Q"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "POSITIVE"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Column Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "2.1 mm id - 3. 5{mu}m XTerra C18MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "12.950 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337 999"
                        },
                        {
                          "String": "338 215"
                        },
                        {
                          "String": "339 24"
                        },
                        {
                          "String": "295 8"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "SPLASH",
                    "URL": "https://massbank.eu/MassBank/Result.jsp?splash=splash10-000i-0009000000-60850fc4790b3c56a91b",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0009000000-60850fc4790b3c56a91b"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337:999,338:215,339:24,295:8,",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337:999,338:215,339:24,295:8,"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 89,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-NC"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "MoNA ID",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/display/WA001020",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "WA001020"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "MS Category",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Experimental"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "MS Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS1"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ZQ, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-Q"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "positive"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "12.950 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337 100"
                        },
                        {
                          "String": "338 21.52"
                        },
                        {
                          "String": "339 2.40"
                        },
                        {
                          "String": "295 0.80"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "SPLASH",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-000i-0009000000-60850fc4790b3c56a91b%27)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0009000000-60850fc4790b3c56a91b"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337:100,338:21.52,339:2.40,295:0.80",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337:100,338:21.52,339:2.40,295:0.80"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 90,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-NC"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "MoNA ID",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/display/WA001019",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "WA001019"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "MS Category",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Experimental"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "MS Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS1"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ZQ, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-Q"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "positive"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "12.950 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "337 100"
                        },
                        {
                          "String": "338 22.72"
                        },
                        {
                          "String": "188 3.10"
                        },
                        {
                          "String": "339 2"
                        },
                        {
                          "String": "359 0.80"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "SPLASH",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-000i-0009000000-41e6d9c94ae3c4129ec3%27)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0009000000-41e6d9c94ae3c4129ec3"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337:100,338:22.72,188:3.10,339:2,359:0.80",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=337:100,338:22.72,188:3.10,339:2,359:0.80"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 91,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-NC"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "MoNA ID",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/display/WA001018",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "WA001018"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "MS Category",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Experimental"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "MS Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-MS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "MS Level",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MS1"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "Instrument",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ZQ, Waters"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "Instrument Type",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LC-ESI-Q"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "Ionization",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ESI"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "Ionization Mode",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "positive"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "Retention Time",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "12.950 min"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "Top 5 Peaks",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "188 100"
                        },
                        {
                          "String": "337 83.48"
                        },
                        {
                          "String": "338 17.62"
                        },
                        {
                          "String": "189 11.81"
                        },
                        {
                          "String": "105 7.81"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "SPLASH",
                    "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-000i-0907000000-17800f363b08ed95ac7f%27)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "splash10-000i-0907000000-17800f363b08ed95ac7f"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "Thumbnail",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188:100,337:83.48,338:17.62,189:11.81,105:7.81",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=188:100,337:83.48,338:17.62,189:11.81,105:7.81"
                      ],
                      "MimeType": "image/svg"
                    }
                  },
                  {
                    "ReferenceNumber": 92,
                    "Name": "License",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC BY-NC"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Other MS",
                "Description": "This section provides this compound's mass spectrometry (MS) information that is not shown in other sections.",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 2
                },
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Lide, D.R., G.W.A. Milne (eds.). Handbook of Data on Organic Compounds. Volume I. 3rd ed. CRC Press, Inc. Boca Raton ,FL. 1994., p. 4261"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "MASS: 64184 (NIST/EPA/MSDC Mass Spectral Database 1990 version)",
                          "Markup": [
                            {
                              "Start": 22,
                              "Length": 4,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MSDC",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-131526"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "UV Spectra",
            "Description": "Ultraviolet (UV) spectroscopy (or Spectrophotometry) is an analytical technique used to measure how much a molecule absorbs light in the ultraviolet spectral region.  This technique is particularly useful to study aromatic, conjugated, and other substances containing a pi bond.  Modern ultraviolet spectrophotometers also cover the visible light range, in which case the technique is called ultraviolet-visible (UV-Vis) spectroscopy.",
            "URL": "https://chem.libretexts.org/Courses/Brevard_College/CHE_202%3A_Organic_Chemistry_II/05%3A_Structural__Determination_I/5.05%3A_Ultraviolet_and_visible_spectroscopy",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Lide, D.R., G.W.A. Milne (eds.). Handbook of Data on Organic Compounds. Volume I. 3rd ed. CRC Press, Inc. Boca Raton ,FL. 1994., p. 4261"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "UV: 2314 (Absorption Spectra in the UV and Vis Region, Academic Press, New York)"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "IR Spectra",
            "Description": "Infrared spectroscopy (IR spectroscopy) is the spectroscopy that deals with the infrared region of the electromagnetic spectrum extending from 780 nm to about 20000 nm.  The IR spectra tells you what types of vibrational mode (motion) responses occur in a molecule interacting with infrared light.  It is used to help determine the functional groups in a molecule.",
            "URL": "https://chem.libretexts.org/Bookshelves/Physical_and_Theoretical_Chemistry_Textbook_Maps/Supplemental_Modules_(Physical_and_Theoretical_Chemistry)/Spectroscopy/Vibrational_Spectroscopy/Infrared_Spectroscopy",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 2
            },
            "Section": [
              {
                "TOCHeading": "ATR-IR Spectra",
                "Description": "Attenuated total reflection infrared (ATR-IR) spectral data.  ATR is a sampling technique that enables samples to be examined directly in the solid or liquid state without further preparation.  ATR-IR can be applied to the same chemical or biological systems as the transmission IR.  An advantage of ATR-IR over the transmission IR is the limited path length into the sample, because ATR-IR avoids the problem of strong attenuation of the IR signal in highly absorbing media such as aqueous solutions.",
                "URL": "https://chem.libretexts.org/Bookshelves/Analytical_Chemistry/Supplemental_Modules_(Analytical_Chemistry)/Instrumental_Analysis/Spectrometer/ATR-FTIR",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 2
                },
                "Information": [
                  {
                    "ReferenceNumber": 121,
                    "Name": "Instrument Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Bio-Rad FTS"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 121,
                    "Name": "Technique",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ATR-Film (MeCl2) (DuraSamplIR II)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 121,
                    "Name": "Source of Spectrum",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Forensic Spectral Research"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 121,
                    "Name": "Source of Sample",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Alltech Associates, Inc., Grace Davison Discovery Sciences"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 121,
                    "Name": "Catalog Number",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Free base of 01399"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 121,
                    "Name": "Lot Number",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Free base of 543"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 121,
                    "Name": "Copyright",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Copyright © 2012-2024 John Wiley & Sons, Inc. All Rights Reserved."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 121,
                    "Name": "Thumbnail",
                    "URL": "https://spectrabase.com/spectrum/CCvkKc7ex9K",
                    "Value": {
                      "ExternalDataURL": [
                        "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4543563_1"
                      ],
                      "MimeType": "image/png"
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Other Spectra",
            "Description": "Spectral information for this compound that is not shown in other sections.",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Pfleger, K., H. Maurer and A. Weber. Mass Spectral and GC Data of Drugs, Poisons and their Metabolites. Parts I and II. Mass Spectra Indexes. Weinheim, Federal Republic of Germany. 1985., p. 589"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Intense mass spectral peaks: 146 m/z, 189 m/z, 245 m/z, 336 m/z"
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Related Records",
        "Description": "Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.",
        "Section": [
          {
            "TOCHeading": "Related Compounds with Annotation",
            "Description": "Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the \"Related Compounds\" section below this section.  The \"Related Compounds\" include the parent, components, mixtures, and salt forms of this compound record as well as the \"similar compounds\" and \"similar conformers\", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.",
            "URL": "https://doi.org/10.1186/s13321-016-0163-1",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see here for details), but these live search links provide equivalent functionality to the table that was previously shown here.",
                      "Markup": [
                        {
                          "Start": 22,
                          "Length": 19,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/#query=CID3345%20structure&tab=similarity&sort=annothitcnt"
                        },
                        {
                          "Start": 45,
                          "Length": 19,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/#query=CID3345%20structure&tab=similarity_3d&sort=annothitcnt"
                        },
                        {
                          "Start": 144,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Related Compounds",
            "Description": "Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the \"similar compounds\" and \"similar conformers\", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.",
            "URL": "https://doi.org/10.1186/s13321-016-0163-1",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 1
            },
            "Information": [
              {
                "ReferenceNumber": 136,
                "Name": "Same Connectivity Count",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3345/cids/JSON?cids_type=same_connectivity&list_return=redirect",
                "Value": {
                  "Number": [
                    37
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "Same Parent, Connectivity Count",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3345/cids/JSON?cids_type=same_parent_connectivity&list_return=redirect",
                "Value": {
                  "Number": [
                    92
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "Same Parent, Exact Count",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3345/cids/JSON?cids_type=same_parent&list_return=redirect",
                "Value": {
                  "Number": [
                    54
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "Mixtures, Components, and Neutralized Forms Count",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3345/cids/JSON?cids_type=component&list_return=redirect",
                "Value": {
                  "Number": [
                    173
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "Similar Compounds (2D)",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/#query=CID3345%20structure&tab=similarity",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "View in PubChem Search"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "Similar Conformers (3D)",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/#query=CID3345%20structure&tab=similarity_3d",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "View in PubChem Search"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Substances",
            "Description": "Substance records associated with this compound.  In PubChem, the term \"substance\" refers to depositor-provided data for a chemical..",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/docs/substances",
            "Section": [
              {
                "TOCHeading": "PubChem Reference Collection SID",
                "Description": "Substances from the special PubChem Reference Collection associated with this compound.",
                "DisplayControls": {
                  "MoveToTop": true
                },
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/481107979",
                    "Value": {
                      "Number": [
                        481107979
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Related Substances",
                "Description": "Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 1
                },
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Name": "All Count",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3345/sids/JSON?sids_type=all&list_return=redirect",
                    "Value": {
                      "Number": [
                        505
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 136,
                    "Name": "Same Count",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3345/sids/JSON?sids_type=standardized&list_return=redirect",
                    "Value": {
                      "Number": [
                        130
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 136,
                    "Name": "Mixture Count",
                    "URL": "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3345/sids/JSON?sids_type=component&list_return=redirect",
                    "Value": {
                      "Number": [
                        375
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Substances by Category",
                "Description": "Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).",
                "Information": [
                  {
                    "ReferenceNumber": 136,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Chemical Vendors"
                        },
                        {
                          "String": "Curation Efforts"
                        },
                        {
                          "String": "Governmental Organizations"
                        },
                        {
                          "String": "Journal Publishers"
                        },
                        {
                          "String": "Legacy Depositors"
                        },
                        {
                          "String": "NIH Initiatives"
                        },
                        {
                          "String": "Research and Development"
                        },
                        {
                          "String": "Subscription Services"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Other Relationships",
            "Description": "Other types of related records, such as alternative forms, monomers or polymers, components of important mixtures, etc. In this table, the relationship is in parentheses, and the implied grammar is \"the compound summarized on this page ... has this relationship to ... this item in the table.\"",
            "DisplayControls": {
              "ListType": "Columns"
            },
            "Information": [
              {
                "ReferenceNumber": 136,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl Citrate (has salt form)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/13810"
                        },
                        {
                          "Start": 0,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=13810",
                          "Type": "Icon"
                        }
                      ]
                    },
                    {
                      "String": "Fentanyl Hydrochloride (has salt form)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 22,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/83932"
                        },
                        {
                          "Start": 0,
                          "Length": 22,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=83932",
                          "Type": "Icon"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Entrez Crosslinks",
            "Description": "Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 1
            },
            "Information": [
              {
                "ReferenceNumber": 136,
                "Name": "PubMed Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=3345",
                "Value": {
                  "Number": [
                    8174
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "Protein Structures Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_structure&db=pccompound&cmd=Link&from_uid=3345",
                "Value": {
                  "Number": [
                    13
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "Taxonomy Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&db=pccompound&cmd=Link&from_uid=3345",
                "Value": {
                  "Number": [
                    4
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "OMIM Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_omim&db=pccompound&cmd=Link&from_uid=3345",
                "Value": {
                  "Number": [
                    8
                  ]
                }
              },
              {
                "ReferenceNumber": 136,
                "Name": "Gene Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=3345",
                "Value": {
                  "Number": [
                    111
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Associated Chemicals",
            "Description": "Chemicals related to this compound, according to the Hazardous Substances Data Bank (HSDB).  It includes stereoisomers (e.g., enantiomers, cis-trans isomers), salt forms, mixtures, and structural analogues, etc.",
            "URL": "https://www.nlm.nih.gov/databases/download/hsdb.html",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl citrate; 990-73-8",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 18,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/990-73-8",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "NCBI LinkOut",
            "Description": "NCBI LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.",
            "URL": "https://www.ncbi.nlm.nih.gov/projects/linkout/",
            "Information": [
              {
                "ReferenceNumber": 167,
                "Value": {
                  "Boolean": [
                    true
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Chemical Vendors",
        "Description": "A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  ",
        "Information": [
          {
            "ReferenceNumber": 136,
            "Value": {
              "Boolean": [
                true
              ]
            }
          }
        ]
      },
      {
        "TOCHeading": "Drug and Medication Information",
        "Description": "This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.",
        "Section": [
          {
            "TOCHeading": "Drug Indication",
            "Description": "A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.",
            "DisplayControls": {
              "ShowAtMost": 3
            },
            "Information": [
              {
                "ReferenceNumber": 15,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia. These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia. Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.  Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 306,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 369,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Oxygen",
                          "Type": "PubChem Internal Link",
                          "Extra": "Element-Oxygen"
                        },
                        {
                          "Start": 415,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 15,
                "URL": "http://s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00813.pdf?1558725901",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FDA Label"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 41,
                "Name": "Drug Indication",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Effentora is indicated for the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. , , BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. , , Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer. ,",
                      "Markup": [
                        {
                          "Start": 380,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 434,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 471,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxycodone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284603"
                        },
                        {
                          "Start": 510,
                          "Length": 13,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/hydromorphone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284570"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "Drug Indication",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "PecFent is indicated for the management of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equi-analgesic dose of another opioid for a week or longer.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/PecFent",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 367,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 421,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 458,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxycodone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284603"
                        },
                        {
                          "Start": 497,
                          "Length": 13,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/hydromorphone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284570"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "Drug Indication",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Ionsys is indicated for the management of acute moderate to severe post-operative pain in adult patients.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Ionsys",
                          "Type": "PubChem Internal Link",
                          "Extra": "multiple-CIDs"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "Drug Indication",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "For the control of pain associated with orthopaedic and soft tissue surgery in dogs."
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "Drug Indication",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Management of acute moderate to severe post-operative pain for use in a hospital setting only"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 113,
                "Value": {
                  "ExternalTableName": "collection=opentargetsdrugindication&devel=1"
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug Classes",
            "Description": "Drug classes of this compound, based on its therapeutic uses and/or structure. The data presented in this section is from LiverTox.",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/source/15404",
            "Information": [
              {
                "ReferenceNumber": 16,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Breast Feeding; Lactation; Milk, Human; Analgesics, Opioid; Narcotics; Anesthetics, Intravenous; Opiates"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug Transformations",
            "Description": "This section provides information how a drug may be chemically transformed (in vivo or in the environment), such as by acetylation, oxidation, hydrogenation, etc.",
            "Information": [
              {
                "ReferenceNumber": 111,
                "Reference": [
                  "S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl has known transformation products that include Norfentanyl.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 56,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Medication Guides",
            "Description": "FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events.",
            "URL": "https://www.fda.gov/drugs/drug-safety-and-availability/medication-guides",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 5,
                "ColumnsFromNamedLists": {
                  "Name": [
                    "Drug",
                    "Active Ingredient",
                    "Form;Route",
                    "Company",
                    "Date"
                  ],
                  "UseNamesAsColumnHeadings": true
                }
              },
              "ShowAtMost": 3
            },
            "Information": [
              {
                "ReferenceNumber": 49,
                "Name": "Drug",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "DURAGESIC-100",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 13,
                          "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 49,
                "Name": "Active Ingredient",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 49,
                "Name": "Form;Route",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FILM, EXTENDED RELEASE;TRANSDERMAL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 49,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "JANSSEN PHARMS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 49,
                "Name": "Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "3/4/21"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 50,
                "Name": "Drug",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "DURAGESIC-12",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 12,
                          "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 50,
                "Name": "Active Ingredient",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 50,
                "Name": "Form;Route",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FILM, EXTENDED RELEASE;TRANSDERMAL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 50,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "JANSSEN PHARMS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 50,
                "Name": "Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "3/4/21"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 51,
                "Name": "Drug",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "DURAGESIC-25",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 12,
                          "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 51,
                "Name": "Active Ingredient",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 51,
                "Name": "Form;Route",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FILM, EXTENDED RELEASE;TRANSDERMAL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 51,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "JANSSEN PHARMS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 51,
                "Name": "Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "3/4/21"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 52,
                "Name": "Drug",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "DURAGESIC-37",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 12,
                          "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 52,
                "Name": "Active Ingredient",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 52,
                "Name": "Form;Route",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FILM, EXTENDED RELEASE;TRANSDERMAL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 52,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "JANSSEN PHARMS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 52,
                "Name": "Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "3/4/21"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 53,
                "Name": "Drug",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "DURAGESIC-50",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 12,
                          "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 53,
                "Name": "Active Ingredient",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 53,
                "Name": "Form;Route",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FILM, EXTENDED RELEASE;TRANSDERMAL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 53,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "JANSSEN PHARMS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 53,
                "Name": "Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "3/4/21"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 54,
                "Name": "Drug",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "DURAGESIC-75",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 12,
                          "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 54,
                "Name": "Active Ingredient",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 54,
                "Name": "Form;Route",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FILM, EXTENDED RELEASE;TRANSDERMAL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 54,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "JANSSEN PHARMS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 54,
                "Name": "Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "3/4/21"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 55,
                "Name": "Drug",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "SUBSYS",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 6,
                          "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202788s023lbl.pdf#page=40"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 55,
                "Name": "Active Ingredient",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 55,
                "Name": "Form;Route",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "SPRAY;SUBLINGUAL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 55,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "BTCP PHARMA"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 55,
                "Name": "Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "12/3/21"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "WHO Essential Medicines",
            "Description": "The WHO Essential Medicines present a list of minimum medicine needs for a basic health-care system, listing the most efficacious, safe and cost-effective medicines for priority conditions.",
            "URL": "https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 4,
                "ColumnsFromNamedLists": {
                  "Name": [
                    "Drug",
                    "Drug Classes",
                    "Formulation",
                    "Indication"
                  ],
                  "UseNamesAsColumnHeadings": true
                }
              },
              "ShowAtMost": 3
            },
            "Information": [
              {
                "ReferenceNumber": 131,
                "Name": "Drug",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://list.essentialmeds.org/medicines/17"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 131,
                "Name": "Drug Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Opioid analgesics"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 131,
                "Name": "Formulation",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "(1) Local - Topical - Transdermal patch: 12 Âµg/hour; 25 Âµg/hour; 50 Âµg/hour; 75 Âµg/hour; 100 Âµg/hour; (2) Oral - Solid: 100 to 800 Âµg sub-lingual tablet (as citrate); 200 to 1600 Âµg lozenge (as citrate); (3) Oral - Other: 200 to 1200 Âµg buccal film (as citrate)",
                      "Markup": [
                        {
                          "Start": 163,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-31348"
                        },
                        {
                          "Start": 201,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-31348"
                        },
                        {
                          "Start": 261,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-31348"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 131,
                "Name": "Indication",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "(1) Chronic cancer pain; (2) Other specified chronic cancer related pain"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Approved Drugs",
            "Description": "Drugs@FDA includes information about approved drugs and biological products for human use in the United States.",
            "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda",
            "Information": [
              {
                "ReferenceNumber": 17,
                "Value": {
                  "ExternalTableName": "collection=fdadrug&query_type=synonym&query='^FENTANYL$'"
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Orange Book",
            "Description": "The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.",
            "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
            "Information": [
              {
                "ReferenceNumber": 56,
                "Value": {
                  "ExternalTableName": "collection=fdaorangebook&query_type=synonym&query='^FENTANYL$'"
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA National Drug Code Directory",
            "Description": "The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).",
            "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory",
            "Information": [
              {
                "ReferenceNumber": 95,
                "Value": {
                  "ExternalTableName": "collection=fdandc&query_type=synonym&query='^FENTANYL$'"
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Green Book",
            "Description": "The FDA Green Book lists most of FDA-approved animal drug products, along with associated patents and market exclusivity information.",
            "URL": "https://www.fda.gov/animal-veterinary/products/approved-animal-drug-products-green-book",
            "Information": [
              {
                "ReferenceNumber": 47,
                "Value": {
                  "ExternalTableName": "collection=fdagreen&query_type=synonym&query='^Fentanyl$'"
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug Labels",
            "Description": "This section provides the drug labeling information for drug products associated with this compound. This information is from The National Library of Medicine (NLM)'s DailyMed, which provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., \"in use\" labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, cosmetics, dietary supplements, and medical foods.",
            "URL": "https://dailymed.nlm.nih.gov/dailymed/",
            "Information": [
              {
                "ReferenceNumber": 11,
                "Name": "Drug and label",
                "Value": {
                  "ExternalTableName": "collection=dailymed&query_type=synonym&query='^FENTANYL$'"
                }
              },
              {
                "ReferenceNumber": 11,
                "Name": "Active ingredient and drug",
                "Value": {
                  "ExternalTableName": "collection=dailymed_i&query_type=synonym&query='^FENTANYL$'"
                }
              }
            ]
          },
          {
            "TOCHeading": "Clinical Trials",
            "Description": "Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.",
            "Section": [
              {
                "TOCHeading": "ClinicalTrials.gov",
                "Description": "Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.",
                "URL": "http://clinicaltrials.gov/",
                "Information": [
                  {
                    "ReferenceNumber": 8,
                    "Name": "ClinicalTrials.gov",
                    "Value": {
                      "ExternalTableName": "clinicaltrials",
                      "ExternalTableNumRows": 475
                    }
                  }
                ]
              },
              {
                "TOCHeading": "EU Clinical Trials Register",
                "Description": "Brief clinical trials summary from the EU Clinical Trials Register.",
                "URL": "https://www.clinicaltrialsregister.eu/",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Name": "EU Clinical Trials Register",
                    "Value": {
                      "ExternalTableName": "clinicaltrials_eu",
                      "ExternalTableNumRows": 90
                    }
                  }
                ]
              },
              {
                "TOCHeading": "NIPH Clinical Trials Search of Japan",
                "Description": "Brief clinical trials summary from the NIPH Clinical Trials Search of Japan, which allows one to cross-search four national clinical research information registries in Japan: the Japan Registry of Clinical Trials (JRCT), the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials (JMACCT).",
                "URL": "https://rctportal.niph.go.jp/en/",
                "Information": [
                  {
                    "ReferenceNumber": 100,
                    "Name": "NIPH Clinical Trials Search of Japan",
                    "Value": {
                      "ExternalTableName": "clinicaltrials_jp",
                      "ExternalTableNumRows": 88
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "DEA Drug and Chemical Information",
            "Description": "DEA drug factsheet, controlled substances, and chemical information include the drug name, street names, uses, effects, legal status in the U.S. and the links to the DEA website.",
            "URL": "https://www.deadiversion.usdoj.gov/drug_chem_info/",
            "Information": [
              {
                "ReferenceNumber": 12,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://www.deadiversion.usdoj.gov/drug_chem_info/fentanyl.pdf"
                        }
                      ]
                    },
                    {
                      "String": "(Trade names:Actiq®, Fentora™, Duragesic®)",
                      "Markup": [
                        {
                          "Start": 13,
                          "Length": 5,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Actiq",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 21,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentora",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 31,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Duragesic",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ],
            "Section": [
              {
                "TOCHeading": "DEA Drug Facts",
                "Description": "Controlled substances information provided by the Drug Enforcement Agency (DEA) Factsheets, including the drug name, street names, uses, effects, legal status in the U.S. and the link to the DEA factsheet.",
                "URL": "https://www.dea.gov/factsheets",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ListType": "Bulleted"
                },
                "Information": [
                  {
                    "ReferenceNumber": 13,
                    "Name": "Drug Name",
                    "URL": "https://www.dea.gov/factsheets/fentanyl",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 13,
                    "Name": "What is Fentanyl?",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl is a potent synthetic opioid drug approved by the Food and Drug Administration for use as an analgesic (pain relief) and anesthetic. It is approximately 100 times more potent than morphine and 50 times more potent than heroin as an analgesic.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 189,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 228,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5462328"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 13,
                    "Name": "Street Title",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Apace, China Girl, China Town, Dance Fever, Friend, Goodfellas, Great Bear, He-Man, Jackpot, King Ivory, Murder 8, Poison and Tango & Cash"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 13,
                    "Name": "How is it consumed?",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "snorted/sniffed, smoked, orally by pill or tablet, spiked onto blotter paper, patches, sold alone or in combination with heroin and other substances, has been identified in fake pills, mimicking pharmaceutical drugs such as oxycodone.",
                          "Markup": [
                            {
                              "Start": 121,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5462328"
                            },
                            {
                              "Start": 224,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxycodone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284603"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 13,
                    "Name": "What is their effect on the body?",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Similar to other opioid analgesics, fentanyl produces effects such as: relaxation, euphoria, pain relief, sedation, confusion, drowsiness, dizziness, nausea and vomiting, urinary retention, pupillary constriction, and respiratory depression.",
                          "Markup": [
                            {
                              "Start": 36,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 13,
                    "Name": "What are the effects of an overdose?",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Overdose can cause stupor, changes in pupil size, clammy skin, cyanosis, coma, and respiratory failure leading to death. The presence of a triad of symptoms such as coma, pinpoint pupils, and respiratory depression strongly suggests opioid intoxication."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 13,
                    "Name": "Class",
                    "URL": "https://www.dea.gov/taxonomy/term/331",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Narcotics (Opioids)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 13,
                    "Name": "Fact sheet",
                    "URL": "https://www.dea.gov/sites/default/files/2023-06/Fentanyl%202022%20Drug%20Fact%20Sheet-update.pdf",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "PDF"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "DEA Controlled Substances",
                "Description": "This section provides information on Drug Enforcement Agency (DEA) controlled substances, including substance name, DEA code number and schedule, and whether the substance is a narcotic or not.",
                "URL": "https://www.deadiversion.usdoj.gov/schedules/",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  }
                },
                "Information": [
                  {
                    "ReferenceNumber": 14,
                    "Name": "Substance",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 14,
                    "Name": "DEA Controlled Substances Code Number",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "9801"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 14,
                    "Name": "Controlled Substances Act Schedule",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Schedule II - Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 14,
                    "Name": "Class",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Opiates"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 96,
                    "Name": "Non-Proprietary Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "FENTANYL"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 96,
                    "Name": "DEA Substances Act Schedule",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Schedule II"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 97,
                    "Name": "Non-Proprietary Name",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "FENTANYL TRANSDERMAL"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 97,
                    "Name": "DEA Substances Act Schedule",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Schedule II"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "EMA Drug Information",
            "Description": "Drug information from the European Medicines Agency (EMA).",
            "URL": "https://www.ema.europa.eu/en",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 2
            },
            "Information": [
              {
                "ReferenceNumber": 41,
                "Name": "Medicine",
                "URL": "https://www.ema.europa.eu/en/medicines/human/EPAR/effentora",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Effentora"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 41,
                "Name": "Category",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Human drugs"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 41,
                "Name": "Therapeutic area",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Pain;  Cancer"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 41,
                "Name": "Active Substance",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 41,
                "Name": "INN/Common name",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 41,
                "Name": "Pharmacotherapeutic Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Analgesics"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 41,
                "Name": "Status",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "This medicine is authorized for use in the European Union"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 41,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Teva B.V."
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 41,
                "Name": "Market Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "2008-04-04"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "Medicine",
                "URL": "https://www.ema.europa.eu/en/medicines/human/EPAR/pecfent",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "PecFent"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "Category",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Human drugs"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "Therapeutic area",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Pain;  Cancer"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "Active Substance",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "INN/Common name",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "Pharmacotherapeutic Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Analgesics"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "Status",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "This medicine is authorized for use in the European Union"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Kyowa Kirin Holdings B.V."
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "Market Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "2010-08-31"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "Medicine",
                "URL": "https://www.ema.europa.eu/en/medicines/human/EPAR/ionsys",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Ionsys"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "Category",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Human drugs"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "Therapeutic area",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Pain, Postoperative"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "Active Substance",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl hydrochloride"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "INN/Common name",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "Pharmacotherapeutic Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Analgesics"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "Status",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Withdrawn"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Incline Therapeutics Europe Ltd"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "Market Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "2015-11-18"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "Medicine",
                "URL": "https://www.ema.europa.eu/en/medicines/veterinary/EPAR/recuvyra",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Recuvyra"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "Category",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Veterinary drugs"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "Active Substance",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "INN/Common name",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "Pharmacotherapeutic Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Nervous system"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "Status",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Withdrawn"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Eli Lilly and Company LimitedÂ "
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "Market Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "2011-10-06"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "Medicine",
                "URL": "https://www.ema.europa.eu/en/medicines/human/EPAR/ionsys-0",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Ionsys"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "Category",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Human drugs"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "Therapeutic area",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Pain, Postoperative"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "Active Substance",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl hydrochloride"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "INN/Common name",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "fentanyl"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "Pharmacotherapeutic Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Analgesics"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "Status",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Withdrawn"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Janssen-Cilag International NV"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "Market Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "2006-01-24"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Therapeutic Uses",
            "Description": "Therapeutic uses information for this compound, provided by the Hazardous Substances Data Bank (HSDB).",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/source/11933",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "National Library of Medicine's Medical Subject Headings. Fentanyl. Online file (MeSH, 2017). Available from, as of April 26, 2017: https://www.nlm.nih.gov/mesh/2017/mesh_browser/MBrowser.html"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Analgesics, Opioid; Adjuvants, Anesthesia; Narcotics; Anesthetics, Intravenous"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "NIH/NLM; ClinicalTrials.Gov. Available from, as of June 20, 2017: https://clinicaltrials.gov/"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "/CLINICAL TRIALS/ ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. The Web site is maintained by the National Library of Medicine (NLM) and the National Institutes of Health (NIH). Each ClinicalTrials.gov record presents summary information about a study protocol and includes the following: Disease or condition; Intervention (for example, the medical product, behavior, or procedure being studied); Title, description, and design of the study; Requirements for participation (eligibility criteria); Locations where the study is being conducted; Contact information for the study locations; and Links to relevant information on other health Web sites, such as NLM's MedlinePlus for patient health information and PubMed for citations and abstracts for scholarly articles in the field of medicine. Fentanyl is included in the database.",
                      "Markup": [
                        {
                          "Start": 906,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2236"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl citrate is a strong analgesic used preoperatively, during surgery, and in the immediate postoperative period for its analgesic action. In addition, the drug may be used to prevent or relieve tachypnea and postoperative emergence delirium. Fentanyl citrate is used parenterally to provide preoperative anxiolysis and sedation and as a supplement to anesthesia. The drug may be especially useful preoperatively before surgery of short duration or minor surgery in outpatients and in diagnostic procedures or treatments that require the patient to be awake or very lightly anesthetized. Fentanyl citrate may be used as a supplement to general or regional anesthesia, including neuroleptanalgesia in which it is often used in combination with droperidol. When attenuation of the response to surgical stress is especially important, fentanyl citrate may be administered with oxygen and a skeletal muscle relaxant to provide anesthesia without the use of additional anesthetic agents. /Included in US product label/",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 248,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 593,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 748,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/droperidol",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3168"
                        },
                        {
                          "Start": 837,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 879,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Oxygen",
                          "Type": "PubChem Internal Link",
                          "Extra": "Element-Oxygen"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2237"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl citrate buccal lozenges, buccal tablets, sublingual tablets, and nasal spray, and fentanyl sublingual spray are used for the management of breakthrough pain in patients who are already being treated with, and are tolerant of, opiates used around the clock for persistent cancer pain. /Include in US product label/",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 91,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "For more Therapeutic Uses (Complete) data for Fentanyl (11 total), please visit the HSDB record page.",
                      "Markup": [
                        {
                          "Start": 84,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Therapeutic-Uses-(Complete)"
                        },
                        {
                          "Start": 46,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug Warnings",
            "Description": "Drug warnings information collected by the Hazardous Substances Data Bank (HSDB) from various sources, including US Pharmacopeia (USP), physicians desk references, MSDS, etc.",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/source/11933",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "US Natl Inst Health; DailyMed. Current Medication Information for Fentanyl Citrate (Fentanyl Citrate) Lozenge (Updated: February 2012). Available from, as of Jun3 1, 2017: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=552ba162-76ed-4bc9-8c2c-fac7a1804da0"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "/BOXED WARNING/ WARNING: RISK OF RESPIRATORY DEPRESSION. Fatal respiratory depression has occurred in patients treated with oral transmucosal fentanyl citrate, including following use in opioid non-tolerant patients and improper dosing. The substitution of oral transmucosal fentanyl citrate for any other fentanyl product may result in fatal overdose. Due to the risk of respiratory depression, oral transmucosal fentanyl citrate is contraindicated in the management of acute or postoperative pain including headache/migraine and in opioid non-tolerant patients. Death has been reported in children who have accidentally ingested oral transmucosal fentanyl citrate. Oral transmucosal fentanyl citrate must be kept out of reach of children. The concomitant use of oral transmucosal fentanyl citrate with CYP3A4 inhibitors may result in an increase in fentanyl plasma concentrations, and may cause potentially fatal respiratory depression. /Fentanyl citrate lozenge/",
                      "Markup": [
                        {
                          "Start": 142,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 275,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 306,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 414,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 649,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 685,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 782,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 851,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 940,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "US Natl Inst Health; DailyMed. Current Medication Information for Fentanyl Citrate (Fentanyl Citrate) Lozenge (Updated: February 2012). Available from, as of June 1, 2017: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=552ba162-76ed-4bc9-8c2c-fac7a1804da0"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "/BOXED WARNING/ WARNING: MEDICATION ERRORS. Substantial differences exist in the pharmacokinetic profile of oral transmucosal fentanyl citrate compared to other fentanyl products that result in clinically important differences in the extent of absorption of fentanyl that could result in fatal overdose. When prescribing, do not convert patients on a ug per ug basis from any other fentanyl products to oral transmucosal fentanyl citrate. When dispensing, do not substitute an oral transmucosal fentanyl citrate prescription for other fentanyl products. /Fentanyl citrate lozenge/",
                      "Markup": [
                        {
                          "Start": 126,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 161,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 258,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 382,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 421,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 495,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 535,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 555,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "US Natl Inst Health; DailyMed. Current Medication Information for Fentanyl Citrate (Fentanyl Citrate) Lozenge (Updated: February 2012). Available from, as of June 1, 2017: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=552ba162-76ed-4bc9-8c2c-fac7a1804da0"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "/BOXED WARNING/ WARNING: ABUSE POTENTIAL. Oral transmucosal fentanyl citrate contains fentanyl, an opioid agonist and a Schedule II controlled substance, with an abuse liability similar to other opioid analgesics. Oral transmucosal fentanyl citrate can be abused in a manner similar to other opioid agonists, legal or illicit. This should be considered when prescribing or dispensing oral transmucosal fentanyl citrate in situations where the physician or pharmacist is concerned about an increased risk of misuse, abuse or diversion.  Because of the risk for misuse, abuse, addiction, and overdose, oral transmucosal fentanyl citrate is available only through a restricted program, required by the Food and Drug Administration, called a Risk Evaluation and Mitigation Strategy (REMS). Under the Transmucosal Immediate Release Fentanyl (TIRF) REMS Access program, outpatients, healthcare professionals who prescribe to outpatients, pharmacies, and distributors must enroll in the program. /Fentanyl citrate lozenge/",
                      "Markup": [
                        {
                          "Start": 60,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 86,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 232,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 402,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 618,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 827,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 990,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "US Natl Inst Health; DailyMed. Current Medication Information for Abstral (Fentanyl Citrate) Tablet, Orally Disintegrating (Updated: December 2016). Available from, as of June 1, 2017: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e60f00e9-2cf4-4c20-b570-1c2ea426c8c7"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "/BOXED WARNING/ LIFE-THREATENING RESPIRATORY DEPRESSION. Serious, life-threatening and/or fatal respiratory depression has occurred in patients treated with Abstral, including following use in opioid non-tolerant patients and improper dosing. Monitor for respiratory depression, especially during initiation of Abstral or following a dose increase. The substitution of Abstral for any other fentanyl product may result in fatal overdose..  Due to the risk of respiratory depression, Abstral is contraindicated in the management of acute or postoperative pain including headache/migraine and in opioid non-tolerant patients. /Abstral (fentanyl citrate) tablet, orally disintegrating/",
                      "Markup": [
                        {
                          "Start": 157,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Abstral",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 311,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Abstral",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 369,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Abstral",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 391,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 483,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Abstral",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 625,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Abstral",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 634,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "For more Drug Warnings (Complete) data for Fentanyl (54 total), please visit the HSDB record page.",
                      "Markup": [
                        {
                          "Start": 81,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Drug-Warnings-(Complete)"
                        },
                        {
                          "Start": 43,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Reported Fatal Dose",
            "Description": "The fatal dose (also called lethal dose) is the amount of a chemical that is likely to cause death; it varies in relation to the type of animal and the route of administration.  This section provides information on the fatal human dose from the Hazardous Substances Data Bank (HSDB).",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/source/11933",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Ellenhorn, M.J. and D.G. Barceloux. Medical Toxicology - Diagnosis and Treatment of Human Poisoning. New York, NY: Elsevier Science Publishing Co., Inc. 1988., p. 745"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Minimum Lethal Dosage: Fentanyl 250 ug.",
                      "Markup": [
                        {
                          "Start": 23,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug Tolerance",
            "Description": "Drug tolerance refers to the reduced reaction of the body to a drug following its repeated use. Although increasing its dosage may re-amplify the drug's effects, this may accelerate tolerance, further reducing the drug's effects.  This section provides information on drug tolerance in humans and other species.",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2245-6"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "In opiate-naive (nontolerant) patients, minimum effective analgesic serum fentanyl concentrations range from 0.2-2 ng/mL. Adverse effects of the drug in opiate-naive patients generally increase as serum concentrations exceed 2 ng/mL, although respiratory depression (e.g., hypoventilation) can occur throughout the therapeutic range of fentanyl serum concentrations, especially in patients with underlying pulmonary conditions or those receiving concomitant therapy with respiratory depressants. CNS depression becomes prominent as serum fentanyl concentrations exceed 3 ng/mL in opiate-naive patients, and anesthesia and profound respiratory depression generally occur at concentrations of 10-20 ng/mL. With continued use, tolerance to the pharmacologic and adverse effects of the drug develop, but the rate of development of tolerance exhibits considerable interindividual variation.",
                      "Markup": [
                        {
                          "Start": 74,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 336,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 538,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:9618424",
                  "Bot G et al; J Pharmacol Exp Ther 285 (3): 1207-18 (1998)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl, and its structural analogs lofentanil and sufentanil, are potent analgesics used clinically in the management of pain. However, the high analgesic potency of these compounds is limited by the development of tolerance after chronic use. To investigate whether their tolerance development may be related to mu receptor desensitization, the cloned mouse mu receptor as well as mutant forms of the receptor were stably expressed in HEK 293 cells and tested for their response to continuous opioid treatment. Fentanyl and its analogs potently bound to the mu receptor and effectively inhibited cAMP accumulation. Three-hour pretreatment of mu receptors with fentanyl and its analogs desensitized the mu receptor by uncoupling it from adenylyl cyclase. The fentanyl analogs caused a slight internalization of the mu receptor as accessed by antibody binding to the epitope-tagged mu receptor. Truncation of the mu receptor by removal of its carboxyl terminus at Glu341 did not affect the ability of the fentanyl analogs to bind to and activate the mu receptor nor did it prevent the fentanyl analogs from desensitizing the receptor. In a previous study we showed that morphine did not desensitize the cloned mu receptor even though it is a potent and effective agonist at the mu receptor. Mutagenesis studies revealed that morphine interacts differently with the mu receptor to activate it than do the fentanyl analogs which may explain its lack of desensitization of the mu receptor. These results indicate that desensitization of the mu receptor may be a molecular basis for the development of tolerance to fentanyl and its analogs.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 37,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/lofentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-123642"
                        },
                        {
                          "Start": 52,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        },
                        {
                          "Start": 514,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 599,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6076"
                        },
                        {
                          "Start": 663,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 761,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1006,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1086,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1171,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 1326,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 1405,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1612,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Pharmacology and Biochemistry",
        "Description": "Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.",
        "Section": [
          {
            "TOCHeading": "Pharmacodynamics",
            "Description": "Pharmacodynamic information for this compound as a drug (i.e., what does this drug do to the body).  Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the body.",
            "URL": "https://www.ncbi.nlm.nih.gov/books/NBK507791/",
            "Information": [
              {
                "ReferenceNumber": 15,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl produces strong analgesia through its activation of opioid receptors. It has a duration of action of several hours and a wider therapeutic index as patients develop tolerance to opioids. Fentanyl is associated with a risk of addiction and abuse and should not be mixed with alcohol or benzodiazepines.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 196,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "MeSH Pharmacological Classification",
            "Description": "Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.",
            "URL": "https://meshb.nlm.nih.gov/record/ui?ui=D020228",
            "Information": [
              {
                "ReferenceNumber": 162,
                "Name": "Narcotics",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)",
                      "Markup": [
                        {
                          "Start": 270,
                          "Length": 37,
                          "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68009294"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 163,
                "Name": "Analgesics, Opioid",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)",
                      "Markup": [
                        {
                          "Start": 135,
                          "Length": 46,
                          "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68000701"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 164,
                "Name": "Anesthetics, Intravenous",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)",
                      "Markup": [
                        {
                          "Start": 454,
                          "Length": 52,
                          "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68018686"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 165,
                "Name": "Adjuvants, Anesthesia",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)",
                      "Markup": [
                        {
                          "Start": 140,
                          "Length": 49,
                          "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68000759"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Pharmacological Classification",
            "Description": "Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA \"Established Pharmacologic Class\" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.",
            "URL": "https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              }
            },
            "Information": [
              {
                "ReferenceNumber": 57,
                "Name": "FDA UNII",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "UF599785JZ"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 57,
                "Name": "Active Moiety",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 57,
                "Name": "Pharmacological Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Mechanisms of Action [MoA] - Full Opioid Agonists"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 57,
                "Name": "Pharmacological Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Established Pharmacologic Class [EPC] - Opioid Agonist"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 57,
                "Name": "FDA Pharmacology Summary",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is an Opioid Agonist. The mechanism of action of fentanyl is as a Full Opioid Agonist.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 58,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 96,
                "Name": "Non-Proprietary Name",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 96,
                "Name": "Pharmacological Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Opioid Agonist [EPC]; Full Opioid Agonists [MoA]"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 97,
                "Name": "Non-Proprietary Name",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FENTANYL TRANSDERMAL"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 97,
                "Name": "Pharmacological Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Opioid Agonist [EPC]; Full Opioid Agonists [MoA]"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "ATC Code",
            "Description": "The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.",
            "URL": "https://www.whocc.no/atc/structure_and_principles/",
            "Information": [
              {
                "ReferenceNumber": 41,
                "Name": "ATC Code",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N02AB03"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 42,
                "Name": "ATC Code",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N02AB03"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 43,
                "Name": "ATC Code",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N02AB03"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 44,
                "Name": "ATC Code",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "QN02AB03"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 45,
                "Name": "ATC Code",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N02AB03"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 111,
                "Reference": [
                  "S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355"
                ],
                "URL": "https://www.whocc.no/atc_ddd_index/?code=N02AB03",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N02AB03"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 129,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N - Nervous system",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 1,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N"
                        }
                      ]
                    },
                    {
                      "String": "N01 - Anesthetics",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 3,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N01"
                        }
                      ]
                    },
                    {
                      "String": "N01A - Anesthetics, general",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 4,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N01A"
                        }
                      ]
                    },
                    {
                      "String": "N01AH - Opioid anesthetics",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 5,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N01AH"
                        }
                      ]
                    },
                    {
                      "String": "N01AH01 - Fentanyl",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N01AH01"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 130,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N - Nervous system",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 1,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N"
                        }
                      ]
                    },
                    {
                      "String": "N02 - Analgesics",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 3,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N02"
                        }
                      ]
                    },
                    {
                      "String": "N02A - Opioids",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 4,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N02A"
                        }
                      ]
                    },
                    {
                      "String": "N02AB - Phenylpiperidine derivatives",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 5,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N02AB"
                        },
                        {
                          "Start": 8,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Phenylpiperidine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-20038"
                        }
                      ]
                    },
                    {
                      "String": "N02AB03 - Fentanyl",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=N02AB03"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 131,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N01AH01; N02AB03"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Absorption, Distribution and Excretion",
            "Information": [
              {
                "ReferenceNumber": 15,
                "Name": "Absorption",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl sublingual tablets are 54% bioavailable, transmucosal lozenges are 50% bioavailable, buccal tablets are 65% bioavailable, sublingual spray is 76% bioavailable, and nasal spray is 20% more bioavailable than transmucosal (or approximately 64% bioavailable).  Fentanyl transmucosal lozenges reach a Cmax of 0.4±0.1ng/mL for a 200µg dose and 2.5±0.6ng/mL for a 1600µg dose with a Tmax of 20-40 minutes. The AUC was 172±96ng\\*min/mL for a 200µg dose and 1508±1360ng\\*min/mL for a 1600µg dose.  Fentanyl sublingual spray reached a Cmax of 0.20±0.06ng/mL for a 100µg dose and 1.61±0.60ng/mL for an 800µg dose with a Tmax of 0.69-1.25 hours, decreasing as the dose increased. The AUC was 1.25±0.67ng\\*h/mL for a 100µg dose and 10.38±3.70ng\\*h/mL for a 800µg dose.  Fentanyl transdermal systems reached a Cmax of 0.24±0.20ng/mL with a Tmax of 3.6±1.3h for a 25µg/h dose. The AUC was 0.42±0.35ng/mL\\*h.  Fentanyl nasal spray reaches a Cmax of 815±301pg/mL with a Tmax of less than 1 hour for a 200µg/100µL dose. The AUC was 3772pg\\*h/mL.",
                      "Markup": [
                        {
                          "Start": 306,
                          "Length": 3,
                          "Type": "Subscript"
                        },
                        {
                          "Start": 386,
                          "Length": 3,
                          "Type": "Subscript"
                        },
                        {
                          "Start": 535,
                          "Length": 3,
                          "Type": "Subscript"
                        },
                        {
                          "Start": 619,
                          "Length": 3,
                          "Type": "Subscript"
                        },
                        {
                          "Start": 806,
                          "Length": 3,
                          "Type": "Subscript"
                        },
                        {
                          "Start": 836,
                          "Length": 3,
                          "Type": "Subscript"
                        },
                        {
                          "Start": 935,
                          "Length": 3,
                          "Type": "Subscript"
                        },
                        {
                          "Start": 963,
                          "Length": 3,
                          "Type": "Subscript"
                        },
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 266,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 498,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 766,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 903,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 15,
                "Name": "Route of Elimination",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Within 72 hours, 75% of a dose of fentanyl is excreted in the urine with <7% unchanged, and 9% is excreted in the feces with <1% unchanged.",
                      "Markup": [
                        {
                          "Start": 34,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 15,
                "Name": "Volume of Distribution",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "The intravenous volume of distribution is 4L/kg (3-8L/kg). The oral volume of distribution is 25.4L/kg. In hepatically impaired patients, the intravenous volume of distribution ranges from 0.8-8L/kg.  Fentanyl crosses the blood brain barrier and the placenta.",
                      "Markup": [
                        {
                          "Start": 201,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 15,
                "Name": "Clearance",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Total plasma clearance of fentanyl is 0.5L/hr/kg (0.3-0.7L/hr/kg) or 42L/hr. Following an intravenous dose, surgical patients displayed a clearance of 27-75L/h, hepatically impaired patients displayed a clearance of 3-80L/h, and renally impaired patients displayed a clearance of 30-78L/h.",
                      "Markup": [
                        {
                          "Start": 26,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2243"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Because release of fentanyl from fentanyl transdermal systems and percutaneous permeability of the drug are temperature dependent, serum fentanyl concentrations could theoretically increase by approximately one-third in patients with a body temperature of 40 °C. Patients who develop a fever while using fentanyl transdermal system should be observed closely for manifestations of opiate toxicity, and dosage of the drug should be adjusted accordingly. Patients should be cautioned to avoid strenuous exertion that leads to increased core body temperature while wearing the transdermal system. Because application of heat over the fentanyl transdermal system increases mean systemic exposure and peak plasma concentrations of the drug by 120 and 61%, respectively, and has resulted in fatal overdosage, patients wearing a fentanyl transdermal system should be advised to avoid exposing the application site or surrounding area to direct external heat sources.",
                      "Markup": [
                        {
                          "Start": 19,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 33,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 137,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 304,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 631,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 822,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:25626156",
                  "Heikkinen EM et al; Basic Clin Pharmacol Toxicol 117 (3): 156-63 (2015)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "... The aim of this study was to characterize fentanyl pharmacokinetics in pregnant sheep after intravenous and transdermal dosing during surgical procedure performed to ewe and fetus. Pharmacokinetic parameters reported for non-pregnant sheep and nominal transdermal dose rate were utilized for a priori calculation to achieve analgesic fentanyl concentration (0.5-2 ng/mL) in maternal plasma. A total of 20 Aland landrace ewes at 118-127 gestational days were used. In the first protocol, 1 week before surgery, 10 animals received 2 ug/kg fentanyl intravenous bolus, and on the operation day, transdermal fentanyl patches at nominal dose rate of 2 ug/kg/hr were applied to antebrachium, and ewes were then given a 2 ug/kg intravenous bolus followed by an intra-operative 2.5 ug/kg/hr infusion. In the second protocol, 10 animals received fentanyl only as transdermal patches on the operation day and oxycodone for rescue analgesia. The data were analyzsed with population pharmacokinetic modelling. Intra- and post-operative fentanyl concentrations were similar and slightly lower than the a priori predictions, and elimination and distribution clearances appeared slower during than before or after the surgery. Transdermal patches provided sustained fentanyl absorption for up to 5 days, but the absorption rate was slower than the nominal dose rate and showed a high interindividual variability.",
                      "Markup": [
                        {
                          "Start": 46,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 338,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 542,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 608,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 841,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 903,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxycodone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284603"
                        },
                        {
                          "Start": 1028,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1255,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:2864047",
                  "Lullmann H et al; Br J Anaesth 57 (10): 1012-7 (1985)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "The influence of the pH of the incubation medium on the cellular accumulation of tritiated fentanyl, lofentanil, and alfentanil was investigated in isolated guinea pig atria. Fentanyl and lofentanil accumulated in atrial tissue up to about 30- and 50-fold, respectively. The amount of drug bound when equilibrium was attained was found to be dependent upon the pH of the medium. By plotting binding equilibria v. pH of the bath, curves were obtained which resembled titration curves. Half-maximal binding was attained at pH values close to the pKa values of fentanyl and lofentanil. Alfentanil was found to accumulate less. The uptake by the tissue was strongly proportional to the extracellular concentration. Atria equilibrated with fentanyl at pH 8.5 released the compound rapidly when exposed to a pH of 7.0, even in the continuous presence of fentanyl in the bath. The consequences of the findings for in vivo conditions are discussed with respect to a possible augmentation of the actions of fentanyl by respiratory acidosis.",
                      "Markup": [
                        {
                          "Start": 91,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 101,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/lofentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-123642"
                        },
                        {
                          "Start": 117,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 175,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 188,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/lofentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-123642"
                        },
                        {
                          "Start": 558,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 571,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/lofentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-123642"
                        },
                        {
                          "Start": 583,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 735,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 848,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 998,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:25065851",
                  "Krinsky CS et al; J Forensic Sci 59 (5): 1275-9 (2014)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is a synthetic opioid agonist used for pain control. Often administered as a transdermal patch, it is an interesting drug for study of postmortem redistribution. We hypothesized that fentanyl concentrations would increase over time after death, as measured in blood drawn on the day prior to autopsy and in blood drawn at the time of autopsy in ten cases where fentanyl patches were identified at the scene. Concentrations were compared, and heart blood to femoral blood ratios were calculated as markers of postmortem redistribution. Fentanyl concentrations measured in peripheral blood drawn the day of autopsy (peripheral blood 2 [PB2]) were higher than those drawn the day prior to autopsy (peripheral blood 1 [PB1]) with a mean ratio (PB2/PB1) of 1.80. The ratio of heart blood concentrations (HB) to femoral blood concentrations drawn at autopsy (PB2) had a mean ratio (HB/PB2) of 1.08. Some cases had blood from the same source analyzed at two different laboratories, and concentrations of fentanyl in those samples showed inter- and intralaboratory differences up to 25 ng/mL. Postmortem fentanyl concentrations may be affected by antemortem factors, postmortem redistribution, and laboratory variability. Forensic pathologists must use caution in interpreting fentanyl levels as part of death investigation.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 192,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 370,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 544,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1006,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1105,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1278,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "For more Absorption, Distribution and Excretion (Complete) data for Fentanyl (32 total), please visit the HSDB record page.",
                      "Markup": [
                        {
                          "Start": 106,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Absorption-Distribution-and-Excretion-(Complete)"
                        },
                        {
                          "Start": 68,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Metabolism/Metabolites",
            "Description": "Metabolites are substances made or used when the body breaks down food, drugs or chemicals, or its own tissue (for example, fat or muscle tissue). This process is called metabolism and makes energy and the materials needed for growth, reproduction, and maintaining health. Metabolism also helps get rid of toxic substances.",
            "Information": [
              {
                "ReferenceNumber": 15,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is metabolized to a number of inactive metabolites. Fentanyl is 99% N-dealkylated to norfentanyl by cytochrome P450. It can also be amide hydrolyzed to despropionylfentanyl, or alkyl hydroxylated to hydroxyfentanyl which is N-dealkylated to hydroxynorfentanyl.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 61,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 94,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        },
                        {
                          "Start": 161,
                          "Length": 20,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/despropionylfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-88890"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2247"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl does not appear to be metabolized in skin when administered transdermally. Data from clinical studies and from studies using a human keratinocyte cell assay indicate that about 92% of a dose delivered from the fentanyl transdermal system is accounted for as unchanged drug in systemic circulation. Total plasma clearance of fentanyl is reported to be about 500 mL/hour per kg (range: 300-700 mL/hour per kg) or 42-53 L/hour.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 219,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 333,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2247"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl citrate is metabolized extensively in the liver and the intestinal mucosa. Animal studies indicate that the drug undergoes oxidation via the microsomal enzymes in the liver and intestinal mucosa (principally cytochrome P-450 [CYP] isoform 3A4) to form norfentanyl; the drug also undergoes hydrolysis to form 4-N-anilinopiperidine and propionic acid. Norfentanyl has been shown to be pharmacologically inactive in animal studies. Fentanyl is excreted in the urine as inactive metabolites and as unchanged drug. Less than 10% of a dose is excreted in urine unchanged and only about 1% is excreted in the feces as unchanged drug.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 261,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        },
                        {
                          "Start": 343,
                          "Length": 14,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/propionic%20acid",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-1032"
                        },
                        {
                          "Start": 359,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        },
                        {
                          "Start": 438,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:8452277",
                  "Silverstein JH et al; Anesth Analg 76 (3): 618-21 (1993)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "This study was undertaken to determine if metabolites of fentanyl might be useful in the detection and monitoring of substance abuse. The presence of fentanyl and two of its metabolites in the urine and saliva of seven female patients receiving small doses (110 +/- 56 micrograms) of fentanyl was studied up to 96 hr from the time of administration. Fentanyl and its two metabolites (norfentanyl and despropionylfentanyl) were extracted from samples and analyzed by gas chromatography/mass spectrometry. Unchanged fentanyl was detectable in urine in all patients immediately postoperatively and in 3 of 7 patients at 24 hr. By 72 hr, fentanyl was undetectable. Norfentanyl was present in larger quantities than fentanyl immediately postoperatively and was detected in all patients at 48 hr and in 4 of 7 patients at 96 hr. Despropionylfentanyl was not detected in any of the urine specimens tested. Neither fentanyl nor its metabolites could be detected consistently at any time in saliva. Saliva testing does not appear to be a viable alternative to urine testing based on this study. Urinary norfentanyl might be considered as the substance of choice when testing for fentanyl abuse.",
                      "Markup": [
                        {
                          "Start": 57,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 150,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 284,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 350,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 384,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        },
                        {
                          "Start": 400,
                          "Length": 20,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/despropionylfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-88890"
                        },
                        {
                          "Start": 514,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 634,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 661,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        },
                        {
                          "Start": 711,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 823,
                          "Length": 20,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Despropionylfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-88890"
                        },
                        {
                          "Start": 907,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1094,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        },
                        {
                          "Start": 1170,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 111,
                "Reference": [
                  "S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl has known human metabolites that include Phenylacetaldehyde and Norfentanyl.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 50,
                          "Length": 18,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Phenylacetaldehyde",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-998"
                        },
                        {
                          "Start": 73,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 128,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is metabolized primarily via human cytochrome P450 3A4 isoenzyme system.\u000ARoute of Elimination: Fentanyl is metabolized primarily via human cytochrome P450 3A4 isoenzyme system and mostly eliminated in urine. Within 72 hours of IV fentanyl administration, approximately 75% of the dose is excreted in urine, mostly as metabolites with less than 10% representing unchanged drug.\u000AHalf Life: 7  hours (range 3-12)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 104,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 239,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Biological Half-Life",
            "Description": "The time required for a biological system (e.g., human body) to eliminate, by natural processes, half of the amount of a chemical (e.g., alcohol, medication, or radioactive material) that has entered it.",
            "Information": [
              {
                "ReferenceNumber": 15,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "The half life of fentanyl is 7  hours. The half life of fentanyl sublingual spray is 5-12 hours.",
                      "Markup": [
                        {
                          "Start": 17,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 56,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:7171414",
                  "Haberer JP et al; Br J Anaesth 54 (12): 1267-70 (1982)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl kinetics were studied in patients with cirrhosis and in patients with normal hepatic and renal function undergoing surgery under general anaesthesia, the latter group served as the controls. Plasma fentanyl concentrations declined bi-exponentially in the controls with an average elimination half-life (T1/2 beta) of 263 min; total plasma clearance (Cl) as 10.8 mL/kg/min, and total apparent volume of distribution (V beta) 3.81 L/kg. No significant change was observed in patients with cirrhosis: T1/2 beta was 304 min, Cl 11.3 mL/kg/min and V beta 4.41 L/kg. These data suggest that the elimination half-life of fentanyl is not primarily influenced by the rate at which it is metabolized in the liver.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 207,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 623,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:2729633",
                  "Varvel JR et al; Anesthesiology 70 (6): 928-34 (1989)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl was administered intravenously and transdermally to eight surgical patients to determine the systemic bioavailability and rate of absorption of the transdermally administered drug. Serum fentanyl concentrations reached a plateau approximately 14 hr after placement of the transdermal fentanyl delivery system. This plateau was maintained until removal of the system at 24 hr. The decline in serum fentanyl concentrations after removal of the transdermal system had a terminal half-life of 17.0 +/- 2.3 hr (mean +/- SD), considerably longer than the terminal elimination half-life seen after intravenous administration of fentanyl in the same patients (6.1 +/- 2.0 hr). ...",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 196,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 293,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 406,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 630,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Streisand JB et al; Anesthesiology 75 (2): 223-9 (1991)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "... In order to determine the bioavailability and absorption of fentanyl from OTFC, 12 volunteers were given intravenous fentanyl citrate or OTFC 15 ug/kg on each of two occasions. On a third occasion, the authors assessed oral administration (gastrointestinal absorption) by giving eight of the same volunteers the same dose of a solution of fentanyl citrate to swallow. In each study, arterial blood samples were taken over 24 hr for analysis of plasma fentanyl. After intravenous (iv) administration of fentanyl ... the terminal elimination half-life was 425 +/- 102 min. ...",
                      "Markup": [
                        {
                          "Start": 64,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 121,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 343,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        },
                        {
                          "Start": 455,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 506,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2247"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Following IV administration of fentanyl citrate in healthy individuals, the estimated initial distribution half-life was about 6 minutes, the second distribution half-life was about 1 hour, and the terminal half-life was about 16 hours.",
                      "Markup": [
                        {
                          "Start": 31,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2247"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Studies of IV fentanyl suggest that clearance of the drug may be decreased and half-life increased in geriatric patients. Although the pharmacokinetic profile of fentanyl in healthy Caucasian adults 65 years of age or older (mean age: 71 years) generally was similar to that in adults 18-45 years of age following application of a fentanyl transdermal system labeled as delivering 100 ug/hour for 72 hours, the mean half-life of the drug was longer in geriatric individuals compared with younger adults (34.4 versus 23.5 hours).",
                      "Markup": [
                        {
                          "Start": 14,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 162,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 331,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Mechanism of Action",
            "Description": "In medicine, the term \"mechanism of action\" (also called MOA) is used to describe how a drug or other substance produces an effect in the body. For example, a drug's mechanism of action could be how it affects a specific target in a cell, such as an enzyme, or a cell function, such as cell growth. Knowing the mechanism of action of a drug may help provide information about the safety of the drug and how it affects the body. It may also help identify the right dose of a drug and which patients are most likely to respond to treatment.",
            "Information": [
              {
                "ReferenceNumber": 15,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl binds to opioid receptors, especially the mu opioid receptor, which are coupled to G-proteins. Activation of opioid receptors causes GTP to be exchanged for GDP on the G-proteins which in turn down regulates adenylate cyclase, reducing concentrations of cAMP. Reduced cAMP decreases cAMP dependant influx of calcium ions into the cell. The exchange of GTP for GDP results in hyperpolarization of the cell and inhibition of nerve activity.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 142,
                          "Length": 3,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/GTP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-135398633"
                        },
                        {
                          "Start": 217,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/adenylate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6083"
                        },
                        {
                          "Start": 263,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6076"
                        },
                        {
                          "Start": 277,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6076"
                        },
                        {
                          "Start": 292,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6076"
                        },
                        {
                          "Start": 317,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Calcium",
                          "Type": "PubChem Internal Link",
                          "Extra": "Element-Calcium"
                        },
                        {
                          "Start": 361,
                          "Length": 3,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/GTP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-135398633"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:12513698",
                  "Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC140036",
                  "Gharagozlou P et al; BMC Pharmacol 3: 1 (2003)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "The aim of the present study was to describe the activity of a set of opioid drugs, including partial agonists, in a cell system expressing only mu opioid receptors. Receptor activation was assessed by measuring the inhibition of forskolin-stimulated cyclic adenosine mono phosphate (cAMP) production. Efficacies and potencies of these ligands were determined relative to the endogenous ligand beta-endorphin and the common mu agonist, morphine. Among the ligands studied naltrexone, WIN 44,441 and SKF 10047, were classified as antagonists, while the remaining ligands were agonists. Agonist efficacy was assessed by determining the extent of inhibition of forskolin-stimulated cAMP production. The rank order of efficacy of the agonists was fentanyl = hydromorphone = beta-endorphin > etorphine = lofentanil = butorphanol = morphine = nalbuphine = nalorphine > cyclazocine = dezocine = metazocine >or= xorphanol. The rank order of potency of these ligands was different from that of their efficacies; etorphine > hydromorphone > dezocine > xorphanol = nalorphine = butorphanol = lofentanil > metazocine > nalbuphine > cyclazocine > fentanyl > morphine >>>> beta-endorphin. These results elucidate the relative activities of a set of opioid ligands at mu opioid receptor and can serve as the initial step in a systematic study leading to understanding of the mode of action of opioid ligands at this receptor. Furthermore, these results can assist in understanding the physiological effect of many opioid ligands acting through mu opioid receptors.",
                      "Markup": [
                        {
                          "Start": 230,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/forskolin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-47936"
                        },
                        {
                          "Start": 284,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6076"
                        },
                        {
                          "Start": 394,
                          "Length": 14,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/beta-endorphin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-16132316"
                        },
                        {
                          "Start": 436,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 472,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/naltrexone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5360515"
                        },
                        {
                          "Start": 499,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/SKF%2010047",
                          "Type": "PubChem Internal Link",
                          "Extra": "multiple-CIDs"
                        },
                        {
                          "Start": 658,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/forskolin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-47936"
                        },
                        {
                          "Start": 679,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6076"
                        },
                        {
                          "Start": 743,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 754,
                          "Length": 13,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/hydromorphone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284570"
                        },
                        {
                          "Start": 770,
                          "Length": 14,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/beta-endorphin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-16132316"
                        },
                        {
                          "Start": 787,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/etorphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-26721"
                        },
                        {
                          "Start": 799,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/lofentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-123642"
                        },
                        {
                          "Start": 812,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/butorphanol",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5361092"
                        },
                        {
                          "Start": 826,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 837,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/nalbuphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5311304"
                        },
                        {
                          "Start": 850,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/nalorphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284595"
                        },
                        {
                          "Start": 863,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cyclazocine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-19143"
                        },
                        {
                          "Start": 877,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dezocine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3033053"
                        },
                        {
                          "Start": 888,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/metazocine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-62518"
                        },
                        {
                          "Start": 904,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/xorphanol",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5488631"
                        },
                        {
                          "Start": 1003,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/etorphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-26721"
                        },
                        {
                          "Start": 1015,
                          "Length": 13,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/hydromorphone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284570"
                        },
                        {
                          "Start": 1031,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dezocine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3033053"
                        },
                        {
                          "Start": 1042,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/xorphanol",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5488631"
                        },
                        {
                          "Start": 1054,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/nalorphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284595"
                        },
                        {
                          "Start": 1067,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/butorphanol",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5361092"
                        },
                        {
                          "Start": 1081,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/lofentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-123642"
                        },
                        {
                          "Start": 1094,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/metazocine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-62518"
                        },
                        {
                          "Start": 1107,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/nalbuphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5311304"
                        },
                        {
                          "Start": 1120,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cyclazocine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-19143"
                        },
                        {
                          "Start": 1134,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1145,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 1159,
                          "Length": 14,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/beta-endorphin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-16132316"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:24704555",
                  "Tanaka K et al; Eur J Pharmacol 733: 68-74 (2014)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Diabetic neuropathy is one of the most frequent complications of diabetes mellitus. Therefore, the present study was designed to investigate the anti-hyperalgesic mechanism of fentanyl in a mouse model of streptozotocin-induced diabetic neuropathy. The antinociceptive response was assessed by recording the latency in a tail-flick test. The tail-flick latency in diabetic mice was significantly shorter than that in non-diabetic mice. Fentanyl, at doses of 3 and 10 ug/kg, s.c., produced a dose-dependent increase in the tail-flick latencies in diabetic mice. While fentanyl (3 ug/kg, s.c.) did not produce a significant inhibition of the tail-flick response in non-diabetic mice, it significantly prolonged the tail-flick latency in diabetic mice to the same level as the baseline latency in non-diabetic mice. Although pretreatment with naloxone (3 mg/kg, s.c.) completely antagonized fentanyl-induced antinociception in non-diabetic mice, it had no effect on the antinociceptive effect of fentanyl in diabetic mice. Pretreatment with either of the voltage-gated sodium channel openers fenvarelarte and veratridine practically abolished the antinociceptive effects of fentanyl in diabetic mice. However, neither fenvarelate nor veratridine affected the antinociceptive effect of fentanyl in non-diabetic mice. These results suggest that the anti-hyperalgesic effect of fentanyl is mediated through the blockade of sodium channels in diabetic mice, whereas opioid receptors mediate the antinociceptive effect of fentanyl in non-diabetic mice.",
                      "Markup": [
                        {
                          "Start": 176,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 205,
                          "Length": 14,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/streptozotocin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-29327"
                        },
                        {
                          "Start": 436,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 567,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 840,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/naloxone",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5284596"
                        },
                        {
                          "Start": 888,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 993,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1066,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Sodium",
                          "Type": "PubChem Internal Link",
                          "Extra": "Element-Sodium"
                        },
                        {
                          "Start": 1106,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/veratridine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6280"
                        },
                        {
                          "Start": 1171,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1231,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/veratridine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6280"
                        },
                        {
                          "Start": 1282,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1372,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1417,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Sodium",
                          "Type": "PubChem Internal Link",
                          "Extra": "Element-Sodium"
                        },
                        {
                          "Start": 1514,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:14662727",
                  "Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574178",
                  "Terman GW et al; Br J Pharmacol 141 (1):55-64 (2004)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Tolerance to opioids frequently follows repeated drug administration and affects the clinical utility of these analgesics. Studies in simple cellular systems have demonstrated that prolonged activation of opioid receptors produces homologous receptor desensitization by G-protein receptor kinase mediated receptor phosphorylation and subsequent beta-arrestin binding. To define the role of this regulatory mechanism in the control of the electrophysiological and behavioral responses to opioids, we used mice having a targeted disruption of the G-protein receptor kinase 3 (GRK3) gene. Mice lacking GRK3 did not differ from wild-type littermates neither in their response latencies to noxious stimuli on the hot-plate test nor in their acute antinociceptive responses to fentanyl or morphine. Tolerance to the electrophysiological response to the opioid fentanyl, measured in vitro in the hippocampus, was blocked by GRK3 deletion. In addition, tolerance to the antinociceptive effects of fentanyl was significantly reduced in GRK3 knockouts compared to wild-type littermate controls. Tolerance to the antinociceptive effects of morphine was not affected by GRK3 deletion although morphine tolerance in hippocampal slices from GRK3 knockout mice was significantly inhibited. Tolerance developed more slowly in vitro to morphine than fentanyl supporting previous work in in vitro systems showing a correlation between agonist efficacy and GRK3-mediated desensitization. The results of these studies suggest that GRK3-mediated mechanisms are important components of both electrophysiologic and behavioral opioid tolerance. Fentanyl, a high efficacy opioid, more effectively produced GRK3-dependent effects than morphine, a low efficacy agonist.",
                      "Markup": [
                        {
                          "Start": 771,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 783,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 854,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 989,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1129,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 1181,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 1319,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 1333,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1621,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 1709,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:26056051",
                  "Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492890",
                  "Kuhar JR et al; Cell Signal 27 (9): 1799-806 (2015)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "G protein-coupled receptor desensitization is typically mediated by receptor phosphorylation by G protein-coupled receptor kinase (GRK) and subsequent arrestin binding; morphine, however, was previously found to activate a c-Jun N-terminal kinase (JNK)-dependent, GRK/arrestin-independent pathway to produce mu opioid receptor (MOR) inactivation in spinally-mediated, acute anti-nociceptive responses. In the current study, we determined that JNK2 was also required for centrally-mediated analgesic tolerance to morphine using the hotplate assay. We compared JNK activation by morphine and fentanyl in JNK1(-/-), JNK2(-/-), JNK3(-/-), and GRK3(-/-) mice and found that both compounds specifically activate JNK2 in vivo; however, fentanyl activation of JNK2 was GRK3-dependent, whereas morphine activation of JNK2 was GRK3-independent. In MOR-GFP expressing HEK293 cells, treatment with either arrestin siRNA, the Src family kinase inhibitor PP2, or the protein kinase C (PKC) inhibitor Go6976 indicated that morphine activated JNK2 through an arrestin-independent Src- and PKC-dependent mechanism, whereas fentanyl activated JNK2 through a Src-GRK3/arrestin-2-dependent and PKC-independent mechanism. This study resolves distinct ligand-directed mechanisms of JNK activation by mu opioid agonists and understanding ligand-directed signaling at MOR may improve opioid therapeutics.",
                      "Markup": [
                        {
                          "Start": 169,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 512,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 577,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 590,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 729,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 785,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 986,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Go6976",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3501"
                        },
                        {
                          "Start": 1008,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 1106,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:18685878",
                  "Zollner C, Schafer M; Anaesthesist 57 (7): 729-40 (2008)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Opioids are the most effective and widely used drugs in the treatment of severe acute and chronic pain. They act through opioid receptors that belong to the family of G protein-coupled receptors. Three classes of opioid receptors (mu, delta, kappa), expressed in the central and peripheral nervous system, have been identified. The analgesic effect of opioids is mediated through multiple pathways of opioid receptor signaling (e.g., G(i/o) coupling, cAMP inhibition, Ca(++) channel inhibition). The standard exogenous opioid analgesics used in the operating room are fentanyl, sufentanil, morphine, alfentanil, and remifentanil.",
                      "Markup": [
                        {
                          "Start": 451,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6076"
                        },
                        {
                          "Start": 568,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 578,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        },
                        {
                          "Start": 590,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 600,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 616,
                          "Length": 12,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/remifentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-60815"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Human Metabolite Information",
            "Description": "Information on metabolites generated from this compound in the human body.  The data in this section is from the Human Metabolome Database.",
            "URL": "https://hmdb.ca/",
            "Section": [
              {
                "TOCHeading": "Cellular Locations",
                "Description": "Cellular locations of this compound or its metabolites (e.g., cytoplasm, nucleus, lysosome, mitochondria, membrane, extracelluar).",
                "DisplayControls": {
                  "ListType": "Columns"
                },
                "Information": [
                  {
                    "ReferenceNumber": 60,
                    "Name": "Cellular Locations",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Membrane"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Metabolite Pathways",
                "Description": "Metabolic pathways related to this chemical.  A metabolic pathway is a series of chemical reactions in a cell that build and breakdown molecules for cellular processes.",
                "URL": "https://bio.libretexts.org/Bookshelves/Introductory_and_General_Biology/Book%3A_General_Biology_(Boundless)/06%3A_Metabolism/6.03%3A__Energy_and_Metabolism_-_Metabolic_Pathways",
                "DisplayControls": {
                  "ListType": "Columns"
                },
                "Information": [
                  {
                    "ReferenceNumber": 60,
                    "Name": "Metabolite Pathways",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl Action Pathway",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 23,
                              "URL": "http://smpdb.ca/view/SMP00415"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Transformations",
            "Description": "Transformations indicate that a compound (predecessor) is transformed into another compound (successor) through a particular process (such as metabolism or fermentation) or medium (such as an animal or plant). The specificity of a transformation may vary depending on the available scientific evidence. A transformation may involve a series or cascade of changes between the predecessor (reactant) and successor (product). The presence of a successor in a sample may imply the predecessor. Predecessor: chemical being transformed. Transformation: process or medium. Successor: transformation product of predecessor. Evidence: the publication providing evidence for this transformation. Dataset: the integrated content containing the transformation information. Source: the entity or group that compiled the dataset containing the transformation information.",
            "Information": [
              {
                "ReferenceNumber": 111,
                "Value": {
                  "ExternalTableName": "transformations"
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Use and Manufacturing",
        "Description": "This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.",
        "Section": [
          {
            "TOCHeading": "Uses",
            "Description": "Major uses of this chemical, including both consumer uses and industrial uses.",
            "Information": [
              {
                "ReferenceNumber": 36,
                "Name": "EPA CPDat Chemical and Product Categories",
                "Reference": [
                  "The Chemical and Products Database, a resource for exposure-relevant data on chemicals in consumer products, Scientific Data, volume 5, Article number: 180125 (2018), DOI:10.1038/sdata.2018.125"
                ],
                "Value": {
                  "ExternalTableName": "cpdat"
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "21 CFR 1308.12(c) (9) (USFDA); U.S. National Archives and Records Administration's Electronic Code of Federal Regulations. Available from, as of April 25, 2017: https://www.ecfr.gov"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl (DEA Code Number: 9801) is a Schedule II controlled substance.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "US Department of Justice/Office of Diversion Control; Schedule of Controlled Substances. Available from, as of April 25, 2017: https://www.deadiversion.usdoj.gov/21cfr/21usc/812.htm"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Schedule II Controlled Substance: (A) The drug or other substance has a high potential for abuse; (B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions; and (C) Abuse of the drug or other substances may lead to severe psychological or physical dependence."
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "National Library of Medicine's Medical Subject Headings. Fentanyl. Online file (MeSH, 2017). Available from, as of April 26, 2017: https://www.nlm.nih.gov/mesh/2017/mesh_browser/MBrowser.html"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Analgesics, Opioid; Adjuvants, Anesthesia; Narcotics; Anesthetics, Intravenous"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "MEDICATION (VET)"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "MEDICATION"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 112,
                "Reference": [
                  "DOI:10.1021/acs.est.5b03332"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Use (kg; approx.) in Germany (2009): >100",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 36,
                          "Type": "Bold"
                        }
                      ]
                    },
                    {
                      "String": "Use (kg) in USA (2002): 159",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 23,
                          "Type": "Bold"
                        }
                      ]
                    },
                    {
                      "String": "Consumption (g per capita; approx.) in Germany (2009): 0.00122",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 54,
                          "Type": "Bold"
                        }
                      ]
                    },
                    {
                      "String": "Consumption (g per capita) in the USA (2002): 0.000564",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 45,
                          "Type": "Bold"
                        }
                      ]
                    },
                    {
                      "String": "Calculated removal (%): 49.6",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 23,
                          "Type": "Bold"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 125,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is a member of the class of drugs known as fentanyls, rapid-acting opioid (synthetic opiate) drugs that alleviate pain without causing loss of consciousness (analgesic). Fentanyl depresses central nervous system (CNS) and respiratory function. Exposure to fentanyl may be fatal. Fentanyl is estimated to be 80 times as potent as morphine and hundreds of times more potent than heroin. It is a drug of abuse. Fentanyl (and other opioids) could possibly be used as an incapacitating agent to impair a person’s ability to function. In October 2002, the Russian military reportedly used “a fentanyl derivative” against terrorists holding hostages in a Moscow theater; 127 of the hostages died. (It is unclear whether the gas used also included other chemical agent(s).) Fentanyl is odorless.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 179,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 265,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 288,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 338,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5288826"
                        },
                        {
                          "Start": 386,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5462328"
                        },
                        {
                          "Start": 417,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 595,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 775,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 128,
                "Reference": [
                  "L1484: Drugs.com http://www.drugs.com/cons/Fentanyl.html"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "For the treatment of cancer patients with severe pain that breaks through their regular narcotic therapy. Used as an inhalation anesthetic. (L1484)"
                    }
                  ]
                }
              }
            ],
            "Section": [
              {
                "TOCHeading": "Use Classification",
                "Description": "This section contains use classification/category information for this compound from various sources.",
                "Information": [
                  {
                    "ReferenceNumber": 41,
                    "Name": "Use Classification",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Human drugs -> Analgesics -> Human pharmacotherapeutic group -> EMA Drug Category"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 42,
                    "Name": "Use Classification",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Human drugs -> Analgesics -> Human pharmacotherapeutic group -> EMA Drug Category"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 43,
                    "Name": "Use Classification",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Human drugs -> Analgesics -> Human pharmacotherapeutic group -> EMA Drug Category"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 44,
                    "Name": "Use Classification",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Veterinary drugs -> Nervous system -> Veterinary pharmacotherapeutic group -> EMA Drug Category"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 45,
                    "Name": "Use Classification",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Human drugs -> Analgesics -> Human pharmacotherapeutic group -> EMA Drug Category"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 46,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 56,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 111,
                    "Reference": [
                      "S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Pharmaceuticals -> Nervous System -> Anaesthetics -> Opioids"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 111,
                    "Reference": [
                      "S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Pharmaceuticals"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 125,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "-> NIOSH Emergency Response Categories"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Methods of Manufacturing",
            "Description": "Methods of producing this compound in an industrial scale, provided by the Hazardous Substances Data Bank (HSDB).",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/source/11933",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Troy, D.B. (Ed); Remmington The Science and Practice of Pharmacy. 21 st Edition. Lippincott Williams & Williams, Philadelphia, PA 2005, p. 1531"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "One method consists of condensing propionyl chloride with N-(4-piperidyl)aniline, then treating the resulting N-(4-piperidyl)propionanilide with phenethyl chloride, aiding each condensation by the presence of a suitable dehydrochlorinating agent. Reaction of the base with an equimolar portion of citric acid yields the (1:1) citrate. /Fentanyl citrate/",
                      "Markup": [
                        {
                          "Start": 34,
                          "Length": 18,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/propionyl%20chloride",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-62324"
                        },
                        {
                          "Start": 145,
                          "Length": 18,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/phenethyl%20chloride",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-231496"
                        },
                        {
                          "Start": 297,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/citric%20acid",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-311"
                        },
                        {
                          "Start": 326,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-31348"
                        },
                        {
                          "Start": 336,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 734"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Preparation: P.A.J. Janssen, France patent 1344366; idem, United States of America patent 3164600 (1963, 1965 both to Janssen)"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Formulations/Preparations",
            "Description": "Information on Formulations/Preparations of this chemical, collected by the Hazardous Substances Data Bank (HSDB) from various sources.",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/source/11933",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2248"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Table: Fentanyl Preparations [Table#4533]",
                      "Markup": [
                        {
                          "Start": 29,
                          "Length": 12,
                          "Type": "Inline Table",
                          "Extra": "[Table#4533]"
                        },
                        {
                          "Start": 7,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Name": "[Table#4533]",
                "Value": {
                  "Binary": [
                    "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"
                  ],
                  "MimeType": "text/csv"
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2248"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Table: Fentanyl Citrate Preparations [Table#4534]",
                      "Markup": [
                        {
                          "Start": 37,
                          "Length": 12,
                          "Type": "Inline Table",
                          "Extra": "[Table#4534]"
                        },
                        {
                          "Start": 7,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20Citrate",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-13810"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Name": "[Table#4534]",
                "Value": {
                  "Binary": [
                    "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"
                  ],
                  "MimeType": "text/csv"
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "NIDA; Emerging Trends: Gulf Coast HIDTA (Gulf Coast High Intensity Drug Trafficking Area) and the Georgia Bureau of Investigation Issue Synthetic Opioids Alert (May 16, 2017). Available from, as of June 30, 2017: https://www.drugabuse.gov/emerging-trends/flakka-al"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "There have been two new alerts issued related to synthetic opioids. The Gulf Coast High Intensity Drug Trafficking Area has issued an alert for a substance with the street name \"Grey Death.\" The substance appears similar to concrete mixing powder and varies in texture, which ranges from a chunky rock-like material to a fine powder. It is not a single drug, but typically contains several potent opioids, including whatever a drug dealer has on hand in varying proportions. It has a potency much higher than heroin and is reportedly administered via injection, ingestion, insufflation, and smoking. The analysis of each grey death sample collected in the gulf coast region so far revealed the presence of three opioids: U-47700, heroin, and fentanyl; though the amount of each drug within grey death varied from sample to sample.",
                      "Markup": [
                        {
                          "Start": 509,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5462328"
                        },
                        {
                          "Start": 730,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5462328"
                        },
                        {
                          "Start": 742,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2249"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Topical: Transdermal System, iontophoretic: 40 ug (of fentanyl) per activation (9.7 mg/system), Ionsys (C-II; in sealed tray with 1 controller and 1 drug unit) (Medicines Company).",
                      "Markup": [
                        {
                          "Start": 54,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 96,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Ionsys",
                          "Type": "PubChem Internal Link",
                          "Extra": "multiple-CIDs"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "USDOJ/Drug Enforcement Administration; Drugs of Abuse - A DEA Resource Guide p.40, (2017 ed.). Available from, as of November 1, 2017: https://www.dea.gov/pr/multimedia-library/publications/drug_of_abuse.pdf"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Common street names include: Apache, China Girl, China Town, Dance Fever, Friend, Goodfellas, Great Bear, He-Man, Jackpot, King Ivory, Murder 8, and Tango & Cash."
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "General Manufacturing Information",
            "Description": "General manufacturing information for this chemical, provided by the Hazardous Substances Data Bank (HSDB) and EPA TSCA Chemical Substance Inventory.",
            "DisplayControls": {
              "ListType": "Columns"
            },
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 508"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl is a synthetic opioid related to the phenylpiperidines.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Ellenhorn, M.J. and D.G. Barceloux. Medical Toxicology - Diagnosis and Treatment of Human Poisoning. New York, NY: Elsevier Science Publishing Co., Inc. 1988., p. 744"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl was introduced into the United States in 1968 as an intravenous synthetic anesthetic/analgesic under the trade name Sublimaze or Innovar (fentanyl and droperidol).",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 125,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Sublimaze",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 138,
                          "Length": 7,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Innovar",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3168"
                        },
                        {
                          "Start": 147,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 160,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/droperidol",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3168"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Booth, N.H., L.E. McDonald (eds.). Veterinary Pharmacology and Therapeutics. 5th ed. Ames, Iowa: Iowa State University Press, 1982., p. 268"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl has been used illegally as a CNS stimulant in racehorses. The iv admin of fentanyl (total dose of 1, 5, or 10 mg) in thoroughbreds increases spontaneous locomotion 15-fold within a few minutes; this effect can last up to one hour. Limb movements are well controlled & coordinated; the horse rarely stumbles or bumps into objects.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 83,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Ellenhorn, M.J. and D.G. Barceloux. Medical Toxicology - Diagnosis and Treatment of Human Poisoning. New York, NY: Elsevier Science Publishing Co., Inc. 1988., p. 744"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Legal derivatives of fentanyl: 1) Sufentanyl ... 2) Alfentanyl ... 3) Lofentanyl ... 4) Carfentanyl ... .",
                      "Markup": [
                        {
                          "Start": 21,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 34,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Sufentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        },
                        {
                          "Start": 52,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Alfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 70,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Lofentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-123642"
                        },
                        {
                          "Start": 88,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Carfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-62156"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "For more General Manufacturing Information (Complete) data for Fentanyl (7 total), please visit the HSDB record page.",
                      "Markup": [
                        {
                          "Start": 100,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=General-Manufacturing-Information-(Complete)"
                        },
                        {
                          "Start": 63,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Identification",
        "Description": "This section contains laboratory methods used to identify this chemical.",
        "Section": [
          {
            "TOCHeading": "Analytic Laboratory Methods",
            "Description": "Analytic laboratory methods for analyzing this compound in a sample. The information in this section is collected by the Hazardous Substances Data Bank (HSDB) from various sources.",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Sisco E et al; Forensic Chemistry 4: 108-15 (2017)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl and fentanyl analogues represent a current and emerging threat in the United States as pure illicit narcotics and in mixtures with heroin. Because of their extreme potency, methods to safely and rapidly detect these compounds are of high interest. This work investigates the use of thermal desorption direct analysis in real time mass spectrometry (TD-DART-MS) and ion mobility spectrometry (IMS) as tools for the rapid and sensitive (nanogram to picograms) detection of fentanyl, 16 fentanyl analogues, and five additional opioids. Competitive ionization studies highlight that detection of these compounds in the presence of heroin is readily achievable, down to 0.1% fentanyl by mass with TD-DART-MS. With IMS, detection of nanogram levels of fentanyl in a binary fentanyl and heroin mixture is possible but can be complicated by decreased resolution in certain commercial instrument models. Modifications to the alarm windows can be used to ensure detection of fentanyl in binary mixtures. Additionally, three complex background matrices (fingerprint residue, dirt, and plasticizers) are shown to have a minimal effect of the detection of these compounds. Wipe sampling of the exterior of bags of questioned powders is shown to be a safe alternative method for field screening and identification, removing the need to handle potentially lethal amounts of material.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 13,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 140,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5462328"
                        },
                        {
                          "Start": 480,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 493,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 636,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5462328"
                        },
                        {
                          "Start": 679,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 755,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 776,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 789,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5462328"
                        },
                        {
                          "Start": 974,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Schuetz H et al; Aerztl Lab 36 (5): 113-23 (1990)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Thin-layer chromatographic screening of 500 toxicologically relevant substances by corrected Rf values in two systems."
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:2374407",
                  "Henderson GL et al; J Anal Toxicol 14 (3): 172-5 (1990)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Rapid screening of fentanyl (China White) powder samples by solid-phase radioimmunoassay.",
                      "Markup": [
                        {
                          "Start": 19,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "Suzuki S; Forensic Sci Int 43 (1): 15-19 (1989)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Spectrometric discrimination of five monomethylated fentanyl isomers including fentanyl by gas chromatography/Fourier transform-infrared spectrometry.",
                      "Markup": [
                        {
                          "Start": 52,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 79,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "For more Analytic Laboratory Methods (Complete) data for Fentanyl (13 total), please visit the HSDB record page.",
                      "Markup": [
                        {
                          "Start": 95,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Analytic-Laboratory-Methods-(Complete)"
                        },
                        {
                          "Start": 57,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Clinical Laboratory Methods",
            "Description": "Clinical laboratory methods for detecting, isolating, separating, and/or analyzing this compound in a sample.  The information in this section is collected by the Hazardous Substances Data Bank (HSDB) from various sources.",
            "Information": [
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:3148625",
                  "Bjorkman S, Stanski DR; J Chromatogr 433: 95-104 (1988)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Simultaneous determination of fentanyl and alfentanil in rat blood and tissues by capillary column gas chromatography with a fused-silica capillary. The extn. recoveries from tissue averaged 88% for fentanyl, 72% for alfentanil and 87% for sufentanil.",
                      "Markup": [
                        {
                          "Start": 30,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 43,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 199,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 217,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 240,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:20658494",
                  "Cooreman S et al; J Sep Sci 33 (17-18): 2654-62 (2010)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl, norfentanyl, alfentanil, sufentanil, remifentanil and 3-methylfentanyl are potent, short-acting, synthetic narcotic analgesics that are not revealed in standard opiate immunoassays. In this article, a fully validated analytical method for the determination of these fentanyl-type compounds in plasma and urine is presented, consisting of a liquid-liquid extraction followed by a LC-MS/MS analysis using electrospray ionisation in the positive ionisation mode. Fentanyl-d(5) and norfentanyl-d(5) were used as internal standards. The lower LOQ in plasma and urine was 0.1 ng/mL for fentanyl, norfentanyl, alfentanil, remifentanil and 3-methylfentanyl, and 0.2 ng/mL for sufentanil. The method proved linear over a concentration range of 0.2-50 ng/mL for sufentanil and 0.1-50 ng/mL for all other analytes, with correlation coefficients of 0.998 or better. The analytical procedure showed excellent selectivity and precision (all CVs below 15%) for all analytes. Accuracy was good, except for sufentanil, where deviations of more than 15% from nominal concentrations were observed. No matrix effects were observed, and stability of stock and internal standard solutions was within acceptability limits.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 10,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        },
                        {
                          "Start": 23,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 35,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        },
                        {
                          "Start": 47,
                          "Length": 12,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/remifentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-60815"
                        },
                        {
                          "Start": 64,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/3-methylfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-61996"
                        },
                        {
                          "Start": 276,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 470,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 488,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        },
                        {
                          "Start": 590,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 600,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/norfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-259381"
                        },
                        {
                          "Start": 613,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 625,
                          "Length": 12,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/remifentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-60815"
                        },
                        {
                          "Start": 642,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/3-methylfentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-61996"
                        },
                        {
                          "Start": 678,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        },
                        {
                          "Start": 762,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        },
                        {
                          "Start": 1000,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 734"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "LC-MS/MS determination in human plasma and urine."
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Reference": [
                  "PMID:2521746",
                  "Tobin T et al; Res Commun Chem Pathol Pharmacol 63 (1): 129-52 (1989)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Immunoassay detection of drugs in racing horses. XI. ELISA and RIA detection of fentanyl, alfentanil, sufentanil and carfentanil in equine blood and urine. of fentanyl (designer fentanyls), and carfentanil and detected these drugs in urine for several hours after their administration to horses. It does not, however, cross-react significantly with alfentanil. An RIA for alfentanil was also developed. This test allows detection of alfentanil in blood and urine of horses for up to 4 hr after administration of this drug. As such, these tests are capable of improving the quality and reducing the cost of prerace and postrace testing for fentanyl, sufentanil, carfentanil, and alfentanil and a number of their congeners in racing horses. Similarly, these tests are capable of screening for these drugs in human drug abuse monitoring.",
                      "Markup": [
                        {
                          "Start": 80,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 90,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 102,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        },
                        {
                          "Start": 117,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/carfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-62156"
                        },
                        {
                          "Start": 159,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 194,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/carfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-62156"
                        },
                        {
                          "Start": 349,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 372,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 433,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        },
                        {
                          "Start": 639,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 649,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-41693"
                        },
                        {
                          "Start": 661,
                          "Length": 11,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/carfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-62156"
                        },
                        {
                          "Start": 678,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-51263"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Description": "PEER REVIEWED",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "For more Clinical Laboratory Methods (Complete) data for Fentanyl (17 total), please visit the HSDB record page.",
                      "Markup": [
                        {
                          "Start": 95,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Clinical-Laboratory-Methods-(Complete)"
                        },
                        {
                          "Start": 57,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Safety and Hazards",
        "Description": "Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.",
        "Section": [
          {
            "TOCHeading": "Hazards Identification",
            "Description": "This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.",
            "URL": "https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf",
            "Section": [
              {
                "TOCHeading": "GHS Classification",
                "Description": "GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/ghs/",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 1
                },
                "Information": [
                  {
                    "ReferenceNumber": 39,
                    "Name": "Pictogram(s)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "          ",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 1,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS06.svg",
                              "Type": "Icon",
                              "Extra": "Acute Toxic"
                            },
                            {
                              "Start": 1,
                              "Length": 1,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg",
                              "Type": "Icon",
                              "Extra": "Irritant"
                            },
                            {
                              "Start": 2,
                              "Length": 1,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg",
                              "Type": "Icon",
                              "Extra": "Health Hazard"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 39,
                    "Name": "Signal",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Danger",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 6,
                              "Type": "Color",
                              "Extra": "GHSDanger"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 39,
                    "Name": "GHS Hazard Statements",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "H300 (98.7%): Fatal if swallowed [Danger Acute toxicity, oral]",
                          "Markup": [
                            {
                              "Start": 34,
                              "Length": 6,
                              "Type": "Color",
                              "Extra": "GHSDanger"
                            }
                          ]
                        },
                        {
                          "String": "H310 (44.2%): Fatal in contact with skin [Danger Acute toxicity, dermal]",
                          "Markup": [
                            {
                              "Start": 42,
                              "Length": 6,
                              "Type": "Color",
                              "Extra": "GHSDanger"
                            }
                          ]
                        },
                        {
                          "String": "H317 (15.6%): May cause an allergic skin reaction [Warning Sensitization, Skin]",
                          "Markup": [
                            {
                              "Start": 51,
                              "Length": 7,
                              "Type": "Color",
                              "Extra": "GHSWarning"
                            }
                          ]
                        },
                        {
                          "String": "H330 (48.1%): Fatal if inhaled [Danger Acute toxicity, inhalation]",
                          "Markup": [
                            {
                              "Start": 32,
                              "Length": 6,
                              "Type": "Color",
                              "Extra": "GHSDanger"
                            }
                          ]
                        },
                        {
                          "String": "H334 (15.6%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]",
                          "Markup": [
                            {
                              "Start": 89,
                              "Length": 6,
                              "Type": "Color",
                              "Extra": "GHSDanger"
                            }
                          ]
                        },
                        {
                          "String": "H361 (15.6%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]",
                          "Markup": [
                            {
                              "Start": 67,
                              "Length": 7,
                              "Type": "Color",
                              "Extra": "GHSWarning"
                            }
                          ]
                        },
                        {
                          "String": "H362 (13%): May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]"
                        },
                        {
                          "String": "H413 (11.7%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 39,
                    "Name": "Precautionary Statement Codes",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "P203, P233, P260, P261, P262, P263, P264, P270, P271, P272, P273, P280, P284, P301+P316, P302+P352, P304+P340, P316, P318, P320, P321, P330, P333+P317, P342+P316, P361+P364, P362+P364, P403, P403+P233, P405, and P501"
                        },
                        {
                          "String": "(The corresponding statement to each P-code can be found at the GHS Classification page.)",
                          "Markup": [
                            {
                              "Start": 64,
                              "Length": 18,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/ghs/#_prec"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 39,
                    "Name": "ECHA C&L Notifications Summary",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Aggregated GHS information provided per 77 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 177,
                              "Type": "Italics"
                            }
                          ]
                        },
                        {
                          "String": "Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 281,
                              "Type": "Italics"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Hazard Classes and Categories",
                "Description": "The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/ghs/",
                "DisplayControls": {
                  "ShowAtMost": 2
                },
                "Information": [
                  {
                    "ReferenceNumber": 39,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Acute Tox. 2 (98.7%)"
                        },
                        {
                          "String": "Acute Tox. 1 (44.2%)"
                        },
                        {
                          "String": "Skin Sens. 1 (15.6%)"
                        },
                        {
                          "String": "Acute Tox. 1 (48.1%)"
                        },
                        {
                          "String": "Resp. Sens. 1 (15.6%)"
                        },
                        {
                          "String": "Repr. 2 (15.6%)"
                        },
                        {
                          "String": "Lact. (13%)"
                        },
                        {
                          "String": "Aquatic Chronic 4 (11.7%)"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Explosion Hazards",
                "Description": "This section provides information on the explosion hazards of this chemical under various conditions (e.g., when mixed with air, oxidants, or other agents; when used indoor, outdoor, or in sewer; when stored in a container; when heated, etc.).",
                "Information": [
                  {
                    "ReferenceNumber": 125,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "-"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Hazards Summary",
                "Description": "This section provides an overview of the key hazards information of this compound.",
                "Information": [
                  {
                    "ReferenceNumber": 58,
                    "Reference": [
                      "ACGIH - Documentation of the TLVs and BEIs, 7th Ed. Cincinnati: ACGIH Worldwide, 2020. TLVs and BEIs"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl is a solid. It is a Schedule II controlled substance. Fentanyl citrate is a strong analgesic used preoperatively, during surgery, and in the immediate postoperative period for its analgesic action. . . . Introduced into clinical practice in the 1960s, the analgesic fentanyl is 100 times more potent than morphine. [HSDB] TLV Basis is CNS impairment and respiratory depression; [ACGIH TLVs and BEIs]",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 63,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            },
                            {
                              "Start": 275,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 314,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Safety and Hazard Properties",
            "Description": "This section lists the chemical's safety and hazard characteristics, such as the explosive/flammable limits, critical temperature and pressure, exposure limits, etc.",
            "Section": [
              {
                "TOCHeading": "Physical Dangers",
                "Description": "The possibility of physical injury or sickness that could result in grave physical harm or death.  An example of physical dangers is fire/explosion due to raw materials.",
                "Information": [
                  {
                    "ReferenceNumber": 125,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "-"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Fire Fighting",
            "Description": "This section provides fire fighting information, including fire fighting procedures and hazards.",
            "Information": [
              {
                "ReferenceNumber": 125,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "- Burning may produce carbon monoxide, carbon dioxide, and nitrogen oxides.",
                      "Markup": [
                        {
                          "Start": 22,
                          "Length": 15,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/carbon%20monoxide",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-281"
                        },
                        {
                          "Start": 39,
                          "Length": 14,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/carbon%20dioxide",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-280"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Accidental Release Measures",
            "Description": "This section provides recommendations on the appropriate response to spills, leaks, or releases, including containment and cleanup practices to prevent or minimize exposure to people, properties, or the environment. It may also include recommendations distinguishing between responses for large and small spills where the spill volume has a significant impact on the hazard.",
            "URL": "https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf",
            "Section": [
              {
                "TOCHeading": "Disposal Methods",
                "Description": "Disposal methods or procedures for this chemical or hazardous waste containing it.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "SRP: Expired or waste pharmaceuticals shall carefully take into consideration applicable DEA, EPA, and FDA regulations. It is not appropriate to dispose by flushing the pharmaceutical down the toilet or discarding to trash. If possible return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator."
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Exposure Control and Personal Protection",
            "Description": "This section provides information on the exposure limits, engineering controls, and personal protective measures that can be used to minimize worker exposure.  The information in this section includes OSHA Permissible Exposure Limits (PELs), American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Values (TLVs), and any other exposure limit used or recommended by the chemical manufacturer, importer, or employer preparing the safety data sheet, where available. In addition, this section contains information on appropriate engineering controls (e.g., use local exhaust ventilation, or use only in an enclosed system) as well as recommendations for personal protective measures to prevent illness or injury from exposure to chemicals, such as personal protective equipment (PPE) (e.g., appropriate types of eye, face, skin or respiratory protection needed based on hazards and potential exposure).",
            "URL": "https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf",
            "Section": [
              {
                "TOCHeading": "Threshold Limit Values (TLV)",
                "Description": "The threshold limit value (TLV) of a chemical is an airborne concentration at which a worker can be exposed day after day for a working lifetime without adverse effect.  There are three types of TLVs for chemicals. [1] Threshold limit value - time-weighted average (TLV-TWA): average exposure on the basis of a 8h/day, 40h/week work schedule. [2] Threshold limit value - short-term exposure limit (TLV-STEL): a 15-minute TWA exposure that should not be exceeded at any time during a workday, even if the 8-hour TWA is within the TLV-TWA. [3] Threshold limit value - ceiling limit (TLV-C): absolute exposure limit that should not be exceeded at any time. TLVs are developed by the American Conference of Governmental Industrial Hygienist.  While TLVs are widely accepted occupational exposure limits, they are not standards enforced by the U.S. Government.",
                "URL": "https://www.acgih.org/science/tlv-bei-guidelines/tlv-chemical-substances-introduction/",
                "Information": [
                  {
                    "ReferenceNumber": 58,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "0.00001 [mg/m3], inhalable particulate matter (Surface Level = 1 ug/100cm2)"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 58,
                    "Name": "TLV-STEL",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "0.00002 [mg/m3], inhalable particulate matter"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Effects of Short Term Exposure",
                "Description": "This section provides health effects of short-term exposure to this compound.  The short-term exposure (also called acute exposure) is a short contact with a chemical. It may last a few seconds or a few hours. For example, it might take a few minutes to clean windows with ammonia, use nail polish remover or spray a can of paint. The fumes someone might inhale during these activities are examples of acute exposures.",
                "Information": [
                  {
                    "ReferenceNumber": 125,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "It is unknown whether chronic or repeated exposure to fentanyl increases the risk of carcinogenicity, reproductive toxicity, or developmental toxicity.",
                          "Markup": [
                            {
                              "Start": 54,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Personal Protective Equipment (PPE)",
                "Description": "Personal protective equipment (PPE) to use when handling this chemical.",
                "Information": [
                  {
                    "ReferenceNumber": 125,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "GENERAL INFORMATION"
                        },
                        {
                          "String": "First Responders should use a NIOSH-certified Chemical, Biological, Radiological, Nuclear (CBRN) Self Contained Breathing Apparatus (SCBA) with a Level A protective suit when entering an area with an unknown contaminant or when entering an area where the concentration of the contaminant is unknown. Level A protection should be used until monitoring results confirm the contaminant and the concentration of the contaminant.NOTE:Safe use of protective clothing and equipment requires specific skills developed through training and experience."
                        },
                        {
                          "String": "LEVEL A: (RED ZONE)"
                        },
                        {
                          "String": "Select when the greatest level of skin, respiratory, and eye protection is required. This is the maximum protection for workers in danger of exposure to unknown chemical hazards or levels above the IDLH or greater than the AEGL-2."
                        },
                        {
                          "String": "- A NIOSH-certified CBRN full-face-piece SCBA operated in a pressure-demand mode or a pressure-demand supplied air hose respirator with an auxiliary escape bottle."
                        },
                        {
                          "String": "- A Totally-Encapsulating Chemical Protective (TECP) suit that provides protection against CBRN agents."
                        },
                        {
                          "String": "- Chemical-resistant gloves (outer)."
                        },
                        {
                          "String": "- Chemical-resistant gloves (inner)."
                        },
                        {
                          "String": "- Chemical-resistant boots with a steel toe and shank."
                        },
                        {
                          "String": "- Coveralls, long underwear, and a hard hat worn under the TECP suit are optional items."
                        },
                        {
                          "String": "LEVEL B: (RED ZONE)"
                        },
                        {
                          "String": "Select when the highest level of respiratory protection is necessary but a lesser level of skin protection is required. This is the minimum protection for workers in danger of exposure to unknown chemical hazards or levels above the IDLH or greater than AEGL-2. It differs from Level A in that it incorporates a non-encapsulating, splash-protective, chemical-resistant splash suit that provides Level A protection against liquids but is not airtight."
                        },
                        {
                          "String": "- A NIOSH-certified CBRN full-face-piece SCBA operated in a pressure-demand mode or a pressure-demand supplied air hose respirator with an auxiliary escape bottle."
                        },
                        {
                          "String": "- A hooded chemical-resistant suit that provides protection against CBRN agents."
                        },
                        {
                          "String": "- Chemical-resistant gloves (outer)."
                        },
                        {
                          "String": "- Chemical-resistant gloves (inner)."
                        },
                        {
                          "String": "- Chemical-resistant boots with a steel toe and shank."
                        },
                        {
                          "String": "- Coveralls, long underwear, a hard hat worn under the chemical-resistant suit, and chemical-resistant disposable boot-covers worn over the chemical-resistant suit are optional items."
                        },
                        {
                          "String": "LEVEL C: (YELLOW ZONE)"
                        },
                        {
                          "String": "Select when the contaminant and concentration of the contaminant are known and the respiratory protection criteria factors for using Air Purifying Respirators (APR) or Powered Air Purifying Respirators (PAPR) are met. This level is appropriate when decontaminating patient/victims."
                        },
                        {
                          "String": "- A NIOSH-certified CBRN tight-fitting APR with a canister-type gas mask or CBRN PAPR for air levels greater than AEGL-2."
                        },
                        {
                          "String": "- A NIOSH-certified CBRN PAPR with a loose-fitting face-piece, hood, or helmet and a filter or a combination organic vapor, acid gas, and particulate cartridge/filter combination or a continuous flow respirator for air levels greater than AEGL-1."
                        },
                        {
                          "String": "- A hooded chemical-resistant suit that provides protection against CBRN agents."
                        },
                        {
                          "String": "- Chemical-resistant gloves (outer)."
                        },
                        {
                          "String": "- Chemical-resistant gloves (inner)."
                        },
                        {
                          "String": "- Chemical-resistant boots with a steel toe and shank."
                        },
                        {
                          "String": "- Escape mask, face shield, coveralls, long underwear, a hard hat worn under the chemical-resistant suit, and chemical-resistant disposable boot-covers worn over the chemical-resistant suit are optional items."
                        },
                        {
                          "String": "LEVEL D: (GREEN ZONE)"
                        },
                        {
                          "String": "Select when the contaminant and concentration of the contaminant are known and the concentration is below the appropriate occupational exposure limit or less than AEGL-1 for the stated duration times."
                        },
                        {
                          "String": "- Limited to coveralls or other work clothes, boots, and gloves."
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Regulatory Information",
            "Description": "This section lists the regulations related to the safety, health, and environment of the chemical and its associated products. The regulatory information, which may encompass national and/or regional regulations pertaining to the chemical or mixtures, is presented solely for informational purposes. For additional details, please consult the links to the information sources provided under each data entry.",
            "Information": [
              {
                "ReferenceNumber": 14,
                "Name": "DEA Controlled Substances",
                "Reference": [
                  "21 CFR Sections 1308.11-1308.15 https://www.ecfr.gov/current/title-21/chapter-II/part-1308"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "DEA schedule II controlled substance"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 99,
                "Name": "New Zealand EPA Inventory of Chemical Status",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Fentanyl: HSNO Approval: HSR007044 Approved with controls",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 10,
                          "Length": 4,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/HSNO",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11389353"
                        }
                      ]
                    }
                  ]
                }
              }
            ],
            "Section": [
              {
                "TOCHeading": "FDA Requirements",
                "Description": "FDA requirements regarding this chemical and products containing it.  FDA Requirements means any requirements of the Federal Food, Drug and Cosmetic Act (FDCA), as amended, and any rules or regulations promulgated thereunder which are or may be applicable to the manufacture, sale, labeling or distribution of the products regulated by FDA (e.g., drugs, biologics, dietary supplements, foods, cosmetics, tobacco products, etc.).",
                "URL": "https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "DHHS/FDA; Electronic Orange Book-Approved Drug Products with Therapeutic Equivalence Evaluations. Available from, as of April 25, 2017: https://www.fda.gov/cder/ob/"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "The Approved Drug Products with Therapeutic Equivalence Evaluations identifies currently marketed prescription drug products, including fentanyl, approved on the basis of safety and  effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.",
                          "Markup": [
                            {
                              "Start": 136,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "DHHS/FDA; Electronic Orange Book-Approved Drug Products with Therapeutic Equivalence  Evaluations. Available from, as of April 25, 2017: https://www.fda.gov/cder/ob/"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "The Approved Drug Products with Therapeutic Equivalence Evaluations identifies currently marketed prescription drug products, including fentanyl citrate, approved on the basis of safety and  effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. /Fentanyl citrate/",
                          "Markup": [
                            {
                              "Start": 136,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            },
                            {
                              "Start": 277,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "US FDA/Center for Veterinary Medicine; The Green Book - On Line, Active Ingredients. Fentanyl (437-38-7). Available from, as of April 25, 2017: https://www.fda.gov/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/default.htm"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "The Generic Animal Drug and Patent Restoration act requires that each sponsor of an  approved animal drug must submit to the FDA certain information regarding patents held for  the animal drug or its method of use. The Act requires that this information, as well as a  list of all animal drug products approved for safety and effectiveness, be made available to  the public. Fentanyl is included on this list.",
                          "Markup": [
                            {
                              "Start": 375,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "21 CFR 1308.12(c) (9) (USFDA); U.S. National Archives and Records Administration's Electronic Code of Federal Regulations. Available from, as of April 25, 2017: https://www.ecfr.gov"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. ... Opiates. Unless specifically excepted or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:. Fentanyl (DEA Code Number: 9801) is included on this list.",
                          "Markup": [
                            {
                              "Start": 588,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dextrorphan",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5360697"
                            },
                            {
                              "Start": 604,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/levopropoxyphene",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-200742"
                            },
                            {
                              "Start": 632,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "21 CFR 524.916 (USFDA); U.S. National Archives and Records Administration's Electronic Code of Federal Regulations. Available from, as of April 25, 2017: https://www.ecfr.gov"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Ophthalmic and topical dosage form new animal drugs. Fentanyl. ... Indications for use. For the control of postoperative pain associated with surgical procedures in dogs. ... Limitations. Fentanyl is a Class II controlled substance. Observe all \"black-box warnings\" on product labeling. Federal law restricts this drug to use by or on the order of a licensed veterinarian.",
                          "Markup": [
                            {
                              "Start": 53,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 188,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Other Safety Information",
            "Description": "Miscellaneous safety information for this chemical that is not shown in other sections, such as history, incidents, special reports, and so on.",
            "Information": [
              {
                "ReferenceNumber": 125,
                "Name": "Methods of Dissemination",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "- Indoor Air: Fentanyl can be released into indoor air as fine particles or liquid spray (aerosol).",
                      "Markup": [
                        {
                          "Start": 14,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    },
                    {
                      "String": "- Water: Fentanyl can be used to contaminate water.",
                      "Markup": [
                        {
                          "Start": 2,
                          "Length": 5,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Water",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-962"
                        },
                        {
                          "Start": 9,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        },
                        {
                          "Start": 45,
                          "Length": 5,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-962"
                        }
                      ]
                    },
                    {
                      "String": "- Food: Fentanyl can be used to contaminate food.",
                      "Markup": [
                        {
                          "Start": 8,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    },
                    {
                      "String": "- Outdoor Air: Fentanyl can be released into outdoor air as fine particles or liquid spray (aerosol).",
                      "Markup": [
                        {
                          "Start": 15,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    },
                    {
                      "String": "- Agricultural: If fentanyl is released into the air as fine particles or liquid spray (aerosol), it has the potential to contaminate agricultural products.",
                      "Markup": [
                        {
                          "Start": 19,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-3345"
                        }
                      ]
                    }
                  ]
                }
              }
            ],
            "Section": [
              {
                "TOCHeading": "History and Incidents",
                "Description": "The history and incidents involving the chemical safety and hazards of this compound.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Center for Nonproliferation Studies; The Moscow Theater Hostage Crisis: Incapacitants and Chemical Warfare. Available from, as of April 24, 2006: https://cns.miis.edu/pubs/week/02110b.htm"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "On October 23, 2002, in the middle of an evening performance at a Moscow music theater, some 50 Chechen terrorists equipped with firearms as well as large quantities of explosives suddenly seized the venue and the 800 people inside. The terrorists threatened to kill everyone inside unless Russia ended the war in Chechnya. Although the Chechen militants agreed to release some of the hostages during the first couple of days, negotiations with the Russian authorities eventually stalled. Just before dawn on October 26, Russian special police units resorted to using an incapacitating gas based on the drug fentanyl to end the crisis. All of the Chechen militants were killed, and most of the civilian captives survived. But while the operation was largely a success, at least 117 of the hostages died from the effects of the gas. /Incapacitating gas based on the drug fentanyl/",
                          "Markup": [
                            {
                              "Start": 608,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 870,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Special Reports",
                "Description": "Special reports on the safety and hazard of this chemical.  Most of them are government documents and review articles.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DHHS/NIDA; Research Monograph Series 52: Testing Drugs for Physical Dependence Potential and Abuse Liability (1984) DHHS Pub No. (ADM)87-1332"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DHHS/NIDA; Research Monograph Series 54: Mechanisms of Tolerance and Dependence (1984) DHHS Pub No. (ADM)88-1330"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DHHS/NIDA; Research Monograph Series 56: Etiology of Drug Abuse: Implications for Prevention (1987) DHHS Pub No. (ADM)87-1335"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DHHS/NIDA; Research Monograph Series 59: Current Research on the Consequences of Maternal Drug Abuse (1985) DHHS Pub No. (ADM)85-1400"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "For more Special Reports (Complete) data for Fentanyl (10 total), please visit the HSDB record page.",
                          "Markup": [
                            {
                              "Start": 83,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Special-Reports-(Complete)"
                            },
                            {
                              "Start": 45,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Toxicity",
        "Description": "Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.",
        "Section": [
          {
            "TOCHeading": "Toxicological Information",
            "Description": "This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.",
            "Section": [
              {
                "TOCHeading": "Toxicity Summary",
                "Description": "Summary of the toxicity of this compound, provided by the Hazardous Substances Data Bank (HSDB) and other sources.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "IDENTIFICATION AND USE: Fentanyl is a solid. It is a Schedule II controlled substance. Fentanyl citrate is a strong analgesic used preoperatively, during surgery, and in the immediate postoperative period for its analgesic action. In addition, the drug may be used to prevent or relieve tachypnea and postoperative emergence delirium. HUMAN STUDIES: Introduced into clinical practice in the 1960s, the analgesic fentanyl is 100 times more potent than morphine. Various methods of administration exist including the transdermal patch system, widely used in chronic pain and palliative care settings. Numerous, often imaginative methods of abuse of fentanyl patches have been reported, the majority of fatal fentanyl overdose cases resulting from deliberate abuse or suicide. The most serious adverse effect of fentanyl is respiratory depression. Fentanyl should be administered only under the supervision of qualified clinicians. Patients receiving fentanyl should be advised of the importance of taking the drug exactly as prescribed. Skeletal and thoracic muscle rigidity occurs frequently, especially following rapid IV administration of fentanyl. Muscular rigidity may be associated with reduced pulmonary compliance and/or apnea, laryngospasm, and bronchoconstriction and may be managed by use of assisted or controlled respiration or, if necessary, by IV administration of a neuromuscular blocking agent. Bradycardia may occur following administration of fentanyl and may be controlled with atropine. Delayed chest wall muscle rigidity may develop up to 24 hours after administration or 9 hours after after ending an IV infusion and may persist for hours. Masseter muscle spasm and laryngospasm may also occur. Acute overdosage produces signs of opioid toxicity: circulatory and CNS depression, lethargy, coma, respiratory depression, and decreased GI motility with ileus. Miosis is a variable finding, depending on the particular opioid, co-ingestants, and secondary effects, such as hypoxia. Apnea, hypotension, bradycardia, non-cardiogenic pulmonary edema, seizures, dysrhythmias, and death may occur with severe poisoning. With continued use, tolerance to the pharmacologic and adverse effects of the drug develop, but the rate of development of tolerance exhibits considerable interindividual variation. ANIMAL STUDIES: Fentanyl was not teratogenic in rats at dosages of 10-500 ug/kg daily when administered on days 7-21 of gestation. At an IV dosage of 10-30 ug/kg daily on days 6-18 of gestation in rats, fentanyl was embryotoxic or fetotoxic and slightly increased mean delivery time in animals receiving the highest dosage, but the drug was not teratogenic. At IV doses of 30 ug/kg or subcutaneous doses of 160 ug/kg in rats, fentanyl increased embryonic resorptions. Fentanyl citrate was not mutagenic in the in vitro Ames reverse mutation assay in S. typhimurium or E. coli, or the mouse lymphoma mutagenesis assay, and was not clastogenic in the in vivo mouse micronucleus assay. In veterinary use, overdosage may produce profound respiratory and/or CNS depression in most species. Newborns may be more susceptible to these effects than adult animals. Other toxic effects may include cardiovascular collapse, tremors, reck rigidity, and seizures.",
                          "Markup": [
                            {
                              "Start": 24,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 87,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            },
                            {
                              "Start": 412,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 451,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 647,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 706,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 809,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 845,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 948,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1140,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1460,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1496,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/atropine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-174174"
                            },
                            {
                              "Start": 2330,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 2517,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 2740,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 2782,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 128,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Fentanyl's analgesic activity is, most likely, due to its conversion to morphine. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hypopolarization and reduced neuronal excitability.",
                          "Markup": [
                            {
                              "Start": 230,
                              "Length": 3,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/GTP",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-135398633"
                            },
                            {
                              "Start": 294,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/adenylate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-6083"
                            },
                            {
                              "Start": 316,
                              "Length": 4,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-6076"
                            },
                            {
                              "Start": 405,
                              "Length": 4,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cAMP",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-6076"
                            },
                            {
                              "Start": 424,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/adenylate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-6083"
                            },
                            {
                              "Start": 510,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/substance%20P",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-36511"
                            },
                            {
                              "Start": 523,
                              "Length": 4,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/GABA",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-119"
                            },
                            {
                              "Start": 529,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dopamine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-681"
                            },
                            {
                              "Start": 539,
                              "Length": 13,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/acetylcholine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-187"
                            },
                            {
                              "Start": 557,
                              "Length": 13,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/noradrenaline",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-439260"
                            },
                            {
                              "Start": 634,
                              "Length": 12,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/somatostatin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-16129706"
                            },
                            {
                              "Start": 660,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/glucagon",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-16132283"
                            },
                            {
                              "Start": 670,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 742,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 790,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Calcium",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Calcium"
                            },
                            {
                              "Start": 839,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Calcium",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Calcium"
                            },
                            {
                              "Start": 877,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Potassium",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Potassium"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Carcinogen Classification",
                "Description": "This section provides the International Agency for Research on Cancer (IARC) Carcinogenic Classification and related monograph links.  In the IARC Carcinogenic classification, chemicals are categorized into four groups: Group 1 (carcinogenic to humans), Group 2A (probably carcinogenic to humans), Group 2B (possibly carcinogenic to humans), and Group 3 (not classifiable as to its carcinogenicity to humans).",
                "URL": "https://monographs.iarc.who.int/agents-classified-by-the-iarc/",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  }
                },
                "Information": [
                  {
                    "ReferenceNumber": 128,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "No indication of carcinogenicity to humans (not listed by IARC)."
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Health Effects",
                "Description": "Principal effect(s) of exposure to each substance, listed by OSHA Health Code, Health Effects from various sources.",
                "Information": [
                  {
                    "ReferenceNumber": 128,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Medical problems can include congested lungs, liver disease, tetanus, infection of the heart valves, skin abscesses, anemia and pneumonia. Death can occur from overdose."
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Effects During Pregnancy and Lactation",
                "Description": "Drug effects during pregnancy and lactation.",
                "Information": [
                  {
                    "ReferenceNumber": 16,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "◉ Summary of Use during Lactation"
                        },
                        {
                          "String": "When used epidurally or intravenously during labor or for a short time immediately postpartum, amounts of fentanyl ingested by the neonate are usually small and are not expected to cause any adverse effects in breastfed infants. The results of studies on the effect of epidural fentanyl on breastfeeding initiation and duration are mixed, because of the many different combinations of drugs, dosages and patient populations studied as well as the variety of techniques used and deficient designs of many of the studies.",
                          "Markup": [
                            {
                              "Start": 106,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 278,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "It has been suggested that a cumulative dose of 80 to 150 mcg of fentanyl during labor and delivery reduces breastfeeding success, but another study found no marked decrease in breastfeeding success with doses above 150 mcg in motivated women with previous breastfeeding success.",
                          "Markup": [
                            {
                              "Start": 65,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "In infants placed skin-to-skin after a normal vaginal delivery, epidural fentanyl given during labor may delay the infant's first suckling in a dose-dependent manner, perhaps because it can persist in the infant's serum for over 24 hours after discontinuation. However, it appears that with good breastfeeding support, epidural fentanyl plus bupivacaine has little overall effect on breastfeeding success.",
                          "Markup": [
                            {
                              "Start": 73,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 328,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 342,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            }
                          ]
                        },
                        {
                          "String": "No waiting period or discarding of milk is required before resuming breastfeeding after fentanyl is used for short procedures (e.g., for endoscopy). After general anesthesia, breastfeeding can be resumed as soon as the mother has recovered sufficiently from anesthesia to nurse. When a combination of anesthetic agents is used for a procedure, follow the recommendations for the most problematic medication used during the procedure. Limited information indicates that transdermal fentanyl in a dosage of 100 mcg/hour results in undetectable fentanyl concentrations in breastmilk.",
                          "Markup": [
                            {
                              "Start": 88,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 481,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 542,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "Maternal use of oral opioids during breastfeeding can cause infant drowsiness, which may progress to rare but severe central nervous system depression. Newborn infants seem to be particularly sensitive to the effects of even small dosages of narcotic analgesics. Preterm infants are the most susceptible to fentanyl’s effects because their clearance is substantially reduced. If fentanyl is required by the mother of a newborn, it is not a reason to discontinue breastfeeding; however, once the mother's milk comes in, it is best to provide pain control with a nonnarcotic analgesic and limit maternal intake of fentanyl to a few days at a low dosage with close infant monitoring. If the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness, a physician should be contacted immediately.",
                          "Markup": [
                            {
                              "Start": 307,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 379,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 612,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "◉ Effects in Breastfed Infants"
                        },
                        {
                          "String": "Fentanyl was possibly the cause of statistically significant, but clinically unimportant, lower neurobehavioral scores in a group of 32 newborns who were less than 24 hours old and whose mothers had received epidural fentanyl during labor.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 217,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "An epidural fentanyl dosage greater than 150 mcg during labor was associated with slightly lower neurobehavioral scores in the newborns of 177 breastfeeding mothers on postpartum day 1 compared to a lower total dosage or to no fentanyl; however, this might have been a chance association and was probably due to placental transfer of fentanyl prior to delivery and not from breastmilk after delivery. All women also received epidural bupivacaine.",
                          "Markup": [
                            {
                              "Start": 12,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 227,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 334,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 434,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            }
                          ]
                        },
                        {
                          "String": "A woman was using a transdermal fentanyl patch for chronic back pain during pregnancy and postpartum. The mother required additional analgesia during labor and the infant required treatment for neonatal abstinence syndrome. By 2 weeks postpartum, the mother was using a fentanyl patch in a dosage of 100 mcg/hour which was changed every other day and the infant was being fed the mother's milk every 3 hours. The infant had no additional medical problems and fed well until discharge after day 27 of life, gaining 500 grams.",
                          "Markup": [
                            {
                              "Start": 32,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 270,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A search was performed of the shared database of all U.S. poison control centers for the time period of 2001 to 2017 for calls regarding medications and breastfeeding. Of 2319 calls in which an infant was exposed to a substance via breastmilk, 7 were classified as resulting in a major adverse effect, and one of these involved fentanyl. A one-month-old infant was exposed to fentanyl, morphine, oxycodone, and unspecified benzodiazepines. The infant was admitted to the intensive care unit and described as being agitated and irritable and having tachycardia, confusion, drowsiness, lethargy, miosis, respiratory depression, acidosis, and hyperglycemia. The dosages, routes of administration, and extent of breastfeeding were not reported and the infant survived.",
                          "Markup": [
                            {
                              "Start": 328,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 376,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 386,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 396,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxycodone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284603"
                            }
                          ]
                        },
                        {
                          "String": "◉ Effects on Lactation and Breastmilk"
                        },
                        {
                          "String": "Fentanyl can increase serum prolactin. However, the prolactin level in a mother with established lactation may not affect her ability to breastfeed.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "Five women who were 6 to 15 weeks postpartum were given single doses of 100 mcg of fentanyl, 2 mg of midazolam and 2.5 mg/kg of propofol intravenously before undergoing general anesthesia. The women's milk output following the surgical procedure was less than half of the normal milk output of nursing mothers. The authors speculated that milk volume might be reduced postoperatively because of perioperative fluid restriction and volume losses, as well as stress-induced inhibition of milk production.",
                          "Markup": [
                            {
                              "Start": 83,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 101,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/midazolam",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4192"
                            },
                            {
                              "Start": 128,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/propofol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4943"
                            }
                          ]
                        },
                        {
                          "String": "In 58 breastfeeding mothers who received an epidural fentanyl dosage greater than 150 mcg during labor, 21% reported more difficulty in establishing breastfeeding at 24 hours after delivery compared to 10% of mothers who received to a lower dosage or to no fentanyl. There was no difference in breastfeeding difficulty noted between the groups 24 hours after delivery as determined by a lactation consultant. Women in the high-dose group who could be contacted were more likely to discontinue breastfeeding by 6 weeks after delivery and there was a higher rate of breastfeeding discontinuation at 6 weeks among mothers who reported breastfeeding difficulty 24 hours after delivery. A relatively high dropout rate from the study at 6 weeks clouds the results.",
                          "Markup": [
                            {
                              "Start": 53,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 257,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A retrospective study of a random sample of 425 mothers delivering in a maternity unit found a dose-related increased risk of bottle feeding at hospital discharge associated with fentanyl administered during labor.",
                          "Markup": [
                            {
                              "Start": 179,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A prospective cohort study compared women who received continuous epidural analgesia with fentanyl and either bupivacaine or ropivacaine during labor and delivery (n = 52) to women who received no analgesia (n = 63). The average total fentanyl dosage was 124 mcg and the average total infusion time from start to delivery was 219 minutes. The study found no differences between the groups in breastfeeding effectiveness or infant neurobehavioral status at 8 to 12 hours postpartum or the number exclusively or partially breastfeeding at 4 weeks postpartum.",
                          "Markup": [
                            {
                              "Start": 90,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 110,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 125,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/ropivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-175805"
                            },
                            {
                              "Start": 235,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A randomized, prospective study measured infant breastfeeding behavior following epidural or intravenous fentanyl during delivery in 100 multiparous mothers undergoing cesarean section and delivering full term, healthy infants. Epidural fentanyl was given to 50 women in a dose of 100 to 150 mcg in divided doses followed by a continuous epidural infusion of 20 mcg/hour. Intravenous fentanyl was given to 50 women as a single dose of 50 mcg after delivery. Both groups received epidural or spinal bupivacaine in addition. A slight difference was seen in breastfeeding behavior between the groups, with the infants in the intravenous fentanyl group performing slightly worse than those in the epidural group. However, all mothers were able to breastfeed their infants at 24 hours. None had severe breastfeeding problems; 10 women in the epidural group reported mild or moderate problems and 7 women in the intravenous group reported breastfeeding problems. Twenty mothers in the epidural group and 14 in the intravenous group used supplemental bottle feeding, with the difference not statistically significant.",
                          "Markup": [
                            {
                              "Start": 105,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 237,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 384,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 498,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 634,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A randomized, multicenter trial compared the initiation rate and duration of breastfeeding in women who received high-dose epidural bupivacaine alone, or one of two low-dose combinations of bupivacaine plus fentanyl. The average fentanyl dosages in the two groups were 97 and 151 mcg in the first stage of labor and 10 and 12 mcg of fentanyl during the second stage of labor, respectively, with great variability. A nonepidural matched control group was also compared. No differences in breastfeeding initiation rates or duration were found among the epidural and nonmedicated groups, but women in the nonepidural group who received systemic meperidine had a lower breastfeeding initiation rate than in the other groups.",
                          "Markup": [
                            {
                              "Start": 132,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 190,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 207,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 229,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 333,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 642,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            }
                          ]
                        },
                        {
                          "String": "A nonrandomized study in low-risk mother-infant pairs found that there was no difference overall in the amount of sucking by newborns, whether their mothers received bupivacaine plus fentanyl, or fentanyl alone by epidural infusion in various dosages, or received no analgesia for childbirth. In a subanalysis by sex and number of sucks, female infants were affected by high-dose bupivacaine and high-dose fentanyl, but male infant were not. However, the imbalances of many factors between the study groups makes this study difficult to interpret.",
                          "Markup": [
                            {
                              "Start": 166,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 183,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 196,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 380,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 406,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "In a prospective cohort study, 87 multiparous women who received epidural bupivacaine and fentanyl for pain control during labor and vaginal delivery. A loading dose of 0.125% bupivacaine with fentanyl 50-100 mcg. Epidural analgesia is maintained using 0.0625% bupivacaine and fentanyl 0.2 mcg/mL. The median dose of fentanyl received by the women was 151 mcg (range 30 to 570 mcg). The women completed questionnaires at 1 and 6 weeks postpartum regarding breastfeeding. Most women had prior experience with breastfeeding, support at home and ample time off from work. All women were breastfeeding at 1 week postpartum and 95.4% of women were breastfeeding at 6 weeks postpartum.",
                          "Markup": [
                            {
                              "Start": 74,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 90,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 176,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 193,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 261,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 277,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 317,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A nonrandomized study at one Italian hospital compared primiparous mothers undergoing vaginal delivery who received epidural analgesia (n = 64) to those who did not (n = 64). Mothers who requested the epidural analgesia received an initial dose of 100 mcg of fentanyl diluted to 10 mL with saline. After the initial fentanyl, doses of 15 to 20 mL of 0.1% ropivacaine were administered if needed. The only difference between the groups of mothers was a longer duration of labor among the treated mothers. The quality of infant nursing was equal between the 2 groups of infants on several measures; however, more infants in the treated group breastfed for less than 30 minutes at the first feeding.",
                          "Markup": [
                            {
                              "Start": 259,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 316,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 355,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/ropivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-175805"
                            }
                          ]
                        },
                        {
                          "String": "A national survey of women and their infants from late pregnancy through 12 months postpartum compared the time of lactogenesis II in mothers who did and did not receive pain medication during labor. Categories of medication were spinal or epidural only, spinal or epidural plus another medication, and other pain medication only. Women who received medications from any of the categories had about twice the risk of having delayed lactogenesis II (>72 hours) compared to women who received no labor pain medication."
                        },
                        {
                          "String": "A randomized study compared the effects of cesarean section using general anesthesia, spinal anesthesia, or epidural anesthesia, to normal vaginal delivery on serum prolactin and oxytocin as well as time to initiation of lactation. General anesthesia was performed using propofol 2 mg/kg and rocuronium 0.6 mg/kg for induction, followed by sevoflurane and rocuronium 0.15 mg/kg as needed. After delivery, patients in all groups received an infusion of oxytocin 30 international units in 1 L of saline, and 0.2 mg of methylergonovine if they were not hypertensive. Fentanyl 1 to 1.5 mcg/kg was administered after delivery to the general anesthesia group. Patients in the general anesthesia group (n = 21) had higher post-procedure prolactin levels and a longer mean time to lactation initiation (25 hours) than in the other groups (10.8 to 11.8 hours). Postpartum oxytocin levels in the nonmedicated vaginal delivery group were higher than in the general and spinal anesthesia groups.",
                          "Markup": [
                            {
                              "Start": 179,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxytocin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-439302"
                            },
                            {
                              "Start": 271,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/propofol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4943"
                            },
                            {
                              "Start": 292,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/rocuronium",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-441290"
                            },
                            {
                              "Start": 340,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sevoflurane",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5206"
                            },
                            {
                              "Start": 356,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/rocuronium",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-441290"
                            },
                            {
                              "Start": 452,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxytocin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-439302"
                            },
                            {
                              "Start": 516,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/methylergonovine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-8226"
                            },
                            {
                              "Start": 564,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 863,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxytocin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-439302"
                            }
                          ]
                        },
                        {
                          "String": "A randomized, nonblinded study compared the use of intramuscular meperidine 100 mg to intranasal (mean dose 486 mcg) or subcutaneous (mean dose 300 mcg) fentanyl for labor analgesia. More women in the meperidine group had difficulty establishing lactation (79%) than in the intranasal (39%) or subcutaneous (44%) fentanyl groups. Mothers who received meperidine reported more sedation, had longer labors, and their infants were more likely to be admitted to the nursery.",
                          "Markup": [
                            {
                              "Start": 65,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            },
                            {
                              "Start": 153,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 201,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            },
                            {
                              "Start": 313,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 351,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            }
                          ]
                        },
                        {
                          "String": "A retrospective study in a Spanish public hospital compared the infants of mothers who received an epidural during labor that contained fentanyl and either bupivacaine or ropivacaine. Infants of mothers who received an epidural had a lower frequency of early breastfeeding.",
                          "Markup": [
                            {
                              "Start": 136,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 156,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 171,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/ropivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-175805"
                            }
                          ]
                        },
                        {
                          "String": "A small prospective study in California compared women who received an epidural infusion of fentanyl and ropivacaine to mothers who did not receive an epidermal during labor. All mothers had normal vaginal deliveries and their infants had 1 uninterrupted hour of skin-to-skin contact immediately postpartum. The study found inverse relationships between the amount of fentanyl and the amount of oxytocin received during labor and the time of the first suckling. Because women who received more fentanyl also tended to receive more oxytocin, the study could not clearly separate the effects of the two drugs.",
                          "Markup": [
                            {
                              "Start": 92,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 105,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/ropivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-175805"
                            },
                            {
                              "Start": 368,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 395,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxytocin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-439302"
                            },
                            {
                              "Start": 494,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 531,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxytocin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-439302"
                            }
                          ]
                        },
                        {
                          "String": "A randomized, double-blind study compared three epidural maintenance solutions for labor analgesia in women receiving epidural analgesia during labor: bupivacaine 1 mg/mL, bupivacaine 0.8 mg/mL with fentanyl 1 mcg/mL, or bupivacaine 0.625 mg/mL with fentanyl 2 mcg/mL. At 6 weeks postpartum, the breastfeeding rate was 94% or greater in all groups, with no difference among them. All mothers delivered full-term infants and were highly motivated to breastfeed and almost all had vaginal deliveries.",
                          "Markup": [
                            {
                              "Start": 151,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 172,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 199,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 221,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 250,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A prospective cohort study in 1204 Israeli women on the effect of labor epidural analgesia during labor, the following protocol was used: bupivacaine 0.1% 15 mL and fentanyl 100 mcg in 5-mL increments, followed by an epidural infusion of bupivacaine 0.1% 10 mL and fentanyl 2 mcg/mL, with a patient-controlled epidural analgesia modality with 5 mL bolus with a lock-out time of 15 minutes. At 6 weeks postpartum, the breastfeeding and exclusive breastfeeding rates were lower (74% and 52%, respectively) in mothers who received the epidural analgesia than in those who did not (83% and 68%, respectively). However, the difference was mostly accounted for by parity, with the intervention having little effect on multiparous women.",
                          "Markup": [
                            {
                              "Start": 138,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 165,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 238,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 265,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A prospective study in an Australian hospital compared mothers who received epidural fentanyl analgesia, subcutaneous morphine or neither during labor and delivery. When controlled for labor induction, instrumental delivery and special care nursery admission, no difference was seen between the 3 groups in breastfeeding rates at discharge or at 6 weeks postpartum.",
                          "Markup": [
                            {
                              "Start": 85,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 118,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            }
                          ]
                        },
                        {
                          "String": "A randomized, partially blinded study in a hospital in Thailand compared intravenous meperidine and fentanyl for pain during active labor. Mothers received either meperidine 50 mg (n = 46) or fentanyl 50 mcg (n = 46) initially and then every 1 (fentanyl) or 2 (meperidine) hours as requested by the mother. The percentages of infants who breastfed in the first 24 hours were only 61% for meperidine and 54% for fentanyl, although the difference was not statistically significant. Care of the infants (e.g., skin-to-skin in the first hour) was not reported.",
                          "Markup": [
                            {
                              "Start": 85,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            },
                            {
                              "Start": 100,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 163,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            },
                            {
                              "Start": 192,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 245,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 261,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            },
                            {
                              "Start": 388,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            },
                            {
                              "Start": 411,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A multicenter, prospective cohort study in Hong Kong of 1277 women who gave birth found that women who received epidural analgesia with either fentanyl or morphine had no decreased frequency of breastfeeding in the first hour compared to mothers who did not receive epidural analgesia. All epidural injections were combined with a local anesthetic, but the exact dosages were not given.",
                          "Markup": [
                            {
                              "Start": 143,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 155,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            }
                          ]
                        },
                        {
                          "String": "A prospective, observational study in Norway found that infant spontaneous suckling was negatively associated with any intrapartum fentanyl use. The odds of non-exclusive breastfeeding were doubled with epidural fentanyl analgesia and were 4 times higher with intravenous plus epidural fentanyl compared to no opioid exposure. Compared to higher doses, intravenous fentanyl doses greater than 200 mcg resulted in a reduction in exclusive breastfeeding and spontaneous suckling, and an increase in breastfeeding problems.",
                          "Markup": [
                            {
                              "Start": 131,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 212,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 286,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 365,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "A nonrandomized, nonblinded study in a Serbian hospital of women near term who underwent cesarean section compared general anesthesia (n = 284) to spinal or epidural anesthesia (n = 249). Spinal anesthesia consisted of hyperbaric bupivacaine 12 mg and fentanyl 0.01 mg; epidural anesthesia consisted of isobaric bupivacaine 0.5% (0.5 mg per 10 cm height) and fentanyl 0.05 mg. General anesthesia consisted of propofol 2.3 mg/kg and succinylcholine 1.5 mg/kg for induction and intubation, followed by an anesthetic gas mixture and oxygen. Reportedly, nitric oxide (possibly nitrous oxide) was 50% of the gas before delivery and 67% after delivery. Sevoflurane was also used in some cases. After delivery and cord clamping, mothers received fentanyl 3 mcg/kg and rocuronium 0.5 mg/kg intravenously for placental delivery. After surgery, neuromuscular block reversal was performed with neostigmine and atropine. All patients received 1 mg/kg of diclofenac every 8 h for 24 hours after delivery and 98% of general anesthesia patients also received 100 mg of tramadol and 78.5% received acetaminophen 1 gram. No regional anesthesia patients received tramadol or acetaminophen. Patients receiving one of the regional anesthetic protocols established lactation sooner (56% and 29% after 18 and 24 hours, respectively), while 86% of women receiving general anesthesia did not establish lactation until 36 to 48 hours after surgery.",
                          "Markup": [
                            {
                              "Start": 230,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 252,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 312,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/bupivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2474"
                            },
                            {
                              "Start": 359,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 409,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/propofol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4943"
                            },
                            {
                              "Start": 432,
                              "Length": 15,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/succinylcholine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5314"
                            },
                            {
                              "Start": 530,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Oxygen",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Oxygen"
                            },
                            {
                              "Start": 550,
                              "Length": 12,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/nitric%20oxide",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-145068"
                            },
                            {
                              "Start": 573,
                              "Length": 13,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/nitrous%20oxide",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-948"
                            },
                            {
                              "Start": 647,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Sevoflurane",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5206"
                            },
                            {
                              "Start": 739,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 761,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/rocuronium",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-441290"
                            },
                            {
                              "Start": 883,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/neostigmine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4456"
                            },
                            {
                              "Start": 899,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/atropine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-174174"
                            },
                            {
                              "Start": 942,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/diclofenac",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3033"
                            },
                            {
                              "Start": 1054,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/tramadol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-33741"
                            },
                            {
                              "Start": 1082,
                              "Length": 13,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/acetaminophen",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-1983"
                            },
                            {
                              "Start": 1145,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/tramadol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-33741"
                            },
                            {
                              "Start": 1157,
                              "Length": 13,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/acetaminophen",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-1983"
                            }
                          ]
                        },
                        {
                          "String": "In a study of primiparous women with an uncomplicated pregnancy, some women received epidural analgesia with ropivacaine (dose not specified) and fentanyl in a median dose of 121 mcg (IQR 77 to 192 mcg), some received oxytocin alone and other received neither. Breastfeeding outcomes in the three groups were compared at 3 days, 1 month and 4 months postpartum. The study found no relationship between low-dose oxytocin use and breastfeeding success, but that epidermal analgesia lowered milk supply at 3 days and 1 month postpartum, and decreased rates of breastfeeding at 4 months postpartum.",
                          "Markup": [
                            {
                              "Start": 109,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/ropivacaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-175805"
                            },
                            {
                              "Start": 146,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 218,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxytocin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-439302"
                            },
                            {
                              "Start": 411,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/oxytocin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-439302"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 94,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "◈ What is fentanyl?"
                        },
                        {
                          "String": "Fentanyl is an opioid medication. Opioids are sometimes called narcotics. Fentanyl is used to treat pain and is often given during and after surgery. Brand names of fentanyl include Abstral®, Actiq®, Duragesic®, Fentora®, Ionsys®, Lazanda®, Sublimaze®, and Subsys®.Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take this medication. Your healthcare providers can talk with you about the benefits of treating your condition and the risks of untreated illness during pregnancy.If you have been taking fentanyl regularly or have a dependency or opioid use disorder, you should not just stop taking the medication suddenly. Stopping an opioid medication suddenly could cause you to go into withdrawal. It is not known if or how withdrawal might affect a pregnancy. It is suggested that any reduction in fentanyl be done slowly, and under the direction of your healthcare provider.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 74,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 165,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 182,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Abstral",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            },
                            {
                              "Start": 192,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Actiq",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            },
                            {
                              "Start": 200,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Duragesic",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 212,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentora",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 222,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Ionsys",
                              "Type": "PubChem Internal Link",
                              "Extra": "multiple-CIDs"
                            },
                            {
                              "Start": 231,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Lazanda",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            },
                            {
                              "Start": 241,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Sublimaze",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 257,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Subsys",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 703,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1003,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "◈ I take fentanyl. Can it make it harder for me to get pregnant?",
                          "Markup": [
                            {
                              "Start": 9,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "◈ Studies have not been done to see if taking fentanyl can make it harder to get pregnant.",
                          "Markup": [
                            {
                              "Start": 46,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "◈ Does taking fentanyl increase the chance for miscarriage?",
                          "Markup": [
                            {
                              "Start": 14,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "Miscarriage is common and can occur in any pregnancy for many different reasons. Studies have not been done to see if fentanyl increases the chance for miscarriage. Miscarriage is one of the risks of surgery during pregnancy, so it is hard to tell if a miscarriage following surgery is due to the underlying condition that required surgery, the surgical procedure, or medications (like fentanyl) used during or after surgery.",
                          "Markup": [
                            {
                              "Start": 118,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 386,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "◈ Does taking fentanyl increase the chance of birth defects?",
                          "Markup": [
                            {
                              "Start": 14,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. Based on the studies reviewed, exposure to fentanyl is not expected to increase the chance of birth defects above the background risk.Some studies that have looked at opioids as a group suggest that opioids in general might be associated with birth defects. However, studies have not found a specific pattern of birth defects caused by opioids. Based on these studies, if there is an increased chance for birth defects with opioid use in pregnancy, it is likely to be small.",
                          "Markup": [
                            {
                              "Start": 151,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "◈ Does taking fentanyl in pregnancy increase the chance of other pregnancy-related problems?",
                          "Markup": [
                            {
                              "Start": 14,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "It is not known if fentanyl can cause other pregnancy-related problems, such as preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth).Studies involving people who often use some opioids during their pregnancy have found an increased chance for pregnancy-related problems, including poor growth of the baby, low levels of amniotic fluid (fluid that surrounds baby in uterus), stillbirth, preterm delivery, and C-section. This is more commonly reported in those who are taking heroin or who are using prescribed opioid medication in greater amounts or for longer than recommended by their healthcare provider. Use of an opioid close to the time of delivery can result in withdrawal symptoms in the baby (see the section of this fact sheet on Neonatal Abstinence Syndrome).",
                          "Markup": [
                            {
                              "Start": 19,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 543,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5462328"
                            }
                          ]
                        },
                        {
                          "String": "◈ Will my baby have withdrawal (neonatal abstinence syndrome) if I continue to take fentanyl?",
                          "Markup": [
                            {
                              "Start": 84,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "Temporary problems with breathing or heart rate have been reported in some newborns following the use of fentanyl for pain at delivery. Longer exposure to fentanyl during pregnancy may result in neonatal abstinence syndrome (NAS). Because information about longer exposure to fentanyl in pregnancy is limited, it is not known if the chance for NAS is higher or lower with fentanyl than with other, better studied opioids.Neonatal abstinence syndrome (NAS) is the term used to describe withdrawal symptoms in newborns from opioid medication(s) that a person takes during pregnancy. NAS symptoms can include irritability, crying, sneezing, stuffy nose, poor sleep, extreme drowsiness (very tired), yawning, poor feeding, sweating, tremors, seizures, vomiting, and diarrhea. Most often, symptoms of NAS appear 2 days after birth and may last more than 2 weeks. The chance that NAS will occur depends on the length of time and/or the dose of opioid taken during pregnancy, if other medications were also taken, if baby was born preterm, and/or the size of the baby at birth. If opioids were taken in pregnancy, it is important to let your baby’s healthcare providers know so that they can check for symptoms of NAS and provide the best care for your newborn.",
                          "Markup": [
                            {
                              "Start": 105,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 155,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 276,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 372,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "◈ Does taking fentanyl in pregnancy affect future behavior or learning for the child?",
                          "Markup": [
                            {
                              "Start": 14,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "Short-term use of fentanyl during surgery or for pain after surgery is not expected to cause learning or behavior problems. It is not known if longer use of fentanyl in pregnancy increases the chance for behavior or learning issues. Some studies on opioids as a general group have found more problems with learning and behavior in children exposed to opioids for a long period of time during pregnancy. It is hard to tell if this is due to the medication exposure or other factors that may increase the chances of these problems.",
                          "Markup": [
                            {
                              "Start": 18,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 157,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "◈ What if I have an opioid use disorder?"
                        },
                        {
                          "String": "Studies find that people who are pregnant and take opioids in higher doses or for longer than recommended by their healthcare providers (misuse opioids) have an increased chance for pregnancy problems. These include poor growth of the baby, stillbirth, preterm delivery, and C-section."
                        },
                        {
                          "String": "◈ Fentanyl and breastfeeding:",
                          "Markup": [
                            {
                              "Start": 2,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "Speak to your healthcare provider about your pain and medications that may be used while you are breastfeeding. Fentanyl can get into breast milk. Babies might have problems with the amounts of fentanyl in the breast milk. Talk with your healthcare provider or a MotherToBaby specialist about your specific situation, as information on breastfeeding might change based on the age of your baby, the dose of medication, and other factors.Use of some opioids in breastfeeding might cause babies to be very sleepy and have trouble latching on. Some opioids can cause trouble with breathing. If you are using any opioid, talk to your healthcare provider about how to use the least amount for the shortest time and how to monitor (watch) your baby for any signs of concern. Contact the baby’s healthcare provider immediately if your baby has any problems such as increased sleepiness (more than usual), trouble feeding, trouble breathing, or limpness. Be sure to talk to your healthcare provider about all your breastfeeding questions.",
                          "Markup": [
                            {
                              "Start": 112,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 194,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "◈ If a male takes fentanyl, could it affect fertility (ability to get partner pregnant) or increase the chance of birth defects?",
                          "Markup": [
                            {
                              "Start": 18,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        },
                        {
                          "String": "Studies have not been done to see if fentanyl could affect male fertility or increase the chance of birth defects above the background risk. However, the use of opioids, in general, has been shown to lower fertility in men. In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures at https://mothertobaby.org/fact-sheets/paternal-exposures-pregnancy/.",
                          "Markup": [
                            {
                              "Start": 37,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Exposure Routes",
                "Description": "The way people or other living organisms may come into contact with a hazardous chemical.  Examples of common exposure routes are inhalation, ingestion, skin/eye contact.",
                "Information": [
                  {
                    "ReferenceNumber": 125,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl can be absorbed into the body via inhalation, oral exposure or ingestion, or skin contact. It is not known whether fentanyl can be absorbed systemically through the eye. Fentanyl can be administered intravenously (IV), intramuscularly (IM), or as a skin patch (transdermally).",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 124,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 179,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 128,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Epidural; parental (transdermal, intramuscular)."
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Symptoms",
                "Description": "Symptoms of exposure to this chemical through various routes (for example, ingestion, inhalation, skin contact, and eye contact).",
                "Information": [
                  {
                    "ReferenceNumber": 125,
                    "Name": "Eye Exposure",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "- Irritation may occur."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 125,
                    "Name": "Ingestion Exposure",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "- Contracted or pinpoint pupils (miosis) (may later become dilated), reduced level of consciousness (CNS depression), reduced respiratory function (respiratory depression), reduced blood oxygen content (hypoxia), accumulation of acid in the blood (acidosis), low blood pressure (hypotension), slow heart rate (bradycardia), shock, slowing of muscular movement of the stomach (gastric hypomotility) with intestinal obstruction due to lack of normal muscle function (ileus), accumulation of fluid in the lungs (pulmonary edema), lethargy, coma, and death.",
                          "Markup": [
                            {
                              "Start": 187,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Oxygen",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Oxygen"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 125,
                    "Name": "Inhalation Exposure",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "- See Ingestion Exposure."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 125,
                    "Name": "Skin Exposure",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "- See Ingestion Exposure."
                        },
                        {
                          "String": "- Absorption through the skin may contribute to whole-body (systemic) toxicity."
                        },
                        {
                          "String": "- Absorption increases with skin temperature (based on medical use of transdermal patch)."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 128,
                    "Reference": [
                      "L1484: Drugs.com http://www.drugs.com/cons/Fentanyl.html"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "More common symptoms are dizziness, light-headedness, or feeling faint; drowsiness; nausea or vomiting; unusual tiredness or weakness. Less common or rare ones are blurred or double vision or other vision problems; confusion; constipation; convulsions (seizures); difficult or painful urination; mental depression; shortness of breath, trouble in breathing, tightness in the chest, or wheezing; skin rash, hives, or itching; unusual excitement (L1484)"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Adverse Effects",
                "Description": "An adverse effect is an undesired harmful effect resulting from a medical treatment or other intervention.",
                "Information": [
                  {
                    "ReferenceNumber": 58,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ACGIH Carcinogen - Not Classifiable."
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Acute Effects",
                "Description": "The results from acute animal tests and/or acute human studies are presented in this section. Acute animal studies consist of LD50 and LC50 tests, which present the median lethal dose (or concentration) to the animals. Acute human studies usually consist of case reports from accidental poisonings or industrial accidents. These case reports often help to define the levels at which acute toxic effects are seen in humans.",
                "Information": [
                  {
                    "ReferenceNumber": 7,
                    "Value": {
                      "ExternalTableName": "collection=chemidplus&query_type=sid&query=134974500"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Toxicity Data",
                "Description": "Numeric toxicity data for this compound, collected from multiple sources (including the NCI Investigational Drugs and Haz-Map).",
                "Information": [
                  {
                    "ReferenceNumber": 128,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LD50: 3.1 mg/kg (rat)\u000ALD50: 0.03 mg/kg (monkeys)"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Treatment",
                "Description": "Treatment when exposed to toxin",
                "Information": [
                  {
                    "ReferenceNumber": 128,
                    "Reference": [
                      "L1712: RxList: The Internet Drug Index (2009). http://www.rxlist.com/"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "For the management of hypoventilation, immediate countermeasures include removing the Fentanyl and physically or verbally stimulating the patient. These actions can be followed by administration of a specific narcotic antagonist such as naloxone. The duration of hypoventilation following an overdose may be longer than the effects of the narcotic antagonist's action (the half-life of naloxone ranges from 30 to 81 minutes). The interval between IV antagonist doses should be carefully chosen because of the possibility of re-narcotization after system removal; repeated administration of naloxone may be necessary. Reversal of the narcotic effect may result in acute onset of pain and the release of catecholamines. Always ensure a patent airway is established and maintained, administer oxygen and assist or control respiration as indicated and use an oropharyngeal airway or endotracheal tube if necessary. Adequate body temperature and fluid intake should be maintained. (L1712)",
                          "Markup": [
                            {
                              "Start": 86,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 237,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/naloxone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284596"
                            },
                            {
                              "Start": 386,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/naloxone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284596"
                            },
                            {
                              "Start": 590,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/naloxone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284596"
                            },
                            {
                              "Start": 790,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Oxygen",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Oxygen"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Interactions",
                "Description": "Interactions of this compound with other chemicals, according to the Hazardous Substances Data Bank (HSDB).",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/source/11933",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:25615513",
                      "Hillman AD et al; Pharmacotherapy 35 (1): 112-7 (2015)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Serotonin syndrome is a syndrome identified by a triad of altered mental status, neuromuscular overactivity, and autonomic instability caused by the overstimulation of serotonin in the central nervous system and periphery. Serotonin syndrome may be provoked with the addition or increase in serotonergic agents such as selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, tricyclic antidepressants, and monoamine oxidase inhibitors as well as other agents with serotonergic properties. Some narcotics, including fentanyl and methadone, have these properties and may be associated with the development of serotonin syndrome when used in conjunction with other agents. Currently, there are no identified case reports of narcotics as the sole agent causing serotonin syndrome. This report provides a brief overview of serotonin syndrome, particularly with cases involving administration of narcotics such as fentanyl and methadone. The case described is the first report associated with fentanyl and methadone without the coadministration of other serotonergic agents, and a possible drug interaction with voriconazole is discussed. This raises awareness of using multiple serotonergic narcotics and the potential precipitation of serotonin syndrome.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5202"
                            },
                            {
                              "Start": 168,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/serotonin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5202"
                            },
                            {
                              "Start": 223,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5202"
                            },
                            {
                              "Start": 329,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/serotonin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5202"
                            },
                            {
                              "Start": 360,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/serotonin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5202"
                            },
                            {
                              "Start": 370,
                              "Length": 14,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/norepinephrine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-439260"
                            },
                            {
                              "Start": 546,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 559,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/methadone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4095"
                            },
                            {
                              "Start": 638,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/serotonin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5202"
                            },
                            {
                              "Start": 788,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/serotonin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5202"
                            },
                            {
                              "Start": 849,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/serotonin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5202"
                            },
                            {
                              "Start": 939,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 952,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/methadone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4095"
                            },
                            {
                              "Start": 1018,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1031,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/methadone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4095"
                            },
                            {
                              "Start": 1137,
                              "Length": 12,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/voriconazole",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-71616"
                            },
                            {
                              "Start": 1262,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/serotonin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5202"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:25313880",
                      "Ren J et al; Anesthesiology 122 (2): 424-34 (2015)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "There is an unmet clinical need to develop a pharmacological therapy to counter opioid-induced respiratory depression without interfering with analgesia or behavior. Several studies have demonstrated that 5-HT1A receptor agonists alleviate opioid-induced respiratory depression in rodent models. However, there are conflicting reports regarding their effects on analgesia due in part to varied agonist receptor selectivity and presence of anesthesia. Therefore the authors performed a study in rats with befiradol (F13640 and NLX-112), a highly selective 5-HT1A receptor agonist without anesthesia.  Respiratory neural discharge was measured using in vitro preparations. Plethysmographic recording, nociception testing, and righting reflex were used to examine respiratory ventilation, analgesia, and sedation, respectively. Befiradol (0.2 mg/kg, n = 6) reduced fentanyl-induced respiratory depression (53.7 +/- 5.7% of control minute ventilation 4 min after befiradol vs. saline 18.7 +/- 2.2% of control, n = 9; P < 0.001), duration of analgesia (90.4 +/- 11.6 min vs. saline 130.5 +/- 7.8 min; P = 0.011), duration of sedation (39.8 +/- 4 min vs. saline 58 +/- 4.4 min; P = 0.013); and induced baseline hyperventilation, hyperalgesia, and \"behavioral syndrome\" in nonsedated rats. Further, the befiradol-induced alleviation of opioid-induced respiratory depression involves sites or mechanisms not functioning in vitro brainstem-spinal cord and medullary slice preparations.  The reversal of opioid-induced respiratory depression and sedation by befiradol in adult rats was robust, whereas involved mechanisms are unclear. However, there were adverse concomitant decreases in fentanyl-induced analgesia and altered baseline ventilation, nociception, and behavior.",
                          "Markup": [
                            {
                              "Start": 504,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/befiradol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-9865384"
                            },
                            {
                              "Start": 515,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/F13640",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-9865384"
                            },
                            {
                              "Start": 526,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/NLX-112",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-9865384"
                            },
                            {
                              "Start": 825,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Befiradol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-9865384"
                            },
                            {
                              "Start": 862,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 959,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/befiradol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-9865384"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Evaluations of Drug Interactions. 2nd ed. and supplements. Washington, DC: American Pharmaceutical Assn., 1976, 1978., p. 553"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Chlorpromazine is used concurrently with meperidine to enhance its analgesic effect. However, such concurrent use ... may enhance & prolong the respiratory depression produced by meperidine. ... Fentanyl ... /has/ been reported to interact with promethazine /and may produce similar effects/.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 14,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Chlorpromazine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2726"
                            },
                            {
                              "Start": 41,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            },
                            {
                              "Start": 179,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            },
                            {
                              "Start": 195,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 245,
                              "Length": 12,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/promethazine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4927"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Booth, N.H., L.E. McDonald (eds.). Veterinary Pharmacology and Therapeutics. 5th ed. Ames, Iowa: Iowa State University Press, 1982., p. 267"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Droperidol does not produce analgesia but is a potent neuroleptic agent. It has been suggested that each compound in the droperidol-fentanyl mixture exerts its own pharmacologic action without any well defined antagonistic or potentiating actions. However, there is one exception; droperidol enhances the analgesic potency of fentanyl through a potentiative rather than an additive effect, the mechanism of which is unknown.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Droperidol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3168"
                            },
                            {
                              "Start": 121,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/droperidol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3168"
                            },
                            {
                              "Start": 132,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 281,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/droperidol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3168"
                            },
                            {
                              "Start": 326,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "For more Interactions (Complete) data for Fentanyl (24 total), please visit the HSDB record page.",
                          "Markup": [
                            {
                              "Start": 80,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Interactions-(Complete)"
                            },
                            {
                              "Start": 42,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Antidote and Emergency Treatment",
                "Description": "Information on antidote and emergency treatment when exposed to this chemical.  The information here is from the Hazardous Substances Data Bank (HSDB).",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/source/11933",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Dart, R.C. (ed). Medical Toxicology. Third Edition, Lippincott Williams & Wilkins. Philadelphia, PA. 2004., p. 763"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Acute opioid toxicity is treated with support of respiratory and circulatory function ... and may include the administration of naloxone. Acute overdoses of fentanyl should be monitored for 24 hours. administration of between one-fourth and the full paralyzing dose of a nondepolarizing neuromuscular blocking agent may prevent or reduce the incidence of truncal muscle rigidity. The choice of nondepolarizing blocker dose depends on the dose and speed of the planned fentanyl dose. Naloxone has reversed truncal muscle rigidity. Based on a high degree of protein binding and fat distribution, extracorporeal measures to enhance elimination are unlikely to be of benefit.",
                          "Markup": [
                            {
                              "Start": 128,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/naloxone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284596"
                            },
                            {
                              "Start": 157,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 468,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 483,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Naloxone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284596"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/",
                          "Markup": [
                            {
                              "Start": 324,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . /Poisons A and B/",
                          "Markup": [
                            {
                              "Start": 216,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Oxygen",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Oxygen"
                            },
                            {
                              "Start": 468,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 637,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160-1"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W TKO /SRP: \"To keep open\", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's (LR) if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... .  /Poisons A and B/",
                          "Markup": [
                            {
                              "Start": 378,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/albuterol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-2083"
                            },
                            {
                              "Start": 775,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/diazepam",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3016"
                            },
                            {
                              "Start": 787,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/lorazepam",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3958"
                            },
                            {
                              "Start": 807,
                              "Length": 26,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/proparacaine%20hydrochloride",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-517321"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "For more Antidote and Emergency Treatment (Complete) data for Fentanyl (12 total), please visit the HSDB record page.",
                          "Markup": [
                            {
                              "Start": 100,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Antidote-and-Emergency-Treatment-(Complete)"
                            },
                            {
                              "Start": 62,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Human Toxicity Excerpts",
                "Description": "Excerpts about human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:2136976",
                      "Bailey PL et al; Anesth Analg 70 (1): 8-15 (1990)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/HUMAN EXPOSURE STUDIES/ The magnitude and duration of analgesia and respiratory depression induced by fentanyl (1.0, 2.0, and 4.0 ug/kg) and sufentanil (0.1, 0.2, and 0.4 ug/kg) after intravenous administration over 30 s were measured in 30 healthy young adult male volunteers divided into three groups and studied in a double-blind, randomized fashion. Each volunteer received one dose of fentanyl or sufentanil and no sooner than 48 hr later, the corresponding equipotent dose of the other opioid. End-tidal CO2 and ventilatory and occlusion pressure responses to CO2 rebreathing were used to measure drug-induced respiratory effects. Analgesic effects were assessed by changes in the pain threshold to electric shock applied to the forearm. Plasma levels of fentanyl and sufentanil were measured by radioimmunoassay. Testing and sampling intervals were 5, 30, 60, 90, 120, 240, 300, and 360 min after drug administration. The magnitude and duration of depression of the ventilatory and occlusion pressure response were significantly less with sufentanil compared with fentanyl, irrespective of dose. Ventilatory and occlusion pressure responses returned to control values by 30 and 30 min, respectively, after sufentanil and by 240 and 120 min, respectively, after fentanyl. Statistically significant elevations of the pain threshold were, however, greater and longer lasting after sufentanil compared with fentanyl. Pain threshold returned to control values 180 min after sufentanil but only 90 min after fentanyl. These results suggest that sufentanil may provide better patient comfort with less respiratory depression than does fentanyl.",
                          "Markup": [
                            {
                              "Start": 103,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 142,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-41693"
                            },
                            {
                              "Start": 391,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 403,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-41693"
                            },
                            {
                              "Start": 762,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 775,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-41693"
                            },
                            {
                              "Start": 1047,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-41693"
                            },
                            {
                              "Start": 1072,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1214,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-41693"
                            },
                            {
                              "Start": 1269,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1386,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-41693"
                            },
                            {
                              "Start": 1411,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1477,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-41693"
                            },
                            {
                              "Start": 1510,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1547,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-41693"
                            },
                            {
                              "Start": 1636,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:11574361",
                      "Mildh LH et al; Anesth Analg 93 (4): 939-46 (2001)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/HUMAN EXPOSURE STUDIES/ The relative potencies of fentanyl and alfentanil for respiratory depression were determined in eight healthy male volunteers in a double-blinded, randomized study with a cross-over design. The drugs were delivered by computer-driven infusion with logarithmically ascending plasma concentrations until the respiratory rate reached 2/min and/or oxygen saturation decreased below 85% with subjects breathing room air. Ventilation was measured with respiratory inductive plethysmography, indirect calorimetry, and arterial blood gas analysis, and plasma drug concentrations were determined. Pharmacodynamic modeling was performed using a fractional E(max) model for minute volume and respiratory rate and the concentrations producing 50% depression (i.e., apparent 50% effective concentration [EC(50)] values) were determined. Both drugs decreased ventilation in a similar manner, and drug infusions were terminated at mean +/- SD measured plasma concentrations of 254 +/- 88 ng/mL and 5.1 +/- 1.7 ng/mL for alfentanil and fentanyl, respectively. Alfentanil decreased minute volume from baseline by 54% +/- 19% and respiratory rate by 40% +/- 11% with EC(50) values of 234 +/- 57 ng/mL and 195 +/- 101 ng/mL. The respective decreases for fentanyl were 50% +/- 11%, 41% +/- 15%, and the estimated EC(50) values were 6.1 +/- 1.4 ng/mL and 3.5 +/- 1.4 ng/mL, respectively. Using the apparent EC(50) values, the calculated potency ratio for alfentanil:fentanyl was (mean and 95% confidence interval) 1:39 (1:31-1:46) for minute volume and 1:51 (1:34-1:68) for respiratory rate. This is analogous to the analgesic effect studied earlier. The findings support the notion of parallel analgesic and respiratory depressant effects of alfentanil and fentanyl. Therefore equianalgesic concentrations of both drugs will lead to equally pronounced respiratory depression. This double-blinded, randomized study evaluated the potency ratio of alfentanil and fentanyl-induced respiratory depression. The findings support the notion of parallel analgesic and respiratory depressant effects of alfentanil and fentanyl. Therefore equianalgesic concentrations of both drugs will lead to equally pronounced respiratory depression.",
                          "Markup": [
                            {
                              "Start": 51,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 64,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-51263"
                            },
                            {
                              "Start": 369,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Oxygen",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Oxygen"
                            },
                            {
                              "Start": 1030,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-51263"
                            },
                            {
                              "Start": 1045,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1069,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Alfentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-51263"
                            },
                            {
                              "Start": 1260,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1459,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-51263"
                            },
                            {
                              "Start": 1470,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1747,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-51263"
                            },
                            {
                              "Start": 1762,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1950,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-51263"
                            },
                            {
                              "Start": 1965,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 2098,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/alfentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-51263"
                            },
                            {
                              "Start": 2113,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:8466061",
                      "Streisand JB et al; Anesthesiology 78 (4): 629-34 (1993)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/HUMAN EXPOSURE STUDIES/ Muscle rigidity frequently accompanies induction of anesthesia with opioids. The authors sought to determine whether unconsciousness and amnesia occur when humans develop rigidity and apnea after intravenous fentanyl (without other concomitant anesthetics). The incidence and duration of rigidity and level of consciousness were evaluated and associated plasma concentrations of fentanyl were measured in 12 healthy adult male volunteers given only intravenous fentanyl. Fentanyl was infused at a rate of 150 ug/min until a total of 15 ug/kg had been administered. Arterial blood samples for fentanyl assay were drawn and responsiveness, heart rate (HR), and systolic and diastolic arterial blood pressures were determined at frequent intervals during and after infusion. If rigidity was accompanied by an Spo2 < 90%, positive pressure ventilation with 100% O2 with a mask was instituted until spontaneous ventilation resumed. The incidence of muscular rigidity was 50% (6/12). All subjects who developed rigidity were apneic, unresponsive, and had no recall of commands to breathe or of positive pressure ventilation. Subjects not developing rigidity remained awake and responsive. No subject developing rigidity required neuromuscular blockade to allow positive pressure ventilation and adequate oxygenation (Spo2 > 90%). When rigidity occurred, it started 3 +/- 0.9 (range 1-4) min after the peak plasma fentanyl concentration and lasted for 11.5 +/- 5.8 (range 7-23) min. Rigidity started at a plasma fentanyl concentration of 21.5 +/- 4.4 (range 16-28) ng/mL and ended at 6.9 +/- 1.5 (range 5.2-8.7) ng/ml. Baseline HR was less in the subjects who subsequently developed rigidity (56.7 +/- 7.8 vs. 67.2 +/- 7.8 P = 0.04). No differences in fentanyl plasma concentrations or predicted effect site concentrations for rigidity were detected between subjects who developed rigidity and those who did not. These findings support the hypothesis that unconsciousness occurs in the unstimulated subject during fentanyl-induced apnea and rigidity.",
                          "Markup": [
                            {
                              "Start": 233,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 404,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 486,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 496,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 617,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1432,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1530,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1770,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 2032,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:2470272",
                      "Levy JH et al; Anesthesiology 70 (5): 756-60 (1989)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/HUMAN EXPOSURE STUDIES/ Certain opioids release histamine from cutaneous mast cells to produce local wheal and flare responses and adverse hemodynamic effects. In vivo responses to opioids suggest that cutaneous responses result from the interaction of opioids with opioid receptors on human mast cells. There are no data evaluating or comparing the opioids currently used in anesthesia. Volunteers were injected intradermally with different opioids as well as with naloxone and antihistamines to evaluate their effects on cutaneous mast cell reactivity and cutaneous vascular responses. Fentanyl and morphine produced concentration dependent wheal and flare responses in the range of 5X10-6 M to 1.5X10-3 M. Volunteers were then tested intradermally with different opioids and histamine at a 5X10-4 M concentration to determine their relative cutaneous effects. Morphine, meperidine, fentanyl, and sufentanil produced both wheal and flare responses that were significantly greater than those due to saline (p< 0.05). Naloxone, alfentanil, and nalbuphine did not produce significant wheal or flare responses. Butorphenol was followed by a significant wheal but no flare. Naloxone attentuated cutaneous wheal and flare responses to fentanyl and the flare response to morphine. Intradermal antihistamines (diphenhydramine and cimetidine) produced significant wheal and flare responses. Electron micrographs of biopsies from fentanyl induced wheals demonstrated normal mast cell architecture with no evidence of mast cell degranulation. Opioid effects on wheal and flare responses and mast cell degranulation appear independent of opioid analgesic potency. Opioids produce cutaneous vascular responses dependent on both histamine release from mast cells and direct effects on the vasculature.",
                          "Markup": [
                            {
                              "Start": 49,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/histamine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-774"
                            },
                            {
                              "Start": 467,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/naloxone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284596"
                            },
                            {
                              "Start": 589,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 602,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 779,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/histamine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-774"
                            },
                            {
                              "Start": 864,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 874,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/meperidine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-4058"
                            },
                            {
                              "Start": 886,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 900,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sufentanil",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-41693"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "For more Human Toxicity Excerpts (Complete) data for Fentanyl (60 total), please visit the HSDB record page.",
                          "Markup": [
                            {
                              "Start": 91,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Human-Toxicity-Excerpts-(Complete)"
                            },
                            {
                              "Start": 53,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Non-Human Toxicity Excerpts",
                "Description": "Excerpts about non-human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Booth, N.H., L.E. McDonald (eds.). Veterinary Pharmacology and Therapeutics. 5th ed. Ames, Iowa: Iowa State University Press, 1982., p. 268"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/LABORATORY ANIMALS: Acute Exposure/ In the guinea pig ... /it is/ reported that swelling, lameness, and self-mutilation of the injected leg develops several days to 1 week later in 33% of the animals. The dose that produces this effect is 0.88 mL/kg ..."
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:26770358",
                      "Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694258",
                      "Miao J et al; Int J Clin Exp Med 8 (10): 17684-93 (2015)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Pancreatic cancer is a ... devastating disease with a high mortality rate. Fentanyl has been widely applied to anesthesia and analgesia in pancreatic cancer therapy, and is also demonstrated to inhibit the growth of some kinds of cancer cells in ... studies. To investigate the functions of fentanyl in pancreatic cancer, we conducted a series of in vivo and in vitro experiments using human pancreatic cancer cells SW1990 and fentanyl treatment. The cells were transplanted to BALB/c nude mice to generate pancreatic tumor for monitoring tumor growth. Viability, apoptosis, migration and invasion, and cell cycle of SW1990 cells were also analyzed. To reveal the functional mechanisms of fentanyl, the expression changes of factors in these cellular activities were detected. Results showed a significant inhibition of pancreatic tumor growth in the fentanyl-treated group. Fentanyl also inhibited viability of SW1990 cells in vitro. Detailed results showed fentanyl led to promoted cell apoptosis via arresting cells in G0/G1 phase. It also suppressed cell migration and invasion. Further proofs indicated that the factors related to cell apoptosis (Bcl-2, p53 and Caspase-3), cell cycle (p21, Cyclin D1 and CDK4) and epithelial-mesenchymal transition (E-cadherin, Vimentin and a-SMA) showed the corresponding expression changes. Fentanyl might execute its functions via the suppressed MAPK pathways, since the key factors, p38, ERK1/2 and JNK were all down-regulated by fentanyl. This study indicated fentanyl could inhibit viability and growth of pancreatic cancer cells, providing a possible strategy for pancreatic cancer treatment.",
                          "Markup": [
                            {
                              "Start": 133,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 349,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 485,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 747,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 909,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 933,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1017,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1390,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1531,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1562,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2245"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ Fentanyl was not teratogenic in rats at dosages of 10-500 ug/kg daily when administered on days 7-21 of gestation via an implanted microosmotic minipump.",
                          "Markup": [
                            {
                              "Start": 61,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2245"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ In animal reproduction and developmental studies, there was an increased risk for early embryolethality, decreased pup survival, and developmental delays in surviving pups at fentanyl doses within the human dosage range. At an IV dosage of 10-30 ug/kg daily on days 6-18 of gestation in rats, fentanyl was embryotoxic or fetotoxic and slightly increased mean delivery time in animals receiving the highest dosage, but the drug was not teratogenic. At IV doses of 30 ug/kg or subcutaneous doses of 160 ug/kg in rats, fentanyl increased embryonic resorptions.",
                          "Markup": [
                            {
                              "Start": 236,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 354,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 577,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "For more Non-Human Toxicity Excerpts (Complete) data for Fentanyl (25 total), please visit the HSDB record page.",
                          "Markup": [
                            {
                              "Start": 95,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Non-Human-Toxicity-Excerpts-(Complete)"
                            },
                            {
                              "Start": 57,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Non-Human Toxicity Values",
                "Description": "Quantitative non-human toxicity values (e.g., lethal dose) for this compound.  The data shown here are mostly for lab animals (e.g., rat, mouse, guinea pig, and rabbit).",
                "DisplayControls": {
                  "ShowAtMost": 5
                },
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 734"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LD50 Mouse sc 62 mg/kg /Fentanyl citrate/",
                          "Markup": [
                            {
                              "Start": 24,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 734"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LD50 Mouse iv 11.2 mg/kg /Fentanyl citrate/",
                          "Markup": [
                            {
                              "Start": 26,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2893"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LD50 Rat iv 2910 ug/kg"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2893"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LD50 Rat sc 1500 ug/kg"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2893"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LD50 Rat oral 18 mg/kg"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Ongoing Test Status",
                "Description": "Toxicity test status of this chemical, performed by authoritative entities (e.g., government agencies).",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "EPA has released the Interactive Chemical Safety for Sustainability (iCSS) Dashboard. The iCSS Dashboard provides an interactive tool to explore rapid, automated (or in vitro high-throughput) chemical screening data generated by the Toxicity Forecaster (ToxCast) project and the federal Toxicity Testing in the 21st century (Tox21) collaboration. /The title compound was tested by ToxCast and/or Tox21 assays/[USEPA; ICSS Dashboard Application; Available from, as of May 1, 2017: http://actor.epa.gov/dashboard/]"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Populations at Special Risk",
                "Description": "People within the general population vary greatly in their sensitivity to chemical agents on an individual or mixture basis.  Some segments of the general population may be at greatest risk for adverse outcomes.  Well-known groups at special risk include children, women of childbearing age, the elderly and are also defined by nutritional status, occupations, contamination of local food supplies, gender and genetic inheritance.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2244"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Use of fentanyl hydrochloride iontophoretic transdermal system is contraindicated in patients with substantial respiratory depression, acute or severe bronchial asthma, or known or suspected paralytic ileus and GI obstruction.",
                          "Markup": [
                            {
                              "Start": 7,
                              "Length": 22,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20hydrochloride",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-83932"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2244"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Because of the prolonged duration of effects and risk of serious or life-threatening respiratory depression associated with fentanyl transdermal system, this dosage form is contraindicated in the management of acute, mild, intermittent, or postoperative pain (e.g., following outpatient or day surgery [e.g., tonsillectomy]); in patients who require opiate analgesia for a short period of time; and in patients who are not opiate tolerant. Use of the transdermal system also is contraindicated in patients with substantial respiratory depression, especially in settings where adequate monitoring and equipment for resuscitation are not available; in patients with acute or severe bronchial asthma; and in those with known or suspected paralytic ileus.",
                          "Markup": [
                            {
                              "Start": 124,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2244"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Because of the risk of life-threatening respiratory depression, transmucosal immediate-release preparations of fentanyl (fentanyl citrate buccal lozenges, buccal tablets, sublingual tablets, and nasal spray; fentanyl sublingual spray) are contraindicated in the management of acute or postoperative pain (e.g., migraine or other headaches, dental pain, emergency department use) and in patients who are not opiate tolerant.",
                          "Markup": [
                            {
                              "Start": 111,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 121,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl%20citrate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-13810"
                            },
                            {
                              "Start": 208,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "American Society of Health-System Pharmacists 2017; Drug Information 2017. Bethesda, MD. 2017, p. 2244"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Because fentanyl undergoes extensive hepatic metabolism and there is some evidence that renal excretion contributes to elimination of the drug, fentanyl should be used with caution in patients with renal or hepatic impairment.",
                          "Markup": [
                            {
                              "Start": 8,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 144,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "For more Populations at Special Risk (Complete) data for Fentanyl (16 total), please visit the HSDB record page.",
                          "Markup": [
                            {
                              "Start": 95,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Populations-at-Special-Risk-(Complete)"
                            },
                            {
                              "Start": 57,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Protein Binding",
                "Description": "In this section, \"protein binding\" refers to the degree to which medications attach to plasma proteins (i.e., proteins within the blood, such as human serum albumin, lipoprotein, glycoprotein and globulins). A drug's efficiency may be affected by the degree to which it binds to plasma proteins. The less bound a drug is, the more efficiently it can traverse cell membranes or diffuse.",
                "Information": [
                  {
                    "ReferenceNumber": 15,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl is 80-85% bound to plasma proteins. In one study, a 0.1µg/L solution of fentanyl was 77.9±1.1% bound to human serum albumin and 12.0±5.4% bound to α-1 acid glycoprotein. A 0.1µg/L solution of norfentanyl, the primary metabolite of fentanyl, was 7.62±1.2% bound to human serum albumin and 7.24±1.9% bound to α-1 acid glycoprotein.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 81,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 201,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/norfentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-259381"
                            },
                            {
                              "Start": 240,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Ecological Information",
            "Description": "This section provides information to evaluate the environmental impact of the chemical if it were released to the environment. The information may include data from toxicity tests performed on aquatic and/or terrestrial organisms, where available (e.g., acute or chronic aquatic toxicity data for fish, algae, and crustaceans; toxicity data on birds, bees, and plants).  This section also includes information on whether there is a potential for the chemical to persist or degrade in the environment either through biodegradation or other processes (such as oxidation or hydrolysis) as well as the concentration or amount of the chemical found in the environment (e.g., in plants, animals as well as in the atmosphere or water).",
            "Section": [
              {
                "TOCHeading": "Environmental Fate/Exposure Summary",
                "Description": "This section summarizes the environmental fate/exposure of this chemical, including the natural and artificial sources of the chemical as a pollutant, its environmental fate, biodegradation, abiotic degradation, bioconcentration, etc.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl's production and administration as an opiate analgesic for the treatment of breakthrough and chronic pain may result in its release to the environment through various waste streams. Fentanyl is a Schedule II controlled substance. If released to air, a vapor pressure of 4.43X10-9 mm Hg at 25 °C indicates fentanyl will exist solely in the particulate phase in the atmosphere. Particulate-phase fentanyl will be removed from the atmosphere by wet and dry deposition. Fentanyl contains chromophores that absorb at wavelengths >290 nm and, therefore, may be susceptible to direct photolysis by sunlight. If released to soil, fentanyl is expected to have no mobility based upon an estimated Koc of 39,600. The pKa of fentanyl is 7.3, indicating that this compound will exist partially in cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts. Volatilization from moist soil surfaces is not expected to be an important fate process based upon its pKa and estimated Henry's Law constant of 9.8X10-12 atm-cu m/mole. Fentanyl is not expected to volatilize from dry soil surfaces based upon its vapor pressure. Biodegradation data in soil or water were not available. If released into water, fentanyl is expected to adsorb to suspended solids and sediment based upon the estimated Koc. Volatilization from water surfaces is not expected to be an important fate process based upon this compound's pKa and estimated Henry's Law constant. An estimated BCF of 220 suggests the potential for bioconcentration in aquatic organisms is high. Hydrolysis is not expected to be an important environmental fate process since this compound lacks functional groups that hydrolyze under environmental conditions (pH 5 to 9). Occupational exposure to fentanyl may occur through dermal contact with this compound at workplaces where fentanyl is produced or administered. Exposure to fentanyl among the general population may be limited to those administered the drug as a pain killer, and its illicit use for its intense euphoric effects. (SRC)",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 191,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 314,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 403,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 475,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 631,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 722,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 895,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Carbon",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Carbon"
                            },
                            {
                              "Start": 1114,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1238,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 1281,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 1288,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1402,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 1831,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1912,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1962,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Artificial Pollution Sources",
                "Description": "Pollutants are emitted from a range of natural and man-made (artificial) sources.  This section provides information on the artificial sources of the compound as a pollutant.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "9] (USFDA); U.S. National Archives and Records Administration's Electronic Code of Federal Regulations. Available from, as of April 25, 2017: https://www.ecfr.gov"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl's production and administation as an opiate analgesic(1,2) for the treatment of breakthrough and chronic pain(1) may result in its release to the environment through various waste streams(SRC). Fentanyl (DEA Code Number: 9801) is a Schedule II controlled substance(3).[(1) US Department of Justice, Drug Enforcement Administration. Drug and Chemical Evaluation Section. Fentanyl. Available from, as of May 2, 2017: https://www.deadiversion.usdoj.gov/drug_chem_info/fentanyl.pdf#search=fentanyl (2) Larranaga MD et al, eds; Hawley's Condensed Chemical Dictionary 16th ed., Hoboken, NJ: John Wiley & Sons, Inc., p. 611 (2016) (3) 21 CFR 1308.12(c)",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 203,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 379,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 474,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 494,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:25976511",
                      "Mounteney J et al; Int J Drug Policy 26 (7): 626-31 (2015)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl is a synthetic opioid analgesic historically used as a pain reliever and an anaesthetic. Recent concerns have arisen around the illicit use of fentanyl and its analogues in a number of European countries, linked to their high potency and associated risk of fatal overdose. Evidence has been emerging from Estonia for over a decade of entrenched patterns of fentanyl use, including injection of the drug and hundreds of overdose deaths. More recently, reports indicate that both fentanyl and 3-methylfentanyl (TMF) have been marketed as a replacement for heroin in European countries (e.g. Bulgaria, Slovakia) affected by heroin shortages. In addition, Germany, Finland and the United Kingdom, reported new outbreaks of fentanyl-related deaths. This combination of increasing mortality data alongside law enforcement intelligence suggesting both diversion and illicit production of fentanyls, prompted wider investigation using a targeted multi-source data collection exercise and analysis. This identified that in the European context, fentanyls are 'low use but high risk/harm' substances. Evidence shows that Estonia stands out as having an endemic problem, while the use of fentanyls in other European countries appears to be geographically localised. Developments in illicit supply of fentanyls reflect the complexity of Europe's contemporary drug market: manifesting illicit production and use, the diversion and misuse of medicines, and the online sale of non-controlled new psychoactive substances. Likewise effective and integrated responses will need to address fentanyl production, diversion as well as ensuring the availability of harm reduction measures to users.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 152,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 366,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 487,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 500,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/3-methylfentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-61996"
                            },
                            {
                              "Start": 563,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5462328"
                            },
                            {
                              "Start": 630,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5462328"
                            },
                            {
                              "Start": 728,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1580,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Environmental Fate",
                "Description": "Environmental fate describes where this chemical goes when it gets out into the environment and how it might be chemically transformed in that process.  This section may provide information on multiple types of environmental fates of the chemical (e.g., aquatic fate, terrestrial fate, and atmospheric fate).   ",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Swann RL et al; Res Rev 85: 17-28 (1983)",
                      "(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of May 2, 2017: https://www2.epa.gov/tsca-screening-tools",
                      "(3) Boleda MR et al; Chemosphere 84: 1601-7 (2011)",
                      "(4) Doucette WJ; pp. 141-188 in Handbook of Property Estimation Methods for Chemicals. Boethling RS, Mackay D, eds. Boca Raton, FL: Lewis Publ (2000)",
                      "(5) Gupta PK et al; J Chem Eng Data 53: 841-5 (2008)",
                      "(6) Roy SD, Flynn GL; Parmacol Res 5: 580-6 (1988)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 39,600(SRC), determined from a structure estimation method(2), indicates that fentanyl is expected to be immobile in soil. The pKa of fentanyl is 7.3(3), indicating that this compound will exist partially in cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization of the cation from moist soil is not expected because cations do not volatilize(SRC). Volatilization of the neutral form of fentanyl from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 9.8X10-12 atm-cu m/mole(SRC), based upon its vapor pressure, 4.43X10-9 mm Hg(5), and water solubility, 200 mg/L(6). Fentanyl is not expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(5). Biodegradation data in soil were not available(SRC, 2017).",
                          "Markup": [
                            {
                              "Start": 159,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 215,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 391,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Carbon",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Carbon"
                            },
                            {
                              "Start": 582,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 797,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 828,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Swann RL et al; Res Rev 85: 17-28 (1983)",
                      "(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of May 2, 2017: https://www2.epa.gov/tsca-screening-tools",
                      "(3) Boleda MR et al; Chemosphere 84: 1601-7 (2011)",
                      "(4) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 7-4, 7-5, 15-1 to 15-29 (1990)",
                      "(5) Gupta PK et al; J Chem Eng Data 53: 841-5 (2008)",
                      "(6) Roy SD, Flynn GL; Parmacol Res 5:580-6 (1988)",
                      "(7) Franke C et al; Chemosphere 29: 1501-14 (1994)",
                      "(8) Sangster J; Log Kow Data Bank. Montreal, Quebec, Canada: Sangster Res Lab (1993)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 39,600(SRC), determined from a structure estimation method(2), indicates that fentanyl is expected to adsorb to suspended solids and sediment(SRC). A pKa of 7.3(3) indicates fentanyl will exist partially in the cation form at pH values of 5 to 9 and, therefore, volatilization of the cation from water surfaces is not expected(SRC). Volatilization from water surfaces of neutral fentanyl is not expected(4) based upon an estimated Henry's Law constant of 9.8X10-12 atm-cu m/mole(SRC), from its vapor pressure, 4.43X10-9 mm Hg(5), and water solubility, 200 mg/L(6). Fentanyl is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(4). According to a classification scheme(7), an estimated BCF of 220(SRC), from a log Kow of 4.05(8) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is high. Biodegradation data in water were not available(SRC, 2017).",
                          "Markup": [
                            {
                              "Start": 155,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 251,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 373,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 430,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 456,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 611,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 642,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1027,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Bidleman TF; Environ Sci Technol 22: 361-367 (1988)",
                      "(2) Gupta PK et al; J Chem Eng Data 53: 841-5 (2008)",
                      "(3) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 8-12, 8-13 (1990)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), fentanyl, which has a vapor pressure of 4.43X10-9 mm Hg at 25 °C(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase fentanyl may be removed from the air by wet and dry deposition(SRC). Fentanyl contains chromophores that absorb at wavelengths >290 nm(3) and, therefore, may be susceptible to direct photolysis by sunlight(SRC).",
                          "Markup": [
                            {
                              "Start": 124,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 291,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 360,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Environmental Abiotic Degradation",
                "Description": "Abiotic degradation is a process by which a chemical substance is broken down into smaller molecules by non-biotic means (e.g., hydrolysis, photolysis, and oxidation).",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 7-4, 7-5, 8-12, 8-13 (1990)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(1). Fentanyl contains chromophores that absorb at wavelengths >290 nm(1) and, therefore, may be susceptible to direct photolysis by sunlight(SRC).",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 153,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Environmental Bioconcentration",
                "Description": "This section provides information on environmental bioconcentration for this compound.  Bioconcentration is the accumulation of a chemical in or on an organism when the source of chemical is solely water. Bioconcentration is a term that was created for use in the field of aquatic toxicology. Bioconcentration can also be defined as the process by which a chemical concentration in an aquatic organism exceeds that in water as a result of exposure to a waterborne chemical.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Sangster J; Log Kow Data Bank. Montreal, Quebec, Canada: Sangster Res Lab (1993)",
                      "(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of May 2, 2017: https://www2.epa.gov/tsca-screening-tools/",
                      "(3) Franke C et al; Chemosphere 29: 1501-14 (1994)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "An estimated BCF of 220 was calculated in fish for fentanyl(SRC), using a log Kow of 4.05(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is high, provided the compound is not metabolized by the organism(SRC).",
                          "Markup": [
                            {
                              "Start": 51,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Soil Adsorption/Mobility",
                "Description": "Sorption to soils and sediments is an important factor on the transport and fate of organic contaminants in the environment.  The soil/water adsorption coefficient, also known as solid-water distribution coefficient (Kd), measures the amount of chemical substance adsorbed onto soil per amount of water.  Since adsorption occurs predominantly by partition into the soil organic matter, it is more useful to normalize the Kd value to the organic carbon content of a soil and express the distribution coefficient in Koc (organic carbon normalized distribution coefficient).  The greater the Kd (or Koc) value, the less likely a chemical will leach or contribute to runoff.  A very high value means it is strongly adsorbed onto soil and organic matter and does not move throughout the soil.",
                "URL": "https://toxics.usgs.gov/pubs/FS-087-00/fs-087-00.pdf",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of May 2, 2017: https://www2.epa.gov/tsca-screening-tools",
                      "(2) Swann RL et al; Res Rev 85: 17-28 (1983)",
                      "(3) Boleda MR et al; Chemosphere 84:1601-7 (2011)",
                      "(4) Doucette WJ; pp. 141-188 in Handbook of Property Estimation Methods for Chemicals. Boethling RS, Mackay D, eds. Boca Raton, FL: Lewis Publ (2000)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Using a structure estimation method based on molecular connectivity indices(1), the Koc of fentanyl can be estimated to be 39,600(SRC). According to a classification scheme(2), this estimated Koc value suggests that fentanyl is expected to be immobile. The pKa of fentanyl is 7.3(3), indicating that this compound will exist partially in the cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4).",
                          "Markup": [
                            {
                              "Start": 91,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 216,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 264,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 444,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/element/Carbon",
                              "Type": "PubChem Internal Link",
                              "Extra": "Element-Carbon"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Volatilization from Water/Soil",
                "Description": "Volatilization of chemicals from water/soil is the transfer of the chemical as a gas through the water-air or soil-air interface under environmental conditions",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Boleda MR et al; Chemosphere 84: 1601-7 (2011)",
                      "(2) Gupta PK et al; J Chem Eng Data 53: 841-5 (2008)",
                      "(3) Roy SD, Flynn GL; Parmacol Res 5: 580-6 (1988)",
                      "(4) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 15-1 to 15-29 (1990)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "A pKa of 7.3(1) indicates fentanyl will exist partially in the cation form at pH values of 5 to 9 and, therefore, volatilization of the cation from water and moist soil surfaces is not expected to be an important fate process(SRC). The Henry's Law constant for fentanyl is estimated as 9.8X10-12 atm-cu m/mole(SRC) derived from its vapor pressure, 4.43X10-9 mm Hg(2), and water solubility, 200 mg/L(3). This Henry's Law constant indicates that the neutral form of fentanyl is expected to be essentially nonvolatile from water and moist soil surfaces(4). Fentanyl is not expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(2).",
                          "Markup": [
                            {
                              "Start": 26,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 148,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 261,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 372,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 464,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 520,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 554,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Environmental Water Concentrations",
                "Description": "Concentrations of this chemical in water in various stages of hydrologic cycle (e.g., drinking water, ground water, surface water, and rain/snow).",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Huerat-Fotela M et al Environ Sci Technol 42: 6809-16 (2008)",
                      "(2) Boleda MR et al; Chemosphere 84: 1601-7 (2011)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DRINKING WATER: Fentanyl was not detected (detection limit 0.5 ng/L) in finished drinking water samples collected Jan to Jun 2007 from a Spanish treatment plant(1). Fentanyl was detected at 1.4 ng/L in 1 of 50 tap water samples collected 2008-2009 from 43 Spanish cities; it was not detected (detection limit 1.0 ng/L) in tap water samples collected from 4 cities in France, 3 from Germany and Japan, 2 each from Iceland, Switzerland, United Kingdom, Chile and Peru, and 1 each from Austria, Slovakia, Argentina, Brazil, Colombia, Panama and Uruguay(2).",
                          "Markup": [
                            {
                              "Start": 9,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/WATER",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 16,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 90,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 165,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 214,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 326,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Huerat-Fotela M et al Environ Sci Technol 42: 6809-16 (2008)",
                      "(2) Petrie B et al; Water Res 72: 3-27 (2015)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "SURFACE WATER: Fentanyl was not detected (detection limit 0.5 ng/L) in surface water samples collected Jan, Mar and May 2007 from the Llobregat River and it's tributaries in northeastern Spain(1). The average surface water concentration for fentanyl was reported as <0.1 ng/L(2).",
                          "Markup": [
                            {
                              "Start": 8,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/WATER",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 15,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 79,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 217,
                              "Length": 5,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/water",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-962"
                            },
                            {
                              "Start": 241,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Effluent Concentrations",
                "Description": "Concentration of this compound in effluent.  Effluent is wastewater (treated or untreated) discharged into surface waters from a treatment plant, sewer, or industrial outfall. ",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Loos R et al; Water Res 47: 6475-87 (2013)",
                      "(2) Petrie B et al; Water Res 72: 3-27 (2015)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Fentanyl was detected in 6% of effluent samples collected from 90 European wastewater treatment plants at <0.5-1.6 ng/L (average 0.1 ng/L, median <0.1 ng/L); samples were collected in 2010(1). Influent and effluent concentrations of fentanyl have been reported as 1.3-1.7 and <0.1-0.5 ng/L, respectively, in wastewater treatment plants(2).",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Probable Routes of Human Exposure",
                "Description": "Potential way(s) in which people may come into contact with a hazardous chemical.  Examples of common exposure routes are inhalation, ingestion, skin/eye contact.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Occupational exposure to fentanyl may occur through dermal contact with this compound at workplaces where fentanyl is produced or administered. Exposure to fentanyl among the general population may be limited to those administered the drug as a pain killer, and its illicit use for its intense euphoric effects. (SRC)",
                          "Markup": [
                            {
                              "Start": 25,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 106,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 156,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Body Burden",
                "Description": "Total amount of a chemical present in an organism at a given time.",
                "Information": [
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "(1) Daughton CG, Ruhoy IS; Environ Toxicol Chem 28: 2495-521 (2009)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "The concentration of fentanyl excreted in sweat was 0.17-10.2 ng/uL in persons treated with a total daily dose of 600 ug(1).",
                          "Markup": [
                            {
                              "Start": 21,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:28158759",
                      "Rodda LN et al; J Anal Toxicol 41 (4): 318-324 (2017)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "... Following an observed spike of heroin-fentanyl related deaths in Melbourne, Australia, a study was undertaken to determine the prevalence of these cases. All reportable deaths occurring in Victoria during 2015 and submitted to the toxicology laboratory were analysed using LC-MS-MS to confirm the combination of the heroin marker 6-acetylmorphine and/or morphine, and fentanyl. Over 4,000 coronial cases in 2015 underwent toxicological analysis for these drugs, there were nine cases identified that involved fentanyl-laced heroin. ... The ages ranged from 25 to 57 years with an average of 40 and median of 37 years, and consisted of eight males and one female. The average and median femoral blood concentration of fentanyl was 18 and 20 ng/mL (range: <1-45 ng/mL), and morphine 140 and 80 ng/mL (range: 20-400 ng/mL), respectively. All nine cases had 6-acetylmorphine detectable in blood. Urine analysis was also performed where available. ...",
                          "Markup": [
                            {
                              "Start": 35,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5462328"
                            },
                            {
                              "Start": 42,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 320,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5462328"
                            },
                            {
                              "Start": 334,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/6-acetylmorphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5462507"
                            },
                            {
                              "Start": 358,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 372,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 513,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 528,
                              "Length": 6,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/heroin",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5462328"
                            },
                            {
                              "Start": 721,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:15568716",
                      "Lilleng PK et al; J Forensic Sci 49 (6): 1364-6 (2004)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "... Here we report two cases of fatal intravenous injection of the content from fentanyl patches. Both were male drug addicts, found dead within a one week interval in the same apartment. Post-mortem femoral blood was screened for amphetamines, cannabinoids, cocaine, and opioids with immunological methods (EMIT II) and further with headspace gas chromatography for alcohol and with liquid chromatography mass spectrometry (LC-MS) for different drugs, including fentanyl. ... In the first case, the toxicological analysis revealed fentanyl (2.7 ng/mL), morphine (31.4 ng/mL), and ethanol (1.1 g/L) in postmortem blood and amphetamine, cannabinoids, morphine, and ethanol (1.4 g/L) in postmortem urine. In the second case, the analysis revealed fentanyl (13.8 ng/mL), 7-aminoclonazepam (57.1 ng/mL), and sertralin (91.9 ng/mL) in postmortem blood and a small amount of ethanol (0.1 g/L) in postmortem urine. ...",
                          "Markup": [
                            {
                              "Start": 80,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 259,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/cocaine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-446220"
                            },
                            {
                              "Start": 463,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 532,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 554,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 581,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/ethanol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-702"
                            },
                            {
                              "Start": 623,
                              "Length": 11,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/amphetamine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3007"
                            },
                            {
                              "Start": 650,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 664,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/ethanol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-702"
                            },
                            {
                              "Start": 745,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 768,
                              "Length": 17,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/7-aminoclonazepam",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-188298"
                            },
                            {
                              "Start": 804,
                              "Length": 9,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/sertraline",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-68617"
                            },
                            {
                              "Start": 869,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/ethanol",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-702"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Reference": [
                      "PMID:27473610",
                      "Armenian P et al; Ann Emerg Med 69 (1): 87-90 (2017)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "In 2013 and 2014, more than 700 deaths were attributed to fentanyl and fentanyl analogs in the United States. Of recent concern is the cluster of unintentional fentanyl overdoses because of tablets thought to be \"Norco\" purchased on the street in Northern California. U-47700 (trans-3,4-dichloro-N-[2-(dimethyl-amino)cyclohexyl]-N-methylbenz-amide) is a nonfentanyl-based synthetic opioid with 7.5 times the binding affinity of morphine to mu-opioid. We report a case of fentanyl and U-47700 intoxication from what was thought to be illicitly purchased Norco. A 41-year-old woman presented to the emergency department (ED) for altered mental status shortly after ingesting 3 beige Norco pills bearing a Watson imprint. She had pinpoint pupils and respiratory depression, which reversed after 0.4 mg naloxone administration intravenously. She had complete recovery and was discharged from the ED after a 4-hour observation period. Serum testing with liquid chromatography-quadrupole time-of-flight mass spectrometry (LC 1260 QTOF/MS 6550; Agilent, Santa Clara, CA) confirmed the presence of the medications the patient reported receiving, and additionally fentanyl (15.2 ng/mL) and U-47700 (7.6 ng/mL). In this case report, street Norco purchased in Central California resulted in altered mental status requiring naloxone reversal because of fentanyl and the novel synthetic opioid U-47700. Because these compounds are not detected by routine urine drug testing and physical examination findings are similar to those of a traditional opioid toxidrome, emergency providers should use the patient's history and other circumstantial details to aid in diagnosis. In cases with suspicion of opioid or opioid analogue cause, we recommend that emergency providers contact their local poison control center, medical toxicologist, or public health department to aid in the investigation.",
                          "Markup": [
                            {
                              "Start": 58,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 71,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 160,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 428,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/morphine",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5288826"
                            },
                            {
                              "Start": 471,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 799,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/naloxone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284596"
                            },
                            {
                              "Start": 1155,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            },
                            {
                              "Start": 1312,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/naloxone",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5284596"
                            },
                            {
                              "Start": 1341,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 59,
                    "Description": "PEER REVIEWED",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "For more Body Burden (Complete) data for Fentanyl (16 total), please visit the HSDB record page.",
                          "Markup": [
                            {
                              "Start": 79,
                              "Length": 16,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329#section=Body-Burden-(Complete)"
                            },
                            {
                              "Start": 41,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Fentanyl",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-3345"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Associated Disorders and Diseases",
        "Description": "Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).",
        "DisplayControls": {
          "CreateTable": {
            "FromInformationIn": "Subsections",
            "NumberOfColumns": 2,
            "ColumnHeadings": [
              "Disease",
              "References"
            ],
            "ColumnContents": [
              "Name",
              "Value"
            ]
          }
        },
        "Information": [
          {
            "ReferenceNumber": 9,
            "Value": {
              "ExternalTableName": "consolidateddiseaseassociation"
            }
          },
          {
            "ReferenceNumber": 113,
            "Value": {
              "ExternalTableName": "consolidateddiseaseassociation"
            }
          },
          {
            "ReferenceNumber": 126,
            "Value": {
              "ExternalTableName": "consolidateddiseaseassociation"
            }
          }
        ]
      },
      {
        "TOCHeading": "Literature",
        "Description": "Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/docs/literature",
        "Section": [
          {
            "TOCHeading": "Consolidated References",
            "Description": "The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/docs/literature",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Value": {
                  "ExternalTableName": "literature"
                }
              }
            ]
          },
          {
            "TOCHeading": "NLM Curated PubMed Citations",
            "Description": "The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.",
            "URL": "https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6",
            "Information": [
              {
                "ReferenceNumber": 136,
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=3345",
                "Value": {
                  "Boolean": [
                    true
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Springer Nature References",
            "Description": "Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information.",
            "Information": [
              {
                "ReferenceNumber": 123,
                "Value": {
                  "ExternalTableName": "springernature"
                }
              }
            ]
          },
          {
            "TOCHeading": "Thieme References",
            "Description": "Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.",
            "Information": [
              {
                "ReferenceNumber": 127,
                "Name": "Thieme References",
                "Value": {
                  "ExternalTableName": "ThiemeChemistry"
                }
              }
            ]
          },
          {
            "TOCHeading": "Wiley References",
            "Description": "Literature references related to scientific contents from Wiley journals and books.",
            "Information": [
              {
                "ReferenceNumber": 134,
                "Value": {
                  "ExternalTableName": "wiley"
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical Co-Occurrences in Literature",
            "Description": "Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.",
            "URL": "https://doi.org/10.3389/frma.2021.689059",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Name": "Co-Occurrence Panel",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "ChemicalNeighbor"
                    },
                    {
                      "String": "Chemical"
                    },
                    {
                      "String": "ChemicalName_1"
                    },
                    {
                      "String": "ChemicalName_2"
                    },
                    {
                      "String": "SUMMARY_URL.cid"
                    },
                    {
                      "String": "CID"
                    },
                    {
                      "String": "CID"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical-Gene Co-Occurrences in Literature",
            "Description": "Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.",
            "URL": "https://doi.org/10.3389/frma.2021.689059",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Name": "Co-Occurrence Panel",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "ChemicalGeneSymbolNeighbor"
                    },
                    {
                      "String": "Gene/Protein/Enzyme"
                    },
                    {
                      "String": "ChemicalName"
                    },
                    {
                      "String": "GeneSymbolName"
                    },
                    {
                      "String": "https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:"
                    },
                    {
                      "String": "CID"
                    },
                    {
                      "String": "GeneSymbol"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical-Disease Co-Occurrences in Literature",
            "Description": "Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.",
            "URL": "https://doi.org/10.3389/frma.2021.689059",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Name": "Co-Occurrence Panel",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "ChemicalDiseaseNeighbor"
                    },
                    {
                      "String": "Disease"
                    },
                    {
                      "String": "ChemicalName"
                    },
                    {
                      "String": "DiseaseName"
                    },
                    {
                      "String": "https://meshb.nlm.nih.gov/record/ui?ui="
                    },
                    {
                      "String": "CID"
                    },
                    {
                      "String": "MeSH"
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Patents",
        "Description": "Patent applications/documents that mention this compound.",
        "DisplayControls": {
          "ListType": "Columns"
        },
        "Information": [
          {
            "ReferenceNumber": 15,
            "Value": {
              "StringWithMarkup": [
                {
                  "String": "US6317629",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6317629"
                    }
                  ]
                },
                {
                  "String": "US6200604",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6200604"
                    }
                  ]
                },
                {
                  "String": "US6974590",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6974590"
                    }
                  ]
                },
                {
                  "String": "US8728441",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8728441"
                    }
                  ]
                },
                {
                  "String": "US8753611",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8753611"
                    }
                  ]
                },
                {
                  "String": "US8765100",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8765100"
                    }
                  ]
                },
                {
                  "String": "US7862833",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US7862833"
                    }
                  ]
                },
                {
                  "String": "US8119158",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8119158"
                    }
                  ]
                },
                {
                  "String": "US8092832",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8092832"
                    }
                  ]
                },
                {
                  "String": "US7862832",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US7862832"
                    }
                  ]
                },
                {
                  "String": "US6761910",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6761910"
                    }
                  ]
                },
                {
                  "String": "US6195582",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6195582"
                    }
                  ]
                },
                {
                  "String": "US6881208",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6881208"
                    }
                  ]
                },
                {
                  "String": "US8428709",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8428709"
                    }
                  ]
                },
                {
                  "String": "US8428708",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8428708"
                    }
                  ]
                },
                {
                  "String": "US6169920",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6169920"
                    }
                  ]
                },
                {
                  "String": "US8781571",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8781571"
                    }
                  ]
                },
                {
                  "String": "US6181963",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6181963"
                    }
                  ]
                },
                {
                  "String": "US5843014",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US5843014"
                    }
                  ]
                },
                {
                  "String": "US5697896",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US5697896"
                    }
                  ]
                },
                {
                  "String": "US6975902",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6975902"
                    }
                  ]
                },
                {
                  "String": "US8301238",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8301238"
                    }
                  ]
                },
                {
                  "String": "US9095706",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9095706"
                    }
                  ]
                },
                {
                  "String": "US7579019",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US7579019"
                    }
                  ]
                },
                {
                  "String": "US6159498",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6159498"
                    }
                  ]
                },
                {
                  "String": "US6759059",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6759059"
                    }
                  ]
                },
                {
                  "String": "US7910132",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US7910132"
                    }
                  ]
                },
                {
                  "String": "US8889176",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8889176"
                    }
                  ]
                },
                {
                  "String": "US6432440",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US6432440"
                    }
                  ]
                },
                {
                  "String": "US8216604",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8216604"
                    }
                  ]
                },
                {
                  "String": "US9078814",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9078814"
                    }
                  ]
                },
                {
                  "String": "US8486973",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8486973"
                    }
                  ]
                },
                {
                  "String": "US8835460",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8835460"
                    }
                  ]
                },
                {
                  "String": "US8835459",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8835459"
                    }
                  ]
                },
                {
                  "String": "US9241935",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9241935"
                    }
                  ]
                },
                {
                  "String": "US8486972",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8486972"
                    }
                  ]
                },
                {
                  "String": "US9364656",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9364656"
                    }
                  ]
                },
                {
                  "String": "US9597288",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9597288"
                    }
                  ]
                },
                {
                  "String": "US9642844",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9642844"
                    }
                  ]
                },
                {
                  "String": "US9289387",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9289387"
                    }
                  ]
                },
                {
                  "String": "US9642797",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9642797"
                    }
                  ]
                },
                {
                  "String": "US9731869",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9731869"
                    }
                  ]
                },
                {
                  "String": "US9731121",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9731121"
                    }
                  ]
                },
                {
                  "String": "US9814705",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9814705"
                    }
                  ]
                },
                {
                  "String": "US10016403",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 10,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US10016403"
                    }
                  ]
                },
                {
                  "String": "US10610523",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 10,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US10610523"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "Section": [
          {
            "TOCHeading": "Depositor-Supplied Patent Identifiers",
            "Description": "Patent identifiers provided by data depositors, along with information on those patents.",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Value": {
                  "ExternalTableName": "patent"
                }
              },
              {
                "ReferenceNumber": 136,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Link to all deposited patent identifiers",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 40,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3345/xrefs/PatentID/TXT"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "WIPO PATENTSCOPE",
            "Description": "Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system.",
            "URL": "https://www.wipo.int/patentscope/en/",
            "Information": [
              {
                "ReferenceNumber": 166,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Patents are available for this chemical structure:"
                    },
                    {
                      "String": "https://patentscope.wipo.int/search/en/result.jsf?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 86,
                          "URL": "https://patentscope.wipo.int/search/en/result.jsf?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Orange Book Patents",
            "Description": "Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA). The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.",
            "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
            "Information": [
              {
                "ReferenceNumber": 56,
                "Value": {
                  "ExternalTableName": "collection=fdaorgpt&query_type=synonym&query='^FENTANYL$'"
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical Co-Occurrences in Patents",
            "Description": "Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Name": "Co-Occurrence Panel",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "PatentChemicalChemical"
                    },
                    {
                      "String": "Chemical"
                    },
                    {
                      "String": "ChemicalName"
                    },
                    {
                      "String": "NeighborName"
                    },
                    {
                      "String": "SUMMARY_URL.cid"
                    },
                    {
                      "String": "CID"
                    },
                    {
                      "String": "CID"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical-Disease Co-Occurrences in Patents",
            "Description": "Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Name": "Co-Occurrence Panel",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "PatentChemicalDisease"
                    },
                    {
                      "String": "Disease"
                    },
                    {
                      "String": "ChemicalName"
                    },
                    {
                      "String": "NeighborName"
                    },
                    {
                      "String": "https://meshb.nlm.nih.gov/record/ui?ui="
                    },
                    {
                      "String": "CID"
                    },
                    {
                      "String": "MeSH"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical-Gene Co-Occurrences in Patents",
            "Description": "Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Name": "Co-Occurrence Panel",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "PatentChemicalGene"
                    },
                    {
                      "String": "Gene"
                    },
                    {
                      "String": "ChemicalName"
                    },
                    {
                      "String": "NeighborName"
                    },
                    {
                      "String": "https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:"
                    },
                    {
                      "String": "CID"
                    },
                    {
                      "String": "GeneSymbol"
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Interactions and Pathways",
        "Description": "This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.",
        "Section": [
          {
            "TOCHeading": "Protein Bound 3D Structures",
            "Description": "Experimentally determined 3D structures of the macromolecules (e.g., proteins) that this compounds bind to.  The 3D structures in this section are from multiple sources including the RCSB Protein Data Bank (PDB), PDB in Europe (PDBe), and NCBI Structure database.",
            "Information": [
              {
                "ReferenceNumber": 118,
                "Value": {
                  "ExternalTableName": "pdb"
                }
              },
              {
                "ReferenceNumber": 136,
                "URL": "https://www.ncbi.nlm.nih.gov/structure?cmd=Link&LinkName=pccompound_structure&from_uid=3345",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "View 13 proteins in NCBI Structure"
                    }
                  ]
                }
              }
            ],
            "Section": [
              {
                "TOCHeading": "Ligands from Protein Bound 3D Structures",
                "Description": "Ligands found in experimental protein-ligand co-complexes (e.g., those archived in the Protein Data Bank in Europe (PDBe)).",
                "URL": "https://www.ebi.ac.uk/pdbe/",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "Subsections",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "MoveToTop": true,
                  "ShowAtMost": 1
                },
                "Section": [
                  {
                    "TOCHeading": "PDBe Ligand Code",
                    "Description": "The ligand code for this compound used in the Protein Data Bank in Europe (PDBe).",
                    "Information": [
                      {
                        "ReferenceNumber": 116,
                        "URL": "http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/7V7",
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "7V7"
                            }
                          ]
                        }
                      }
                    ]
                  },
                  {
                    "TOCHeading": "PDBe Structure Code",
                    "Description": "The structure code for the Protein Data Bank in Europe (PDBe) protein-ligand co-complex from which the ligand's 3-D coordinates were taken.",
                    "Information": [
                      {
                        "ReferenceNumber": 116,
                        "URL": "http://www.ebi.ac.uk/pdbe/entry/pdb/5TZO",
                        "Value": {
                          "StringWithMarkup": [
                            {
                              "String": "5TZO"
                            }
                          ]
                        }
                      }
                    ]
                  },
                  {
                    "TOCHeading": "PDBe Conformer",
                    "Description": "The experimental protein-bound 3D structure of this compound in a protein-ligand co-complex archived in the Protein Data Bank in Europe (PDBe).",
                    "Information": [
                      {
                        "ReferenceNumber": 116,
                        "URL": "http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/7V7",
                        "Value": {
                          "ExternalDataURL": [
                            "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/8206009_1"
                          ],
                          "MimeType": "pubchem/compound-gzip-asnb"
                        }
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Chemical-Target Interactions",
            "Description": "Interactions between targets and this compound",
            "Information": [
              {
                "ReferenceNumber": 4,
                "Value": {
                  "ExternalTableName": "consolidatedcompoundtarget"
                }
              },
              {
                "ReferenceNumber": 9,
                "Value": {
                  "ExternalTableName": "consolidatedcompoundtarget"
                }
              },
              {
                "ReferenceNumber": 15,
                "Value": {
                  "ExternalTableName": "collection=consolidatedcompoundtarget&query_type=name&query=^Fentanyl$"
                }
              },
              {
                "ReferenceNumber": 67,
                "Value": {
                  "ExternalTableName": "consolidatedcompoundtarget"
                }
              },
              {
                "ReferenceNumber": 126,
                "Value": {
                  "ExternalTableName": "consolidatedcompoundtarget"
                }
              },
              {
                "ReferenceNumber": 128,
                "Value": {
                  "ExternalTableName": "consolidatedcompoundtarget"
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug-Drug Interactions",
            "Description": "Drug-drug interactions for this compound.  Drug-drug interactions occur when two or more drugs react with each other. This drug-drug interaction may cause you to experience an unexpected side effect. For example, mixing a drug you take to help you sleep (a sedative) and a drug you take for allergies (an antihistamine) can slow your reactions and make driving a car or operating machinery dangerous.",
            "URL": "https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know",
            "Information": [
              {
                "ReferenceNumber": 15,
                "Value": {
                  "ExternalTableName": "collection=drugbankddi&query_type=name&query=^Fentanyl$"
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug-Food Interactions",
            "Description": "Drug-food interactions for this compound. Drug-food/beverage interactions result from drugs reacting with foods or beverages. For example, mixing alcohol with some drugs may cause you to feel tired or slow your reactions.",
            "URL": "https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know",
            "DisplayControls": {
              "ListType": "Bulleted"
            },
            "Information": [
              {
                "ReferenceNumber": 15,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Avoid alcohol."
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Pathways",
            "Description": "Biological pathways in which this compound is involved.",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Value": {
                  "ExternalTableName": "collection=pathway&core=1"
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Biological Test Results",
        "Description": "A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/docs/widgets",
        "Section": [
          {
            "TOCHeading": "BioAssay Results",
            "Description": "Bioactivity data for this compound, reported in PubChem BioAssay records.",
            "Information": [
              {
                "ReferenceNumber": 136,
                "Value": {
                  "ExternalTableName": "bioactivity"
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Classification",
        "Description": "A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.",
        "Section": [
          {
            "TOCHeading": "MeSH Tree",
            "Description": "The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.",
            "URL": "https://www.nlm.nih.gov/mesh",
            "Information": [
              {
                "ReferenceNumber": 137,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1",
                "Value": {
                  "Number": [
                    1
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "NCI Thesaurus Tree",
            "Description": "NCI Thesaurus (NCIt) hierarchy",
            "URL": "https://ncithesaurus.nci.nih.gov",
            "Information": [
              {
                "ReferenceNumber": 158,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112",
                "Value": {
                  "Number": [
                    112
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "ChEBI Ontology",
            "Description": "ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified.",
            "URL": "https://www.ebi.ac.uk/chebi/",
            "Information": [
              {
                "ReferenceNumber": 138,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2",
                "Value": {
                  "Number": [
                    2
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "KEGG: Drug",
            "Description": "Classification/ontology tree for therapeutic categories of drugs in Japan, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).",
            "URL": "https://www.genome.jp/kegg-bin/get_htext?htext=br08301",
            "Information": [
              {
                "ReferenceNumber": 139,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=14",
                "Value": {
                  "Number": [
                    14
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "KEGG: USP",
            "Description": "US Pharmacopeia (USP) drug classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).",
            "URL": "https://www.genome.jp/kegg-bin/get_htext?htext=br08302",
            "Information": [
              {
                "ReferenceNumber": 140,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=15",
                "Value": {
                  "Number": [
                    15
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "KEGG: ATC",
            "Description": "Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).",
            "URL": "https://www.genome.jp/kegg-bin/get_htext?htext=br08303",
            "Information": [
              {
                "ReferenceNumber": 141,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16",
                "Value": {
                  "Number": [
                    16
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "KEGG: Target-based Classification of Drugs",
            "Description": "Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).",
            "URL": "https://www.genome.jp/kegg-bin/get_htext?htext=br08310",
            "Information": [
              {
                "ReferenceNumber": 142,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22",
                "Value": {
                  "Number": [
                    22
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "KEGG: Drug Groups",
            "Description": "KEGG : Drug Groups tree",
            "Information": [
              {
                "ReferenceNumber": 150,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96",
                "Value": {
                  "Number": [
                    96
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "WHO ATC Classification System",
            "Description": "The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.",
            "URL": "https://www.who.int/tools/atc-ddd-toolkit/atc-classification",
            "Information": [
              {
                "ReferenceNumber": 145,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=79",
                "Value": {
                  "Number": [
                    79
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Pharm Classes",
            "Description": "Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA \"Established Pharmacologic Class\" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.",
            "URL": "https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class",
            "Information": [
              {
                "ReferenceNumber": 144,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=78",
                "Value": {
                  "Number": [
                    78
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "ChemIDplus",
            "Description": "Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).",
            "URL": "https://chem.nlm.nih.gov/chemidplus/",
            "Information": [
              {
                "ReferenceNumber": 147,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84",
                "Value": {
                  "Number": [
                    84
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "IUPHAR/BPS Guide to PHARMACOLOGY Target Classification",
            "Description": "Classification of this entity in the context of targets, provided by the IUPHAR/BPS Guide to PHARMACOLOGY.",
            "URL": "https://www.guidetopharmacology.org/",
            "Information": [
              {
                "ReferenceNumber": 149,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=92",
                "Value": {
                  "Number": [
                    92
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "ChEMBL Target Tree",
            "Description": "Classification of this entity in the context of targets, provided by ChEMBL.",
            "URL": "https://www.ebi.ac.uk/chembl/",
            "Information": [
              {
                "ReferenceNumber": 148,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87",
                "Value": {
                  "Number": [
                    87
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "UN GHS Classification",
            "Description": "The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures.",
            "URL": "https://unece.org/about-ghs",
            "Information": [
              {
                "ReferenceNumber": 146,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83",
                "Value": {
                  "Number": [
                    83
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "EPA CPDat Classification",
            "Description": "Classification from the U.S. Environmental Protection Agency's CPDat (Chemical and Products Database).  This database contains information mapping more than 49,000 chemicals to a set of terms categorizing their usage or function in 16,000 consumer products (e.g. shampoo, soap) types based on what chemicals they contain.",
            "URL": "https://www.epa.gov/chemical-research/chemical-and-products-database-cpdat",
            "Information": [
              {
                "ReferenceNumber": 151,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=99",
                "Value": {
                  "Number": [
                    99
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug Enforcement Administration (DEA) Classification",
            "Description": "The United States Drug Enforcement Administration (US DEA) classifies illicit drugs and certain chemicals used to make them into five categories (Schedules I, II, III, IV, and V), depending upon the drug's abuse or dependency potential.  Schedule I drugs have a high potential for abuse and the potential to create severe psychological and/or physical dependence.  Schedule V drugs represent the least potential for abuse.",
            "URL": "https://www.dea.gov/drug-information/drug-scheduling",
            "Information": [
              {
                "ReferenceNumber": 153,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=102",
                "Value": {
                  "Number": [
                    102
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "NORMAN Suspect List Exchange Classification",
            "Description": "A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.",
            "URL": "https://www.norman-network.com/nds/SLE/",
            "Information": [
              {
                "ReferenceNumber": 152,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101",
                "Value": {
                  "Number": [
                    101
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "CCSBase Classification",
            "Description": "CCSbase is an integrated platform that contains collision cross section data for the compound.  The CCSbase classification groups the compounds by the type of adduct ions that can be formed from them (e.g., [M-H]-, [M+H]+, [M+Na]+, [M+K]+).",
            "URL": "https://ccsbase.net/",
            "Information": [
              {
                "ReferenceNumber": 154,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=104",
                "Value": {
                  "Number": [
                    104
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "EPA DSSTox Classification",
            "Description": "Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. ",
            "URL": "https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database",
            "Information": [
              {
                "ReferenceNumber": 155,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105",
                "Value": {
                  "Number": [
                    105
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "EPA Substance Registry Services Tree",
            "Description": "Substance Registry Services (SRS) is the Environmental Protection Agency's (EPA) central system for information about substances that are tracked or regulated by EPA or other sources. It is a resource for basic information about chemicals, biological organisms, and other substances of interest to EPA and its state and tribal partners. SRS makes it possible to identify which EPA data systems, environmental statutes, or other sources have information about a substance and which synonym is used by that system or statute.",
            "Information": [
              {
                "ReferenceNumber": 160,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=123",
                "Value": {
                  "Number": [
                    123
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "MolGenie Organic Chemistry Ontology",
            "Description": "An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A",
            "URL": "https://github.com/MolGenie/ontology/",
            "Information": [
              {
                "ReferenceNumber": 161,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134",
                "Value": {
                  "Number": [
                    134
                  ]
                }
              }
            ]
          }
        ]
      }
    ],
    "Reference": [
      {
        "ReferenceNumber": 1,
        "SourceName": "CAS Common Chemistry",
        "SourceID": "437-38-7",
        "Name": "Fentanyl",
        "Description": "CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.",
        "URL": "https://commonchemistry.cas.org/detail?cas_rn=437-38-7",
        "LicenseNote": "The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.",
        "LicenseURL": "https://creativecommons.org/licenses/by-nc/4.0/",
        "ANID": 12671943
      },
      {
        "ReferenceNumber": 6,
        "SourceName": "ChemIDplus",
        "SourceID": "0000437387",
        "Name": "Fentanyl [USAN:USP:INN:BAN]",
        "Description": "ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000437387",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html",
        "IsToxnet": true,
        "ANID": 770515
      },
      {
        "ReferenceNumber": 15,
        "SourceName": "DrugBank",
        "SourceID": "DB00813",
        "Name": "Fentanyl",
        "Description": "The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.",
        "URL": "https://www.drugbank.ca/drugs/DB00813",
        "LicenseNote": "Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)",
        "LicenseURL": "https://www.drugbank.ca/legal/terms_of_use",
        "ANID": 3606116
      },
      {
        "ReferenceNumber": 37,
        "SourceName": "EPA DSSTox",
        "SourceID": "DTXSID9023049",
        "Name": "Fentanyl",
        "Description": "DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.",
        "URL": "https://comptox.epa.gov/dashboard/DTXSID9023049",
        "LicenseURL": "https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources",
        "ANID": 1151180
      },
      {
        "ReferenceNumber": 40,
        "SourceName": "European Chemicals Agency (ECHA)",
        "SourceID": "207-113-6",
        "Name": "Fentanyl",
        "Description": "The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.",
        "URL": "https://echa.europa.eu/substance-information/-/substanceinfo/100.006.468",
        "LicenseNote": "Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.",
        "LicenseURL": "https://echa.europa.eu/web/guest/legal-notice",
        "ANID": 2053459
      },
      {
        "ReferenceNumber": 48,
        "SourceName": "FDA Global Substance Registration System (GSRS)",
        "SourceID": "UF599785JZ",
        "Name": "FENTANYL",
        "Description": "The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.",
        "URL": "https://gsrs.ncats.nih.gov/ginas/app/beta/substances/UF599785JZ",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 5843297
      },
      {
        "ReferenceNumber": 59,
        "SourceName": "Hazardous Substances Data Bank (HSDB)",
        "SourceID": "3329",
        "Name": "Fentanyl",
        "Description": "The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3329",
        "LicenseURL": "https://www.nlm.nih.gov/web_policies.html",
        "IsToxnet": true,
        "ANID": 2472
      },
      {
        "ReferenceNumber": 60,
        "SourceName": "Human Metabolome Database (HMDB)",
        "SourceID": "HMDB0014951",
        "Name": "Fentanyl",
        "Description": "The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.",
        "URL": "http://www.hmdb.ca/metabolites/HMDB0014951",
        "LicenseNote": "\u0009HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.",
        "LicenseURL": "http://www.hmdb.ca/citing",
        "ANID": 2151395
      },
      {
        "ReferenceNumber": 99,
        "SourceName": "New Zealand Environmental Protection Authority (EPA)",
        "SourceID": "a979263221b7d6736b432e6a399dba26",
        "Name": "Fentanyl",
        "Description": "The New Zealand Environmental Protection Authority is a government agency for regulating activities that affect Aotearoa New Zealand's environment.",
        "URL": "https://www.epa.govt.nz/industry-areas/hazardous-substances/guidance-for-importers-and-manufacturers/hazardous-substances-databases/",
        "LicenseNote": "This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.",
        "LicenseURL": "https://www.epa.govt.nz/about-this-site/general-copyright-statement/",
        "ANID": 37152383
      },
      {
        "ReferenceNumber": 2,
        "SourceName": "CCSbase",
        "SourceID": "134140830",
        "Description": "CCSbase curates experimental collision cross section values measured on various ion mobility platforms as a resource for the research community. CCSbase also builds prediction models for comprehensive prediction of collision cross sections for a given molecule.",
        "ANID": 39645834
      },
      {
        "ReferenceNumber": 3,
        "SourceName": "ChEBI",
        "SourceID": "CHEBI:OBO:3345",
        "Name": "Fentanyl",
        "Description": "Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on 'small' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term \"molecular entity\" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.",
        "URL": "https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:119915",
        "ANID": 2448589
      },
      {
        "ReferenceNumber": 14,
        "SourceName": "Drug Enforcement Administration (DEA)",
        "SourceID": "sc-II-9801-462",
        "Name": "Fentanyl",
        "Description": "Drugs and other substances that are considered controlled substances under the Controlled Substances Act (CSA) - Title 21 CFR parts 1308.11 through 1308.15: https://www.ecfr.gov/current/title-21/chapter-II/part-1308/",
        "URL": "https://www.deadiversion.usdoj.gov/schedules/",
        "LicenseNote": "Unless otherwise indicated, information on Department of Justice websites is in the public domain and may be copied and distributed without permission. Citation of the Department of Justice as source of the information is appreciated, as appropriate.",
        "LicenseURL": "https://www.justice.gov/legalpolicies",
        "ANID": 38483864
      },
      {
        "ReferenceNumber": 57,
        "SourceName": "FDA Pharm Classes",
        "SourceID": "UF599785JZ",
        "Name": "FENTANYL",
        "Description": "FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class",
        "URL": "https://dailymed.nlm.nih.gov/dailymed/browse-drug-classes.cfm",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 6490181
      },
      {
        "ReferenceNumber": 98,
        "SourceName": "NCI Thesaurus (NCIt)",
        "SourceID": "C494::Compound",
        "Description": "NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.",
        "URL": "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C494",
        "LicenseNote": "Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.",
        "LicenseURL": "https://www.cancer.gov/policies/copyright-reuse",
        "ANID": 14396409
      },
      {
        "ReferenceNumber": 113,
        "SourceName": "Open Targets",
        "SourceID": "Compound::CHEMBL596",
        "Name": "FENTANYL",
        "Description": "The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.",
        "URL": "https://platform.opentargets.org/drug/CHEMBL596",
        "LicenseNote": "Datasets generated by the Open Targets Platform are freely available for download.",
        "LicenseURL": "https://platform-docs.opentargets.org/licence",
        "ANID": 45242189
      },
      {
        "ReferenceNumber": 128,
        "SourceName": "Toxin and Toxin Target Database (T3DB)",
        "SourceID": "Compound::T3D2898",
        "Name": "Fentanyl",
        "Description": "The Toxin and Toxin Target Database (T3DB), or, soon to be referred as, the Toxic Exposome Database, is a unique bioinformatics resource that combines detailed toxin data with comprehensive toxin target information.",
        "URL": "http://www.t3db.ca/toxins/T3D2898",
        "LicenseNote": "T3DB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (T3DB) and the original publication.",
        "LicenseURL": "http://www.t3db.ca/downloads",
        "ANID": 20442735
      },
      {
        "ReferenceNumber": 4,
        "SourceName": "ChEMBL",
        "SourceID": "Compound::CHEMBL596",
        "Description": "ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.",
        "URL": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL596/",
        "LicenseNote": "Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).",
        "LicenseURL": "http://www.ebi.ac.uk/Information/termsofuse.html",
        "ANID": 31314321
      },
      {
        "ReferenceNumber": 9,
        "SourceName": "Comparative Toxicogenomics Database (CTD)",
        "SourceID": "D005283::Compound",
        "Name": "Fentanyl",
        "Description": "CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.",
        "URL": "https://ctdbase.org/detail.go?type=chem&acc=D005283",
        "LicenseNote": "It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.",
        "LicenseURL": "http://ctdbase.org/about/legal.jsp",
        "ANID": 9023897
      },
      {
        "ReferenceNumber": 67,
        "SourceName": "IUPHAR/BPS Guide to PHARMACOLOGY",
        "SourceID": "1626::Compound",
        "Name": "fentanyl",
        "Description": "The IUPHAR database contains quantitative information on drug targets and the prescription medicines and experimental drugs that act on them.\u000AAll entries in BioAssay data are marked as active as our curation SOP means we only extract data from the literature for relatively potent compounds.",
        "URL": "https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1626",
        "LicenseNote": "The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)",
        "LicenseURL": "https://www.guidetopharmacology.org/about.jsp#license",
        "ANID": 19626939
      },
      {
        "ReferenceNumber": 126,
        "SourceName": "Therapeutic Target Database (TTD)",
        "SourceID": "D0E1WI",
        "Name": "Fentanyl",
        "Description": "Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.",
        "URL": "https://idrblab.net/ttd/data/drug/details/D0E1WI",
        "ANID": 19774802
      },
      {
        "ReferenceNumber": 5,
        "SourceName": "ChEMBL",
        "SourceID": "Compound::3345",
        "Description": "ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.",
        "LicenseNote": "Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).",
        "LicenseURL": "http://www.ebi.ac.uk/Information/termsofuse.html",
        "ANID": 33563514
      },
      {
        "ReferenceNumber": 7,
        "SourceName": "ChemIDplus",
        "SourceID": "r_134974500",
        "Description": "The toxicity data was from the legacy RTECS data set in ChemIDplus.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000437387",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html",
        "IsToxnet": true,
        "ANID": 19465811
      },
      {
        "ReferenceNumber": 8,
        "SourceName": "ClinicalTrials.gov",
        "SourceID": "cid3345",
        "Description": "ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.",
        "URL": "https://clinicaltrials.gov/",
        "LicenseNote": "The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.",
        "LicenseURL": "https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use",
        "ANID": 5186580
      },
      {
        "ReferenceNumber": 10,
        "SourceName": "Crystallography Open Database (COD)",
        "SourceID": "1551786",
        "Description": "The Crystallography Open Database is an open-access collection of crystal structures of organic, inorganic, metal-organic compounds, and minerals, excluding biopolymers.",
        "URL": "https://www.crystallography.net/cod/1551786.html",
        "LicenseNote": "All data in the COD and the database itself are dedicated to the public domain and licensed under the CC0 License. Users of the data should acknowledge the original authors of the structural data.",
        "LicenseURL": "https://creativecommons.org/publicdomain/zero/1.0/",
        "ANID": 30594906
      },
      {
        "ReferenceNumber": 124,
        "SourceName": "The Cambridge Structural Database",
        "SourceID": "CCDC 716913",
        "Description": "The Cambridge Structural Database provides access to 3D structures of molecules determined experimentally using diffraction techniques.",
        "URL": "https://www.ccdc.cam.ac.uk/structures/Search?Ccdcid=716913",
        "ANID": 3364305
      },
      {
        "ReferenceNumber": 11,
        "SourceName": "DailyMed",
        "SourceID": "882387afebd5bdeeeec447d44868a238",
        "Name": "FENTANYL",
        "Description": "The U.S. National Library of Medicine's DailyMed provides trustworthy information about marketed drugs. DailyMed is the official provider of FDA label information (package inserts).",
        "URL": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=FENTANYL",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html",
        "ANID": 30954702
      },
      {
        "ReferenceNumber": 12,
        "SourceName": "Drug Enforcement Administration (DEA)",
        "SourceID": "dc-39-Fentanyl",
        "Name": "Fentanyl",
        "Description": "The U.S. Drug Enforcement Administration (DEA) enforces the controlled substances laws and regulations of the United States and brings to the criminal and civil justice system of the United States, or any other competent jurisdiction, those organizations and principal members of organizations, involved in the growing, manufacture, or distribution of controlled substances appearing in or destined for illicit traffic in the United States; and to recommend and support non-enforcement programs aimed at reducing the availability of illicit controlled substances on the domestic and international markets.",
        "URL": "https://www.deadiversion.usdoj.gov/drug_chem_info/",
        "LicenseNote": "Unless otherwise indicated, information on Department of Justice websites is in the public domain and may be copied and distributed without permission. Citation of the Department of Justice as source of the information is appreciated, as appropriate.",
        "LicenseURL": "https://www.justice.gov/legalpolicies",
        "ANID": 37126834
      },
      {
        "ReferenceNumber": 13,
        "SourceName": "Drug Enforcement Administration (DEA)",
        "SourceID": "dea-82-Fentanyl",
        "Name": "Fentanyl",
        "Description": "The U.S. Drug Enforcement Administration (DEA) enforces the controlled substances laws and regulations of the United States and brings to the criminal and civil justice system of the United States, or any other competent jurisdiction, those organizations and principal members of organizations, involved in the growing, manufacture, or distribution of controlled substances appearing in or destined for illicit traffic in the United States; and to recommend and support non-enforcement programs aimed at reducing the availability of illicit controlled substances on the domestic and international markets.",
        "URL": "https://www.dea.gov/factsheets/fentanyl",
        "LicenseNote": "Unless otherwise indicated, information on Department of Justice websites is in the public domain and may be copied and distributed without permission. Citation of the Department of Justice as source of the information is appreciated, as appropriate.",
        "LicenseURL": "https://www.justice.gov/legalpolicies",
        "ANID": 38483508
      },
      {
        "ReferenceNumber": 96,
        "SourceName": "National Drug Code (NDC) Directory",
        "SourceID": "7b5d6853ed26e358104671fdac4979aa",
        "Name": "FENTANYL",
        "Description": "The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA.",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 31086975
      },
      {
        "ReferenceNumber": 97,
        "SourceName": "National Drug Code (NDC) Directory",
        "SourceID": "0e5de2dca453133d3109048235a9d18c",
        "Name": "FENTANYL TRANSDERMAL",
        "Description": "The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA.",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 31086977
      },
      {
        "ReferenceNumber": 41,
        "SourceName": "European Medicines Agency (EMA)",
        "SourceID": "196c0d1cbc9313d07b93a3aeafb82cfb",
        "Name": "Effentora (EMEA/H/C/000833)",
        "Description": "The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.",
        "URL": "https://www.ema.europa.eu/en/medicines/human/EPAR/effentora",
        "LicenseNote": "Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.",
        "LicenseURL": "https://www.ema.europa.eu/en/about-us/legal-notice",
        "ANID": 37128480
      },
      {
        "ReferenceNumber": 42,
        "SourceName": "European Medicines Agency (EMA)",
        "SourceID": "303bbc6292a256b9e965e298fc065f9c",
        "Name": "PecFent (EMEA/H/C/001164)",
        "Description": "The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.",
        "URL": "https://www.ema.europa.eu/en/medicines/human/EPAR/pecfent",
        "LicenseNote": "Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.",
        "LicenseURL": "https://www.ema.europa.eu/en/about-us/legal-notice",
        "ANID": 37128488
      },
      {
        "ReferenceNumber": 43,
        "SourceName": "European Medicines Agency (EMA)",
        "SourceID": "2a6fa7130668653e287e71177a0c2291",
        "Name": "Ionsys (EMEA/H/C/002715)",
        "Description": "The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.",
        "URL": "https://www.ema.europa.eu/en/medicines/human/EPAR/ionsys",
        "LicenseNote": "Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.",
        "LicenseURL": "https://www.ema.europa.eu/en/about-us/legal-notice",
        "ANID": 37129125
      },
      {
        "ReferenceNumber": 44,
        "SourceName": "European Medicines Agency (EMA)",
        "SourceID": "073e78c7c394525984c22c497e9f1f38",
        "Name": "Recuvyra (EMEA/V/C/002239)",
        "Description": "The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.",
        "URL": "https://www.ema.europa.eu/en/medicines/veterinary/EPAR/recuvyra",
        "LicenseNote": "Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.",
        "LicenseURL": "https://www.ema.europa.eu/en/about-us/legal-notice",
        "ANID": 37129180
      },
      {
        "ReferenceNumber": 45,
        "SourceName": "European Medicines Agency (EMA)",
        "SourceID": "9cbd8ab331e1e609e76e8aef3ba8fd1e",
        "Name": "Ionsys (EMEA/H/C/000612)",
        "Description": "The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.",
        "URL": "https://www.ema.europa.eu/en/medicines/human/EPAR/ionsys-0",
        "LicenseNote": "Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.",
        "LicenseURL": "https://www.ema.europa.eu/en/about-us/legal-notice",
        "ANID": 37129333
      },
      {
        "ReferenceNumber": 111,
        "SourceName": "NORMAN Suspect List Exchange",
        "SourceID": "nrm_3345",
        "Name": "FENTANYL",
        "Description": "The NORMAN network enhances the exchange of information on emerging environmental substances, and encourages the validation and harmonisation of common measurement methods and monitoring tools so that the requirements of risk assessors and risk managers can be better met. The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point to find suspect lists relevant for various environmental monitoring questions, described in DOI:10.1186/s12302-022-00680-6",
        "LicenseNote": "Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0",
        "LicenseURL": "https://creativecommons.org/licenses/by/4.0/",
        "ANID": 9031411
      },
      {
        "ReferenceNumber": 16,
        "SourceName": "Drugs and Lactation Database (LactMed)",
        "SourceID": "LM356",
        "Name": "Fentanyl",
        "Description": "The LactMed(R) database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. https://www.ncbi.nlm.nih.gov/books/NBK501922/",
        "URL": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM356/",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html",
        "ANID": 24796873
      },
      {
        "ReferenceNumber": 94,
        "SourceName": "Mother To Baby Fact Sheets",
        "SourceID": "fentanyl",
        "Name": "fentanyl",
        "Description": "The MotherToBaby Fact Sheets answer frequently asked questions about many common exposures during pregnancy and breastfeeding, including medications, recreational substances, cosmetic treatments, health conditions, infections, vaccines, and more.",
        "URL": "https://www.ncbi.nlm.nih.gov/books/n/mtb/fentanyl-en/",
        "LicenseNote": "Copyright by OTIS. This work is available under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported license (CC BY-NC-ND 3.0).",
        "LicenseURL": "https://www.ncbi.nlm.nih.gov/books/about/copyright/",
        "ANID": 30371845
      },
      {
        "ReferenceNumber": 18,
        "SourceName": "Drugs@FDA",
        "SourceID": "cacfd808edd2208abb7d8c4743b08a11",
        "Name": "FENTANYL-62",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38971659
      },
      {
        "ReferenceNumber": 19,
        "SourceName": "Drugs@FDA",
        "SourceID": "85e01f8a70fe7c8fc3e57c4a06addd47",
        "Name": "SUBSYS",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38971869
      },
      {
        "ReferenceNumber": 20,
        "SourceName": "Drugs@FDA",
        "SourceID": "8eae745e3c31a91e6e8f6b7780b64226",
        "Name": "FENTANYL-75",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38972157
      },
      {
        "ReferenceNumber": 21,
        "SourceName": "Drugs@FDA",
        "SourceID": "6d534ece34223ed218c18dd8b55049f3",
        "Name": "DURAGESIC-50",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38972780
      },
      {
        "ReferenceNumber": 22,
        "SourceName": "Drugs@FDA",
        "SourceID": "ed460b1f9567fee6365e18fc679ad8e4",
        "Name": "DURAGESIC-37",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38973429
      },
      {
        "ReferenceNumber": 23,
        "SourceName": "Drugs@FDA",
        "SourceID": "6cc82cd580147efbd7737b5ad80ac1f9",
        "Name": "FENTANYL",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38973764
      },
      {
        "ReferenceNumber": 24,
        "SourceName": "Drugs@FDA",
        "SourceID": "ca3818913aa230f4fe3e4a15b5f5590e",
        "Name": "FENTANYL-87",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38974468
      },
      {
        "ReferenceNumber": 25,
        "SourceName": "Drugs@FDA",
        "SourceID": "5c26f96689ed5cd24a35cbf8ae58a561",
        "Name": "FENTORA",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38974593
      },
      {
        "ReferenceNumber": 26,
        "SourceName": "Drugs@FDA",
        "SourceID": "725befa5706337b2bb7306ad94f2eca1",
        "Name": "FENTANYL-37",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38974744
      },
      {
        "ReferenceNumber": 27,
        "SourceName": "Drugs@FDA",
        "SourceID": "b1387df076be7ce1d0fcfda9111835ea",
        "Name": "FENTANYL-50",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38975097
      },
      {
        "ReferenceNumber": 28,
        "SourceName": "Drugs@FDA",
        "SourceID": "c4a5f157ea24025b4ec692c8c44048af",
        "Name": "IONSYS",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38976004
      },
      {
        "ReferenceNumber": 29,
        "SourceName": "Drugs@FDA",
        "SourceID": "19434df6100ddcc5f576f7b0c7006672",
        "Name": "FENTANYL-100",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38977425
      },
      {
        "ReferenceNumber": 30,
        "SourceName": "Drugs@FDA",
        "SourceID": "82cf73abb8fea09cea414d1d165a8e64",
        "Name": "DURAGESIC-25",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38977995
      },
      {
        "ReferenceNumber": 31,
        "SourceName": "Drugs@FDA",
        "SourceID": "f640a889455d66013e30ec339a98717a",
        "Name": "DURAGESIC-100",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38978705
      },
      {
        "ReferenceNumber": 32,
        "SourceName": "Drugs@FDA",
        "SourceID": "aaf565ecfbc5b08ea0d0ae9ec50a22c2",
        "Name": "DURAGESIC-12",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38978832
      },
      {
        "ReferenceNumber": 33,
        "SourceName": "Drugs@FDA",
        "SourceID": "4a7470b8dce7661ed9c14bbf84d99440",
        "Name": "FENTANYL-25",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38979242
      },
      {
        "ReferenceNumber": 34,
        "SourceName": "Drugs@FDA",
        "SourceID": "0d366c17118268b821309e16e4f5ad75",
        "Name": "DURAGESIC-75",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38979405
      },
      {
        "ReferenceNumber": 35,
        "SourceName": "Drugs@FDA",
        "SourceID": "250b25f37c9b432464b67c467b034ac7",
        "Name": "FENTANYL-12",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38979430
      },
      {
        "ReferenceNumber": 131,
        "SourceName": "WHO Model Lists of Essential Medicines",
        "SourceID": "17",
        "Name": "Fentanyl",
        "Description": "The WHO Model Lists of Essential Medicines contains the medications considered to be most effective and safe to meet the most important needs in a health system. It has been updated every two years since 1977.",
        "URL": "https://list.essentialmeds.org/medicines/17",
        "LicenseNote": "Permission from WHO is not required for the use of WHO materials issued under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Intergovernmental Organization (CC BY-NC-SA 3.0 IGO) license.",
        "LicenseURL": "https://www.who.int/about/policies/publishing/copyright",
        "ANID": 13127877
      },
      {
        "ReferenceNumber": 17,
        "SourceName": "Drugs@FDA",
        "SourceID": "882387afebd5bdeeeec447d44868a238",
        "Name": "FENTANYL",
        "Description": "Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.",
        "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38967193
      },
      {
        "ReferenceNumber": 36,
        "SourceName": "EPA Chemical and Products Database (CPDat)",
        "SourceID": "27270_DTXSID9023049",
        "Name": "",
        "Description": "The US EPA Chemical and Products Database (CPDat) is a database containing information mapping more than 49,000 chemicals to a set of terms categorizing their usage or function in 16,000 consumer products (e.g. shampoo, soap) types based on what chemicals they contain.",
        "URL": "https://comptox.epa.gov/dashboard/DTXSID9023049#exposure",
        "LicenseURL": "https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources",
        "ANID": 13740279
      },
      {
        "ReferenceNumber": 112,
        "SourceName": "NORMAN Suspect List Exchange",
        "SourceID": "bce9332c3c5c68a63f565c37e31ee1e2",
        "Name": "FENTANYL",
        "Description": "The NORMAN network enhances the exchange of information on emerging environmental substances, and encourages the validation and harmonisation of common measurement methods and monitoring tools so that the requirements of risk assessors and risk managers can be better met. The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point to find suspect lists relevant for various environmental monitoring questions, described in DOI:10.1186/s12302-022-00680-6",
        "LicenseNote": "Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0",
        "LicenseURL": "https://creativecommons.org/licenses/by/4.0/",
        "ANID": 45730668
      },
      {
        "ReferenceNumber": 125,
        "SourceName": "The National Institute for Occupational Safety and Health (NIOSH)",
        "SourceID": "29750022",
        "Name": "FENTANYL",
        "Description": "The Emergency Response Safety and Health Database (ERSH-DB) is a rapidly accessible occupational safety and health database developed by NIOSH for the emergency response community. https://www.cdc.gov/niosh/ershdb/",
        "URL": "https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750022.html",
        "LicenseNote": "The information provided using CDC Web site is only intended to be general summary information to the public. It is not intended to take the place of either the written law or regulations.",
        "LicenseURL": "https://www.cdc.gov/Other/disclaimer.html",
        "ANID": 2266990
      },
      {
        "ReferenceNumber": 38,
        "SourceName": "EU Clinical Trials Register",
        "SourceID": "cid3345",
        "Description": "The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.",
        "URL": "https://www.clinicaltrialsregister.eu/",
        "ANID": 6479148
      },
      {
        "ReferenceNumber": 39,
        "SourceName": "European Chemicals Agency (ECHA)",
        "SourceID": "101706",
        "Name": "Fentanyl (EC: 207-113-6)",
        "Description": "The information provided here is aggregated from the \"Notified classification and labelling\" from ECHA's C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database",
        "URL": "https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/101706",
        "LicenseNote": "Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.",
        "LicenseURL": "https://echa.europa.eu/web/guest/legal-notice",
        "ANID": 1881011
      },
      {
        "ReferenceNumber": 46,
        "SourceName": "FDA Approved Animal Drug Products (Green Book)",
        "SourceID": "act_Fentanyl",
        "Name": "Fentanyl",
        "Description": "Animal drug and active ingredient information from the FDA Green Book.",
        "URL": "https://www.fda.gov/animal-veterinary/products/approved-animal-drug-products-green-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38979614
      },
      {
        "ReferenceNumber": 56,
        "SourceName": "FDA Orange Book",
        "SourceID": "2bd57c8defcde6e1ef7c380509282e09",
        "Name": "FENTANYL",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 35235406
      },
      {
        "ReferenceNumber": 129,
        "SourceName": "WHO Anatomical Therapeutic Chemical (ATC) Classification",
        "SourceID": "N01AH01",
        "Name": "Fentanyl",
        "Description": "The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.",
        "URL": "https://www.whocc.no/atc_ddd_index/?code=N01AH01",
        "LicenseNote": "Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.",
        "LicenseURL": "https://www.whocc.no/copyright_disclaimer/",
        "ANID": 24381425
      },
      {
        "ReferenceNumber": 130,
        "SourceName": "WHO Anatomical Therapeutic Chemical (ATC) Classification",
        "SourceID": "N02AB03",
        "Name": "Fentanyl",
        "Description": "The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.",
        "URL": "https://www.whocc.no/atc_ddd_index/?code=N02AB03",
        "LicenseNote": "Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.",
        "LicenseURL": "https://www.whocc.no/copyright_disclaimer/",
        "ANID": 24384807
      },
      {
        "ReferenceNumber": 47,
        "SourceName": "FDA Approved Animal Drug Products (Green Book)",
        "SourceID": "tbl_Fentanyl",
        "Name": "Fentanyl",
        "Description": "Animal drug and active ingredient information from the FDA Green Book.",
        "URL": "https://www.fda.gov/animal-veterinary/products/approved-animal-drug-products-green-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 38980670
      },
      {
        "ReferenceNumber": 49,
        "SourceName": "FDA Medication Guides",
        "SourceID": "DURAGESIC-100",
        "Name": "DURAGESIC-100",
        "Description": "FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide",
        "URL": "https://dps.fda.gov/medguide",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 45228333
      },
      {
        "ReferenceNumber": 50,
        "SourceName": "FDA Medication Guides",
        "SourceID": "DURAGESIC-12",
        "Name": "DURAGESIC-12",
        "Description": "FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide",
        "URL": "https://dps.fda.gov/medguide",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 45228334
      },
      {
        "ReferenceNumber": 51,
        "SourceName": "FDA Medication Guides",
        "SourceID": "DURAGESIC-25",
        "Name": "DURAGESIC-25",
        "Description": "FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide",
        "URL": "https://dps.fda.gov/medguide",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 45228335
      },
      {
        "ReferenceNumber": 52,
        "SourceName": "FDA Medication Guides",
        "SourceID": "DURAGESIC-37",
        "Name": "DURAGESIC-37",
        "Description": "FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide",
        "URL": "https://dps.fda.gov/medguide",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 45228336
      },
      {
        "ReferenceNumber": 53,
        "SourceName": "FDA Medication Guides",
        "SourceID": "DURAGESIC-50",
        "Name": "DURAGESIC-50",
        "Description": "FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide",
        "URL": "https://dps.fda.gov/medguide",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 45228337
      },
      {
        "ReferenceNumber": 54,
        "SourceName": "FDA Medication Guides",
        "SourceID": "DURAGESIC-75",
        "Name": "DURAGESIC-75",
        "Description": "FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide",
        "URL": "https://dps.fda.gov/medguide",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 45228338
      },
      {
        "ReferenceNumber": 55,
        "SourceName": "FDA Medication Guides",
        "SourceID": "SUBSYS",
        "Name": "SUBSYS",
        "Description": "FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide",
        "URL": "https://dps.fda.gov/medguide",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 45228759
      },
      {
        "ReferenceNumber": 58,
        "SourceName": "Haz-Map, Information on Hazardous Chemicals and Occupational Diseases",
        "SourceID": "hz22003",
        "Name": "Fentanyl",
        "Description": "Haz-Map® is an occupational health database designed for health and safety professionals and for consumers seeking information about the adverse effects of workplace exposures to chemical and biological agents.",
        "URL": "https://haz-map.com/Agents/22003",
        "LicenseNote": "Copyright (c) 2022 Haz-Map(R). All rights reserved.\u000AUnless otherwise indicated, all materials from Haz-Map are copyrighted by Haz-Map(R). No part of these materials, either text or image may be used for any purpose other than for personal use. Therefore, reproduction, modification, storage in a retrieval system or retransmission, in any form or by any means, electronic, mechanical or otherwise, for reasons other than personal use, is strictly prohibited without prior written permission.",
        "LicenseURL": "https://haz-map.com/About",
        "ANID": 39667603
      },
      {
        "ReferenceNumber": 61,
        "SourceName": "Human Metabolome Database (HMDB)",
        "SourceID": "HMDB0014951_msms_2226737",
        "Name": "HMDB0014951_msms_2226737",
        "Description": "The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.",
        "URL": "https://hmdb.ca/metabolites/HMDB0014951#spectra",
        "LicenseNote": "\u0009HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.",
        "LicenseURL": "http://www.hmdb.ca/citing",
        "ANID": 19277615
      },
      {
        "ReferenceNumber": 62,
        "SourceName": "Human Metabolome Database (HMDB)",
        "SourceID": "HMDB0014951_msms_2228007",
        "Name": "HMDB0014951_msms_2228007",
        "Description": "The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.",
        "URL": "https://hmdb.ca/metabolites/HMDB0014951#spectra",
        "LicenseNote": "\u0009HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.",
        "LicenseURL": "http://www.hmdb.ca/citing",
        "ANID": 19277616
      },
      {
        "ReferenceNumber": 63,
        "SourceName": "Human Metabolome Database (HMDB)",
        "SourceID": "HMDB0014951_msms_2229058",
        "Name": "HMDB0014951_msms_2229058",
        "Description": "The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.",
        "URL": "https://hmdb.ca/metabolites/HMDB0014951#spectra",
        "LicenseNote": "\u0009HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.",
        "LicenseURL": "http://www.hmdb.ca/citing",
        "ANID": 19277617
      },
      {
        "ReferenceNumber": 64,
        "SourceName": "Human Metabolome Database (HMDB)",
        "SourceID": "HMDB0014951_msms_2230377",
        "Name": "HMDB0014951_msms_2230377",
        "Description": "The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.",
        "URL": "https://hmdb.ca/metabolites/HMDB0014951#spectra",
        "LicenseNote": "\u0009HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.",
        "LicenseURL": "http://www.hmdb.ca/citing",
        "ANID": 19277618
      },
      {
        "ReferenceNumber": 65,
        "SourceName": "Human Metabolome Database (HMDB)",
        "SourceID": "HMDB0014951_msms_2231385",
        "Name": "HMDB0014951_msms_2231385",
        "Description": "The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.",
        "URL": "https://hmdb.ca/metabolites/HMDB0014951#spectra",
        "LicenseNote": "\u0009HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.",
        "LicenseURL": "http://www.hmdb.ca/citing",
        "ANID": 19277619
      },
      {
        "ReferenceNumber": 66,
        "SourceName": "Human Metabolome Database (HMDB)",
        "SourceID": "HMDB0014951_msms_2231893",
        "Name": "HMDB0014951_msms_2231893",
        "Description": "The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.",
        "URL": "https://hmdb.ca/metabolites/HMDB0014951#spectra",
        "LicenseNote": "\u0009HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.",
        "LicenseURL": "http://www.hmdb.ca/citing",
        "ANID": 19277620
      },
      {
        "ReferenceNumber": 107,
        "SourceName": "NIST Mass Spectrometry Data Center",
        "SourceID": "MS-MS #1 for PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "Name": "Fentanyl",
        "Description": "The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.",
        "URL": "http://www.nist.gov/srd/nist1a.cfm",
        "LicenseNote": "Data covered by the Standard Reference Data Act of 1968 as amended.",
        "LicenseURL": "https://www.nist.gov/srd/public-law",
        "ANID": 283026
      },
      {
        "ReferenceNumber": 108,
        "SourceName": "NIST Mass Spectrometry Data Center",
        "SourceID": "MS-MS #2 for PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "Name": "Fentanyl",
        "Description": "The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.",
        "URL": "http://www.nist.gov/srd/nist1a.cfm",
        "LicenseNote": "Data covered by the Standard Reference Data Act of 1968 as amended.",
        "LicenseURL": "https://www.nist.gov/srd/public-law",
        "ANID": 285711
      },
      {
        "ReferenceNumber": 68,
        "SourceName": "Japan Chemical Substance Dictionary (Nikkaji)",
        "SourceID": "J5.736C",
        "Description": "The Japan Chemical Substance Dictionary (Nikkaji) has a search system that helps obtain knowledge from dissimilar fields and discover concepts that cross boundaries of specializations.",
        "URL": "http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J5.736C",
        "ANID": 21970426
      },
      {
        "ReferenceNumber": 69,
        "SourceName": "KEGG",
        "SourceID": "D00320",
        "Description": "KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.",
        "URL": "https://www.kegg.jp/entry/D00320",
        "LicenseNote": "Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license",
        "LicenseURL": "https://www.kegg.jp/kegg/legal.html",
        "ANID": 31109379
      },
      {
        "ReferenceNumber": 70,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_1",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13616693
      },
      {
        "ReferenceNumber": 71,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_2",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13616694
      },
      {
        "ReferenceNumber": 72,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_3",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13616695
      },
      {
        "ReferenceNumber": 73,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_4",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13616696
      },
      {
        "ReferenceNumber": 74,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_5",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13616697
      },
      {
        "ReferenceNumber": 75,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_6",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13636560
      },
      {
        "ReferenceNumber": 76,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_7",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13636561
      },
      {
        "ReferenceNumber": 77,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_8",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13636562
      },
      {
        "ReferenceNumber": 78,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_9",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13636563
      },
      {
        "ReferenceNumber": 79,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_10",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13636564
      },
      {
        "ReferenceNumber": 80,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_11",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13636565
      },
      {
        "ReferenceNumber": 81,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_12",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13636566
      },
      {
        "ReferenceNumber": 82,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_13",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13636567
      },
      {
        "ReferenceNumber": 83,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_14",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13636568
      },
      {
        "ReferenceNumber": 84,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_15",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13698627
      },
      {
        "ReferenceNumber": 85,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_16",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13698628
      },
      {
        "ReferenceNumber": 86,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_17",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13698629
      },
      {
        "ReferenceNumber": 87,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_18",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13698630
      },
      {
        "ReferenceNumber": 88,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_19",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13698631
      },
      {
        "ReferenceNumber": 89,
        "SourceName": "MassBank Europe",
        "SourceID": "PJMPHNIQZUBGLI-UHFFFAOYSA-N_20",
        "Name": "Fentanyl",
        "Description": "MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.",
        "URL": "https://massbank.eu/MassBank/Result.jsp?inchikey=PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "LicenseURL": "https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt",
        "ANID": 13698632
      },
      {
        "ReferenceNumber": 90,
        "SourceName": "MassBank of North America (MoNA)",
        "SourceID": "WA001020",
        "Name": "Fentanyl",
        "Description": "MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.",
        "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27PJMPHNIQZUBGLI-UHFFFAOYSA-N%27)",
        "LicenseNote": "The content of the MoNA database is licensed under CC BY 4.0.",
        "LicenseURL": "https://mona.fiehnlab.ucdavis.edu/documentation/license",
        "ANID": 24802827
      },
      {
        "ReferenceNumber": 91,
        "SourceName": "MassBank of North America (MoNA)",
        "SourceID": "WA001019",
        "Name": "Fentanyl",
        "Description": "MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.",
        "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27PJMPHNIQZUBGLI-UHFFFAOYSA-N%27)",
        "LicenseNote": "The content of the MoNA database is licensed under CC BY 4.0.",
        "LicenseURL": "https://mona.fiehnlab.ucdavis.edu/documentation/license",
        "ANID": 24802828
      },
      {
        "ReferenceNumber": 92,
        "SourceName": "MassBank of North America (MoNA)",
        "SourceID": "WA001018",
        "Name": "Fentanyl",
        "Description": "MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.",
        "URL": "https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27PJMPHNIQZUBGLI-UHFFFAOYSA-N%27)",
        "LicenseNote": "The content of the MoNA database is licensed under CC BY 4.0.",
        "LicenseURL": "https://mona.fiehnlab.ucdavis.edu/documentation/license",
        "ANID": 24802829
      },
      {
        "ReferenceNumber": 93,
        "SourceName": "Metabolomics Workbench",
        "SourceID": "43104",
        "Name": "Fentanyl",
        "Description": "The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.",
        "URL": "https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=43104",
        "ANID": 20204496
      },
      {
        "ReferenceNumber": 95,
        "SourceName": "National Drug Code (NDC) Directory",
        "SourceID": "97f06aa8c7cea036a45194fe8a607c1f",
        "Name": "FENTANYL",
        "Description": "The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA.",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 31067196
      },
      {
        "ReferenceNumber": 100,
        "SourceName": "NIPH Clinical Trials Search of Japan",
        "SourceID": "cid3345",
        "Description": "NIPH Clinical Trials Search of Japan allows one to search clinical research (trials) from the registries of three institutions; the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials.",
        "URL": "https://rctportal.niph.go.jp/en/",
        "ANID": 6486741
      },
      {
        "ReferenceNumber": 101,
        "SourceName": "NIST Mass Spectrometry Data Center",
        "SourceID": "GC-MS #1 for PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "Name": "Fentanyl",
        "Description": "The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.",
        "URL": "http://www.nist.gov/srd/nist1a.cfm",
        "LicenseNote": "Data covered by the Standard Reference Data Act of 1968 as amended.",
        "LicenseURL": "https://www.nist.gov/srd/public-law",
        "ANID": 213033
      },
      {
        "ReferenceNumber": 102,
        "SourceName": "NIST Mass Spectrometry Data Center",
        "SourceID": "GC-MS #2 for PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "Name": "Fentanyl",
        "Description": "The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.",
        "URL": "http://www.nist.gov/srd/nist1a.cfm",
        "LicenseNote": "Data covered by the Standard Reference Data Act of 1968 as amended.",
        "LicenseURL": "https://www.nist.gov/srd/public-law",
        "ANID": 270737
      },
      {
        "ReferenceNumber": 103,
        "SourceName": "NIST Mass Spectrometry Data Center",
        "SourceID": "GC-MS #3 for PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "Name": "Fentanyl",
        "Description": "The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.",
        "URL": "http://www.nist.gov/srd/nist1a.cfm",
        "LicenseNote": "Data covered by the Standard Reference Data Act of 1968 as amended.",
        "LicenseURL": "https://www.nist.gov/srd/public-law",
        "ANID": 278638
      },
      {
        "ReferenceNumber": 104,
        "SourceName": "NIST Mass Spectrometry Data Center",
        "SourceID": "GC-MS #4 for PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "Name": "Fentanyl",
        "Description": "The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.",
        "URL": "http://www.nist.gov/srd/nist1a.cfm",
        "LicenseNote": "Data covered by the Standard Reference Data Act of 1968 as amended.",
        "LicenseURL": "https://www.nist.gov/srd/public-law",
        "ANID": 278639
      },
      {
        "ReferenceNumber": 105,
        "SourceName": "NIST Mass Spectrometry Data Center",
        "SourceID": "GC-MS #5 for PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "Name": "Fentanyl",
        "Description": "The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.",
        "URL": "http://www.nist.gov/srd/nist1a.cfm",
        "LicenseNote": "Data covered by the Standard Reference Data Act of 1968 as amended.",
        "LicenseURL": "https://www.nist.gov/srd/public-law",
        "ANID": 278640
      },
      {
        "ReferenceNumber": 106,
        "SourceName": "NIST Mass Spectrometry Data Center",
        "SourceID": "GC-MS #6 for PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "Name": "Fentanyl",
        "Description": "The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.",
        "URL": "http://www.nist.gov/srd/nist1a.cfm",
        "LicenseNote": "Data covered by the Standard Reference Data Act of 1968 as amended.",
        "LicenseURL": "https://www.nist.gov/srd/public-law",
        "ANID": 278641
      },
      {
        "ReferenceNumber": 119,
        "SourceName": "SpectraBase",
        "SourceID": "BRMfiqjdWaw",
        "Name": "Fentanyl",
        "Description": "Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.",
        "URL": "https://spectrabase.com/spectrum/BRMfiqjdWaw",
        "ANID": 4543560
      },
      {
        "ReferenceNumber": 120,
        "SourceName": "SpectraBase",
        "SourceID": "EeDI7sVdVTF",
        "Name": "Fentanyl",
        "Description": "Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.",
        "URL": "https://spectrabase.com/spectrum/EeDI7sVdVTF",
        "ANID": 4543561
      },
      {
        "ReferenceNumber": 109,
        "SourceName": "NIST Mass Spectrometry Data Center",
        "SourceID": "RI for PJMPHNIQZUBGLI-UHFFFAOYSA-N",
        "Name": "Fentanyl",
        "Description": "The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.",
        "URL": "http://www.nist.gov/srd/nist1a.cfm",
        "LicenseNote": "Data covered by the Standard Reference Data Act of 1968 as amended.",
        "LicenseURL": "https://www.nist.gov/srd/public-law",
        "ANID": 300695
      },
      {
        "ReferenceNumber": 110,
        "SourceName": "NLM RxNorm Terminology",
        "SourceID": "4337",
        "Name": "fentanyl",
        "Description": "RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.",
        "URL": "https://rxnav.nlm.nih.gov/id/rxnorm/4337",
        "LicenseNote": "The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.",
        "LicenseURL": "https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html",
        "ANID": 15095979
      },
      {
        "ReferenceNumber": 114,
        "SourceName": "PharmGKB",
        "SourceID": "Compound::PA449599",
        "Name": "fentanyl",
        "Description": "The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including clinical guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships",
        "URL": "https://www.pharmgkb.org/chemical/PA449599",
        "LicenseNote": "PharmGKB data are subject to the Creative Commons Attribution-ShareALike 4.0 license (https://creativecommons.org/licenses/by-sa/4.0/).",
        "LicenseURL": "https://www.pharmgkb.org/page/policies",
        "ANID": 39965498
      },
      {
        "ReferenceNumber": 115,
        "SourceName": "Pharos",
        "SourceID": "Compound::4ZQJCPWP7BNN",
        "Name": "fentanyl",
        "Description": "Pharos gives access to a comprehensive, integrated knowledge-base for the Druggable Genome (DG) to illuminate the uncharacterized and/or poorly annotated portion of the DG, focusing on three of the most commonly drug-targeted protein families: G-protein-coupled receptors (GPCRs), Ion channels (ICs) and Kinases. It is the user interface to the Knowledge Management Center (KMC) for the Illuminating the Druggable Genome (IDG) program.",
        "URL": "https://pharos.nih.gov/ligands/4ZQJCPWP7BNN",
        "LicenseNote": "Data accessed from Pharos and TCRD is publicly available from the primary sources listed above. Please respect their individual licenses regarding proper use and redistribution.",
        "LicenseURL": "https://pharos.nih.gov/about",
        "ANID": 24435921
      },
      {
        "ReferenceNumber": 116,
        "SourceName": "Protein Data Bank in Europe (PDBe)",
        "SourceID": "7V7",
        "Description": "The Protein Data Bank in Europe (PDBe) manages the PDB with its wwPDB partners and provides a high-quality, up-to-date and integrated resource of macromolecular structures to support basic and applied research and education across the sciences.",
        "URL": "http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/7V7",
        "ANID": 8206009
      },
      {
        "ReferenceNumber": 118,
        "SourceName": "RCSB Protein Data Bank (RCSB PDB)",
        "SourceID": "3345",
        "Description": "The RCSB Protein Data Bank (PDB) contains crystallographic data defining 3D shapes of proteins, nucleic acids, and complex assemblies that helps students and researchers understand all aspects of biomedicine and agriculture, from protein synthesis to health and disease.",
        "URL": "https://www.rcsb.org/",
        "LicenseNote": "Data files contained in the PDB archive (ftp://ftp.wwpdb.org) are free of all copyright restrictions and made fully and freely available for both non-commercial and commercial use. Users of the data should attribute the original authors of that structural data.",
        "LicenseURL": "https://www.rcsb.org/pages/policies",
        "ANID": 13146263
      },
      {
        "ReferenceNumber": 121,
        "SourceName": "SpectraBase",
        "SourceID": "CCvkKc7ex9K",
        "Name": "Fentanyl  ",
        "Description": "Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.",
        "URL": "https://spectrabase.com/spectrum/CCvkKc7ex9K",
        "ANID": 4543563
      },
      {
        "ReferenceNumber": 122,
        "SourceName": "SpectraBase",
        "SourceID": "9yR04l1s2nm",
        "Name": "N-[1-(2-PHENYLETHYL)-4-PIPERIDYL]-N-PHENYLPROPANAMIDE;FENTANYL-FREE-BASE",
        "Description": "Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.",
        "URL": "https://spectrabase.com/spectrum/9yR04l1s2nm",
        "ANID": 4543564
      },
      {
        "ReferenceNumber": 123,
        "SourceName": "Springer Nature",
        "SourceID": "25056161-8158624",
        "Description": "Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/?source=15745&sourceid=25056161-8158624",
        "ANID": 3848032
      },
      {
        "ReferenceNumber": 127,
        "SourceName": "Thieme Chemistry",
        "SourceID": "25056161-8160693",
        "Description": "Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. \u000A \u000AOur portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/?source=22163&sourceid=25056161-8160693",
        "LicenseNote": "The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.",
        "LicenseURL": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
        "ANID": 5618751
      },
      {
        "ReferenceNumber": 132,
        "SourceName": "Wikidata",
        "SourceID": "Compound::Q407541",
        "Name": "fentanyl",
        "Description": "Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.",
        "URL": "https://www.wikidata.org/wiki/Q407541",
        "LicenseNote": "CCZero",
        "LicenseURL": "https://creativecommons.org/publicdomain/zero/1.0/",
        "ANID": 44341373
      },
      {
        "ReferenceNumber": 133,
        "SourceName": "Wikipedia",
        "SourceID": "fm_910",
        "Name": "fentanyl",
        "Description": "Chemical information link to Wikipedia.",
        "URL": "https://en.wikipedia.org/wiki/Fentanyl",
        "ANID": 24318967
      },
      {
        "ReferenceNumber": 134,
        "SourceName": "Wiley",
        "SourceID": "12455",
        "Description": "Literature references related to scientific contents from Wiley. Read more: https://onlinelibrary.wiley.com/",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/?source=wiley&sourceid=12455",
        "ANID": 8304073
      },
      {
        "ReferenceNumber": 135,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "68005283",
        "Name": "Fentanyl",
        "Description": "MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "https://www.ncbi.nlm.nih.gov/mesh/68005283",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 136,
        "SourceName": "PubChem",
        "SourceID": "PubChem",
        "Description": "Data deposited in or computed by PubChem",
        "URL": "https://pubchem.ncbi.nlm.nih.gov"
      },
      {
        "ReferenceNumber": 137,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "DescTree",
        "Name": "MeSH Tree",
        "Description": "MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "http://www.nlm.nih.gov/mesh/meshhome.html",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 138,
        "SourceName": "ChEBI",
        "SourceID": "OBO",
        "Name": "ChEBI Ontology",
        "Description": "The ChEBI Ontology is a structured classification of the entities contained within ChEBI.",
        "URL": "http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology"
      },
      {
        "ReferenceNumber": 139,
        "SourceName": "KEGG",
        "SourceID": "br08301",
        "Name": "Therapeutic category of drugs in Japan",
        "Description": "KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.",
        "URL": "http://www.genome.jp/kegg-bin/get_htext?br08301.keg",
        "LicenseNote": "Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license",
        "LicenseURL": "https://www.kegg.jp/kegg/legal.html"
      },
      {
        "ReferenceNumber": 140,
        "SourceName": "KEGG",
        "SourceID": "br08302",
        "Name": "USP drug classification",
        "Description": "KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.",
        "URL": "http://www.genome.jp/kegg-bin/get_htext?br08302.keg",
        "LicenseNote": "Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license",
        "LicenseURL": "https://www.kegg.jp/kegg/legal.html"
      },
      {
        "ReferenceNumber": 141,
        "SourceName": "KEGG",
        "SourceID": "br08303",
        "Name": "Anatomical Therapeutic Chemical (ATC) classification",
        "Description": "KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.",
        "URL": "http://www.genome.jp/kegg-bin/get_htext?br08303.keg",
        "LicenseNote": "Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license",
        "LicenseURL": "https://www.kegg.jp/kegg/legal.html"
      },
      {
        "ReferenceNumber": 142,
        "SourceName": "KEGG",
        "SourceID": "br08310",
        "Name": "Target-based classification of drugs",
        "Description": "KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.",
        "URL": "http://www.genome.jp/kegg-bin/get_htext?br08310.keg",
        "LicenseNote": "Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license",
        "LicenseURL": "https://www.kegg.jp/kegg/legal.html"
      },
      {
        "ReferenceNumber": 144,
        "SourceName": "FDA Pharm Classes",
        "SourceID": "FDA_pharm_tree",
        "Name": "FDA Pharmacological Classification",
        "Description": "FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.",
        "URL": "https://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/ucm162549.htm",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking"
      },
      {
        "ReferenceNumber": 145,
        "SourceName": "WHO Anatomical Therapeutic Chemical (ATC) Classification",
        "SourceID": "ATCTree",
        "Name": "ATC Code",
        "Description": "In the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.",
        "URL": "https://www.whocc.no/atc_ddd_index/",
        "LicenseNote": "Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.",
        "LicenseURL": "https://www.whocc.no/copyright_disclaimer/"
      },
      {
        "ReferenceNumber": 146,
        "SourceName": "GHS Classification (UNECE)",
        "SourceID": "UN_GHS_tree",
        "Name": "GHS Classification Tree",
        "Description": "The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures. It sets up criteria for the classification of chemicals for physical-chemical, health, and environmental hazards of chemical substances and mixtures and sets up standardized hazard information to facilitate global trade of chemicals.  Please note that obsolete codes are added in this classification for completeness purposes, as they are still in use. Any obsolete codes are annotated as such.",
        "URL": "http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html"
      },
      {
        "ReferenceNumber": 147,
        "SourceName": "ChemIDplus",
        "SourceID": "ChemIDplus_tree",
        "Name": "ChemIDplus Chemical Information Classification",
        "Description": "ChemIDplus is a TOXNET (TOXicology Data NETwork) databases that contain chemicals and drugs related information. It is a product of the National Library of Medicine (NLM).",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html",
        "IsToxnet": true
      },
      {
        "ReferenceNumber": 148,
        "SourceName": "ChEMBL",
        "SourceID": "Target Tree",
        "Name": "ChEMBL Protein Target Tree",
        "Description": "The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 34\u000AChEMBL.",
        "URL": "https://www.ebi.ac.uk/chembl/g/#browse/targets",
        "LicenseNote": "Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).",
        "LicenseURL": "http://www.ebi.ac.uk/Information/termsofuse.html"
      },
      {
        "ReferenceNumber": 149,
        "SourceName": "IUPHAR/BPS Guide to PHARMACOLOGY",
        "SourceID": "Target Classification",
        "Name": "Guide to Pharmacology Target Classification",
        "Description": "An expert-driven guide to pharmacological targets and the substances that act on them",
        "URL": "https://www.guidetopharmacology.org/targets.jsp",
        "LicenseNote": "The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)",
        "LicenseURL": "https://www.guidetopharmacology.org/about.jsp#license"
      },
      {
        "ReferenceNumber": 150,
        "SourceName": "KEGG",
        "SourceID": "br08330",
        "Name": "Drug Groups",
        "Description": "KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.",
        "URL": "http://www.genome.jp/kegg-bin/get_htext?br08330.keg",
        "LicenseNote": "Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license",
        "LicenseURL": "https://www.kegg.jp/kegg/legal.html"
      },
      {
        "ReferenceNumber": 151,
        "SourceName": "EPA Chemical and Products Database (CPDat)",
        "SourceID": "cpdat_tree",
        "Name": "EPA CPDat Classification",
        "Description": "CPDat (Chemical and Products Database) is a database containing information mapping more than 49,000 chemicals to a set of terms categorizing their usage or function in 16,000 consumer products. Ref: The Chemical and Products Database, a resource for exposure-relevant data on chemicals in consumer products, Scientific Data, volume 5, Article number: 180125 (2018), DOI:10.1038/sdata.2018.125",
        "URL": "https://www.epa.gov/chemical-research/chemical-and-products-database-cpdat",
        "LicenseURL": "https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources"
      },
      {
        "ReferenceNumber": 152,
        "SourceName": "NORMAN Suspect List Exchange",
        "SourceID": "norman_sle_tree",
        "Name": "NORMAN Suspect List Exchange Classification",
        "Description": "The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.<br>Update: 2024-12-31 06:00:02",
        "URL": "https://www.norman-network.com/nds/SLE/",
        "LicenseNote": "Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0",
        "LicenseURL": "https://creativecommons.org/licenses/by/4.0/"
      },
      {
        "ReferenceNumber": 153,
        "SourceName": "Drug Enforcement Administration (DEA)",
        "SourceID": "dea_tree",
        "Name": "DEA drug and chemical classification",
        "Description": "The DEA drug and chemical classification tree contains DEA drug classes, the controlled substance schedules, substance classes, and chemical lists. The controlled substances are classified into 5 categories [Controlled Substances Act (21 USC sec. 801 et seq.) and 21 CFR Sections 1308.11-1308.15], and the chemical control program contains List I and List II chemicals [21 CFR Section 1310.02(a)].",
        "URL": "https://www.dea.gov/drug-information/drug-scheduling",
        "LicenseNote": "Unless otherwise indicated, information on Department of Justice websites is in the public domain and may be copied and distributed without permission. Citation of the Department of Justice as source of the information is appreciated, as appropriate.",
        "LicenseURL": "https://www.justice.gov/legalpolicies"
      },
      {
        "ReferenceNumber": 154,
        "SourceName": "CCSbase",
        "SourceID": "ccsbase_tree",
        "Name": "CCSbase Classification",
        "Description": "CCSbase is an integrated platform consisting of a comprehensive database of Collision Cross Section (CCS) measurements taken from a variety of sources and a high-quality and high-throughput CCS prediction model trained with this database using machine learning.",
        "URL": "https://ccsbase.net/"
      },
      {
        "ReferenceNumber": 155,
        "SourceName": "EPA DSSTox",
        "SourceID": "dsstoxlist_tree",
        "Name": "CompTox Chemicals Dashboard Chemical Lists",
        "Description": "This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.<br>Update: 2024-12-10 04:43:44",
        "URL": "https://comptox.epa.gov/dashboard/chemical-lists/",
        "LicenseURL": "https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources"
      },
      {
        "ReferenceNumber": 158,
        "SourceName": "NCI Thesaurus (NCIt)",
        "SourceID": "NCIt",
        "Name": "NCI Thesaurus",
        "Description": "The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.",
        "URL": "https://ncit.nci.nih.gov",
        "LicenseNote": "Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.",
        "LicenseURL": "https://www.cancer.gov/policies/copyright-reuse"
      },
      {
        "ReferenceNumber": 160,
        "SourceName": "EPA Substance Registry Services",
        "SourceID": "epasrs_tree",
        "Name": "EPA SRS List Classification",
        "Description": "Substance Registry Services (SRS) is the Environmental Protection Agency's (EPA) central system for information about substances that are tracked or regulated by EPA or other sources. It is a resource for basic information about chemicals, biological organisms, and other substances of interest to EPA and its state and tribal partners. SRS makes it possible to identify which EPA data systems, environmental statutes, or other sources have information about a substance and which synonym is used by that system or statute.",
        "URL": "https://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do",
        "LicenseURL": "https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources"
      },
      {
        "ReferenceNumber": 161,
        "SourceName": "MolGenie",
        "SourceID": "mol_classes",
        "Name": "MolGenie Organic Chemistry Ontology",
        "Description": "An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.",
        "URL": "https://github.com/MolGenie/ontology/",
        "LicenseNote": "CC-BY 4.0",
        "LicenseURL": "https://creativecommons.org/licenses/by/4.0/"
      },
      {
        "ReferenceNumber": 162,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "68009294",
        "Name": "Narcotics",
        "Description": "MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "https://www.ncbi.nlm.nih.gov/mesh/68009294",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 163,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "68000701",
        "Name": "Analgesics, Opioid",
        "Description": "MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "https://www.ncbi.nlm.nih.gov/mesh/68000701",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 164,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "68018686",
        "Name": "Anesthetics, Intravenous",
        "Description": "MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "https://www.ncbi.nlm.nih.gov/mesh/68018686",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 165,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "68000759",
        "Name": "Adjuvants, Anesthesia",
        "Description": "MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "https://www.ncbi.nlm.nih.gov/mesh/68000759",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 166,
        "SourceName": "PATENTSCOPE (WIPO)",
        "Name": "SID 403424318",
        "Description": "The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/403424318"
      },
      {
        "ReferenceNumber": 167,
        "SourceName": "NCBI",
        "SourceID": "LinkOut",
        "Description": "LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.",
        "URL": "https://www.ncbi.nlm.nih.gov/projects/linkout"
      }
    ]
  }
}
